registry_id,year,age,age_group,sex,cancer_type,morphology,grade,basis_of_diagnosis,behavior,residence,treatment_status,vital_status,survival_months,scenario
KE-NRB-2016-00001,2016,17,15-24,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,13.1,moderate_burden
KE-NRB-2012-00002,2012,12,0-14,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,28.5,moderate_burden
KE-NRB-2010-00003,2010,26,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.0,moderate_burden
KE-NRB-2014-00004,2014,28,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,20.8,moderate_burden
KE-NRB-2014-00005,2014,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,2.4,moderate_burden
KE-NRB-2013-00006,2013,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,16.7,moderate_burden
KE-NRB-2017-00007,2017,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.6,moderate_burden
KE-NRB-2012-00008,2012,39,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Radiotherapy,Dead,6.0,moderate_burden
KE-NRB-2018-00009,2018,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-00010,2018,72,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.5,moderate_burden
KE-NRB-2018-00011,2018,54,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.5,moderate_burden
KE-NRB-2011-00012,2011,64,55-64,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.2,moderate_burden
KE-NRB-2016-00013,2016,42,35-44,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-00014,2013,65,65-74,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,43.9,moderate_burden
KE-NRB-2010-00015,2010,33,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,13.4,moderate_burden
KE-NRB-2011-00016,2011,50,45-54,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,2.7,moderate_burden
KE-NRB-2017-00017,2017,51,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.5,moderate_burden
KE-NRB-2016-00018,2016,52,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.5,moderate_burden
KE-NRB-2010-00019,2010,68,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,1.6,moderate_burden
KE-NRB-2016-00020,2016,49,45-54,Male,Leukemia,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.9,moderate_burden
KE-NRB-2013-00021,2013,48,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.7,moderate_burden
KE-NRB-2014-00022,2014,86,75+,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,16.3,moderate_burden
KE-NRB-2013-00023,2013,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,33.7,moderate_burden
KE-NRB-2012-00024,2012,69,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,32.4,moderate_burden
KE-NRB-2018-00025,2018,39,35-44,Male,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.3,moderate_burden
KE-NRB-2018-00026,2018,34,25-34,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00027,2018,64,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.8,moderate_burden
KE-NRB-2009-00028,2009,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,23.2,moderate_burden
KE-NRB-2009-00029,2009,59,55-64,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-00030,2012,68,65-74,Male,Kidney,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,13.0,moderate_burden
KE-NRB-2015-00031,2015,55,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,23.5,moderate_burden
KE-NRB-2012-00032,2012,33,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.4,moderate_burden
KE-NRB-2018-00033,2018,54,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,40.0,moderate_burden
KE-NRB-2015-00034,2015,73,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,11.7,moderate_burden
KE-NRB-2015-00035,2015,43,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.5,moderate_burden
KE-NRB-2015-00036,2015,46,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,13.6,moderate_burden
KE-NRB-2015-00037,2015,27,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00038,2017,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,1.5,moderate_burden
KE-NRB-2012-00039,2012,58,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.4,moderate_burden
KE-NRB-2014-00040,2014,73,65-74,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00041,2012,39,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,20.0,moderate_burden
KE-NRB-2012-00042,2012,61,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Dead,4.1,moderate_burden
KE-NRB-2011-00043,2011,37,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.7,moderate_burden
KE-NRB-2016-00044,2016,39,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,11.3,moderate_burden
KE-NRB-2010-00045,2010,44,35-44,Female,Thyroid,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,27.6,moderate_burden
KE-NRB-2016-00046,2016,53,45-54,Male,Kidney,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.7,moderate_burden
KE-NRB-2018-00047,2018,69,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-00048,2013,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.9,moderate_burden
KE-NRB-2016-00049,2016,54,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,45.3,moderate_burden
KE-NRB-2014-00050,2014,51,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,35.5,moderate_burden
KE-NRB-2018-00051,2018,90,75+,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-00052,2017,93,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.4,moderate_burden
KE-NRB-2016-00053,2016,32,25-34,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,23.9,moderate_burden
KE-NRB-2011-00054,2011,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,19.3,moderate_burden
KE-NRB-2016-00055,2016,59,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,47.4,moderate_burden
KE-NRB-2016-00056,2016,57,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.8,moderate_burden
KE-NRB-2016-00057,2016,33,25-34,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,43.8,moderate_burden
KE-NRB-2018-00058,2018,90,75+,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.2,moderate_burden
KE-NRB-2009-00059,2009,23,15-24,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Peri-urban,N/A,Lost to follow-up,5.8,moderate_burden
KE-NRB-2017-00060,2017,59,55-64,Male,Lung,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.6,moderate_burden
KE-NRB-2016-00061,2016,46,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,4.6,moderate_burden
KE-NRB-2018-00062,2018,38,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.1,moderate_burden
KE-NRB-2014-00063,2014,55,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,19.1,moderate_burden
KE-NRB-2016-00064,2016,25,25-34,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.5,moderate_burden
KE-NRB-2016-00065,2016,62,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,8.8,moderate_burden
KE-NRB-2018-00066,2018,48,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Alive,8.1,moderate_burden
KE-NRB-2016-00067,2016,44,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-00068,2014,21,15-24,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Benign/uncertain,Urban,N/A,Alive,27.9,moderate_burden
KE-NRB-2013-00069,2013,56,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.6,moderate_burden
KE-NRB-2012-00070,2012,33,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.3,moderate_burden
KE-NRB-2018-00071,2018,78,75+,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,3.6,moderate_burden
KE-NRB-2018-00072,2018,35,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.4,moderate_burden
KE-NRB-2011-00073,2011,67,65-74,Male,Other,Leukemia,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,29.1,moderate_burden
KE-NRB-2009-00074,2009,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2010-00075,2010,70,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00076,2016,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-00077,2017,63,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00078,2012,64,55-64,Male,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.7,moderate_burden
KE-NRB-2014-00079,2014,33,25-34,Female,Thyroid,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,15.9,moderate_burden
KE-NRB-2016-00080,2016,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,52.1,moderate_burden
KE-NRB-2017-00081,2017,76,75+,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,29.0,moderate_burden
KE-NRB-2018-00082,2018,66,65-74,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,26.0,moderate_burden
KE-NRB-2016-00083,2016,73,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-00084,2018,47,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,58.7,moderate_burden
KE-NRB-2015-00085,2015,60,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-00086,2014,78,75+,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,7.6,moderate_burden
KE-NRB-2011-00087,2011,68,65-74,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-00088,2011,31,25-34,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.0,moderate_burden
KE-NRB-2014-00089,2014,23,15-24,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,18.3,moderate_burden
KE-NRB-2013-00090,2013,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00091,2017,61,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Alive,48.0,moderate_burden
KE-NRB-2015-00092,2015,66,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-00093,2018,68,65-74,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,10.7,moderate_burden
KE-NRB-2013-00094,2013,45,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00095,2017,37,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-00096,2018,88,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.6,moderate_burden
KE-NRB-2010-00097,2010,55,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Rural,N/A,Alive,38.3,moderate_burden
KE-NRB-2013-00098,2013,72,65-74,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,36.7,moderate_burden
KE-NRB-2011-00099,2011,68,65-74,Male,Oesophagus,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,55.1,moderate_burden
KE-NRB-2011-00100,2011,34,25-34,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.8,moderate_burden
KE-NRB-2015-00101,2015,25,25-34,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,31.4,moderate_burden
KE-NRB-2016-00102,2016,34,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,14.5,moderate_burden
KE-NRB-2009-00103,2009,69,65-74,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-00104,2016,73,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.1,moderate_burden
KE-NRB-2018-00105,2018,78,75+,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.0,moderate_burden
KE-NRB-2010-00106,2010,35,35-44,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,27.6,moderate_burden
KE-NRB-2017-00107,2017,91,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery only,Dead,48.4,moderate_burden
KE-NRB-2015-00108,2015,80,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,8.2,moderate_burden
KE-NRB-2012-00109,2012,55,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-00110,2016,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2010-00111,2010,43,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.7,moderate_burden
KE-NRB-2017-00112,2017,41,35-44,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.8,moderate_burden
KE-NRB-2017-00113,2017,46,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.3,moderate_burden
KE-NRB-2016-00114,2016,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-00115,2017,36,35-44,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.7,moderate_burden
KE-NRB-2018-00116,2018,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2013-00117,2013,34,25-34,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.7,moderate_burden
KE-NRB-2011-00118,2011,68,65-74,Male,Lung,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,29.0,moderate_burden
KE-NRB-2018-00119,2018,71,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,45.6,moderate_burden
KE-NRB-2014-00120,2014,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,2.8,moderate_burden
KE-NRB-2015-00121,2015,55,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,10.0,moderate_burden
KE-NRB-2018-00122,2018,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-00123,2015,39,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.7,moderate_burden
KE-NRB-2018-00124,2018,48,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.2,moderate_burden
KE-NRB-2016-00125,2016,62,55-64,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,15.0,moderate_burden
KE-NRB-2013-00126,2013,53,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.9,moderate_burden
KE-NRB-2011-00127,2011,38,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,7.9,moderate_burden
KE-NRB-2017-00128,2017,18,15-24,Male,Liver,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-00129,2015,52,45-54,Male,Stomach,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,6.7,moderate_burden
KE-NRB-2017-00130,2017,25,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,11.6,moderate_burden
KE-NRB-2017-00131,2017,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,17.0,moderate_burden
KE-NRB-2017-00132,2017,44,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-00133,2014,71,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,2.5,moderate_burden
KE-NRB-2017-00134,2017,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-00135,2014,81,75+,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,8.8,moderate_burden
KE-NRB-2009-00136,2009,50,45-54,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,10.7,moderate_burden
KE-NRB-2011-00137,2011,66,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,32.0,moderate_burden
KE-NRB-2016-00138,2016,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.5,moderate_burden
KE-NRB-2011-00139,2011,57,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-00140,2016,31,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00141,2017,53,45-54,Male,Bladder,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.2,moderate_burden
KE-NRB-2013-00142,2013,84,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,11.6,moderate_burden
KE-NRB-2010-00143,2010,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.0,moderate_burden
KE-NRB-2017-00144,2017,89,75+,Male,Kaposi sarcoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,52.1,moderate_burden
KE-NRB-2013-00145,2013,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,27.3,moderate_burden
KE-NRB-2012-00146,2012,52,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,40.4,moderate_burden
KE-NRB-2016-00147,2016,58,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00148,2015,70,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,1.0,moderate_burden
KE-NRB-2017-00149,2017,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,35.6,moderate_burden
KE-NRB-2016-00150,2016,59,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-00151,2010,39,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,4.2,moderate_burden
KE-NRB-2015-00152,2015,66,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00153,2017,62,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,46.8,moderate_burden
KE-NRB-2017-00154,2017,44,35-44,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.8,moderate_burden
KE-NRB-2010-00155,2010,51,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.7,moderate_burden
KE-NRB-2015-00156,2015,92,75+,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-00157,2009,81,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,17.8,moderate_burden
KE-NRB-2013-00158,2013,35,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.8,moderate_burden
KE-NRB-2012-00159,2012,59,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,0.6,moderate_burden
KE-NRB-2017-00160,2017,71,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,4.2,moderate_burden
KE-NRB-2018-00161,2018,51,45-54,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-00162,2011,92,75+,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,42.2,moderate_burden
KE-NRB-2018-00163,2018,37,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-00164,2012,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.7,moderate_burden
KE-NRB-2014-00165,2014,52,45-54,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Palliative care only,Alive,38.2,moderate_burden
KE-NRB-2017-00166,2017,73,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,2.7,moderate_burden
KE-NRB-2016-00167,2016,64,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,52.8,moderate_burden
KE-NRB-2017-00168,2017,57,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-00169,2014,40,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Imaging + clinical,In situ,Peri-urban,N/A,Alive,0.2,moderate_burden
KE-NRB-2014-00170,2014,43,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,13.4,moderate_burden
KE-NRB-2017-00171,2017,49,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,4.3,moderate_burden
KE-NRB-2012-00172,2012,80,75+,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.5,moderate_burden
KE-NRB-2016-00173,2016,68,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.1,moderate_burden
KE-NRB-2017-00174,2017,29,25-34,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,19.1,moderate_burden
KE-NRB-2013-00175,2013,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.0,moderate_burden
KE-NRB-2012-00176,2012,30,25-34,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,3.0,moderate_burden
KE-NRB-2011-00177,2011,56,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,11.7,moderate_burden
KE-NRB-2018-00178,2018,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,22.5,moderate_burden
KE-NRB-2012-00179,2012,64,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Chemotherapy only,Dead,15.5,moderate_burden
KE-NRB-2017-00180,2017,35,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.0,moderate_burden
KE-NRB-2012-00181,2012,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,7.1,moderate_burden
KE-NRB-2017-00182,2017,33,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,9.0,moderate_burden
KE-NRB-2010-00183,2010,74,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,0.6,moderate_burden
KE-NRB-2009-00184,2009,31,25-34,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,21.8,moderate_burden
KE-NRB-2014-00185,2014,66,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,46.1,moderate_burden
KE-NRB-2014-00186,2014,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,40.9,moderate_burden
KE-NRB-2013-00187,2013,55,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,1.8,moderate_burden
KE-NRB-2017-00188,2017,66,65-74,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Alive,4.8,moderate_burden
KE-NRB-2014-00189,2014,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,38.0,moderate_burden
KE-NRB-2017-00190,2017,38,35-44,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,33.3,moderate_burden
KE-NRB-2014-00191,2014,25,25-34,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,27.4,moderate_burden
KE-NRB-2014-00192,2014,67,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.5,moderate_burden
KE-NRB-2018-00193,2018,63,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-00194,2013,58,55-64,Male,Colorectum,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.0,moderate_burden
KE-NRB-2018-00195,2018,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.9,moderate_burden
KE-NRB-2015-00196,2015,39,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,5.2,moderate_burden
KE-NRB-2016-00197,2016,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.5,moderate_burden
KE-NRB-2009-00198,2009,51,45-54,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,8.7,moderate_burden
KE-NRB-2018-00199,2018,70,65-74,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.6,moderate_burden
KE-NRB-2018-00200,2018,50,45-54,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.0,moderate_burden
KE-NRB-2016-00201,2016,63,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-00202,2010,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.7,moderate_burden
KE-NRB-2011-00203,2011,47,45-54,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00204,2017,41,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00205,2017,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,20.9,moderate_burden
KE-NRB-2015-00206,2015,51,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00207,2013,0,0-14,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.8,moderate_burden
KE-NRB-2015-00208,2015,49,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,7.1,moderate_burden
KE-NRB-2014-00209,2014,64,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.5,moderate_burden
KE-NRB-2017-00210,2017,88,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,8.7,moderate_burden
KE-NRB-2014-00211,2014,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.8,moderate_burden
KE-NRB-2015-00212,2015,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00213,2013,92,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-00214,2009,48,45-54,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.6,moderate_burden
KE-NRB-2018-00215,2018,52,45-54,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,34.8,moderate_burden
KE-NRB-2014-00216,2014,25,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.2,moderate_burden
KE-NRB-2010-00217,2010,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,12.9,moderate_burden
KE-NRB-2011-00218,2011,74,65-74,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.8,moderate_burden
KE-NRB-2018-00219,2018,23,15-24,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,33.4,moderate_burden
KE-NRB-2018-00220,2018,62,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,12.2,moderate_burden
KE-NRB-2012-00221,2012,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,33.1,moderate_burden
KE-NRB-2013-00222,2013,38,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,15.9,moderate_burden
KE-NRB-2015-00223,2015,42,35-44,Male,Liver,Non-keratinizing carcinoma,Unknown,Other,Malignant,Urban,Surgery only,Lost to follow-up,16.9,moderate_burden
KE-NRB-2013-00224,2013,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,16.3,moderate_burden
KE-NRB-2015-00225,2015,74,65-74,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,6.2,moderate_burden
KE-NRB-2011-00226,2011,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,6.5,moderate_burden
KE-NRB-2010-00227,2010,71,65-74,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.1,moderate_burden
KE-NRB-2011-00228,2011,71,65-74,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Alive,16.0,moderate_burden
KE-NRB-2017-00229,2017,28,25-34,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.9,moderate_burden
KE-NRB-2011-00230,2011,54,45-54,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,54.3,moderate_burden
KE-NRB-2013-00231,2013,49,45-54,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,7.6,moderate_burden
KE-NRB-2018-00232,2018,53,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Dead,32.6,moderate_burden
KE-NRB-2016-00233,2016,54,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,2.2,moderate_burden
KE-NRB-2012-00234,2012,40,35-44,Female,Ovary,Sarcoma,Well differentiated (Grade I),Death certificate only,In situ,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-00235,2011,51,45-54,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.0,moderate_burden
KE-NRB-2012-00236,2012,54,45-54,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2012-00237,2012,33,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.4,moderate_burden
KE-NRB-2015-00238,2015,58,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,28.7,moderate_burden
KE-NRB-2011-00239,2011,60,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.1,moderate_burden
KE-NRB-2014-00240,2014,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.2,moderate_burden
KE-NRB-2014-00241,2014,48,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,2.6,moderate_burden
KE-NRB-2013-00242,2013,53,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,12.9,moderate_burden
KE-NRB-2009-00243,2009,36,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00244,2011,75,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,44.5,moderate_burden
KE-NRB-2013-00245,2013,54,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,1.4,moderate_burden
KE-NRB-2014-00246,2014,35,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,40.4,moderate_burden
KE-NRB-2014-00247,2014,57,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,3.0,moderate_burden
KE-NRB-2010-00248,2010,74,65-74,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00249,2013,67,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.5,moderate_burden
KE-NRB-2014-00250,2014,45,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.7,moderate_burden
KE-NRB-2013-00251,2013,65,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.1,moderate_burden
KE-NRB-2016-00252,2016,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00253,2017,60,55-64,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,31.5,moderate_burden
KE-NRB-2017-00254,2017,29,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,29.6,moderate_burden
KE-NRB-2016-00255,2016,73,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,52.0,moderate_burden
KE-NRB-2010-00256,2010,74,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.5,moderate_burden
KE-NRB-2015-00257,2015,63,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,3.8,moderate_burden
KE-NRB-2011-00258,2011,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,32.6,moderate_burden
KE-NRB-2016-00259,2016,5,0-14,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,12.3,moderate_burden
KE-NRB-2010-00260,2010,92,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,28.5,moderate_burden
KE-NRB-2017-00261,2017,69,65-74,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,36.4,moderate_burden
KE-NRB-2018-00262,2018,32,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,18.5,moderate_burden
KE-NRB-2016-00263,2016,1,0-14,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-00264,2012,70,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,43.6,moderate_burden
KE-NRB-2016-00265,2016,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,25.3,moderate_burden
KE-NRB-2013-00266,2013,45,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-00267,2011,29,25-34,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-00268,2016,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.4,moderate_burden
KE-NRB-2015-00269,2015,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,1.5,moderate_burden
KE-NRB-2011-00270,2011,95,75+,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.7,moderate_burden
KE-NRB-2011-00271,2011,93,75+,Male,Skin (melanoma),Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,23.8,moderate_burden
KE-NRB-2013-00272,2013,56,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00273,2012,74,65-74,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.9,moderate_burden
KE-NRB-2012-00274,2012,59,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,20.1,moderate_burden
KE-NRB-2011-00275,2011,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Peri-urban,N/A,Dead,15.2,moderate_burden
KE-NRB-2015-00276,2015,63,55-64,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.6,moderate_burden
KE-NRB-2014-00277,2014,71,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,8.1,moderate_burden
KE-NRB-2013-00278,2013,45,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,39.7,moderate_burden
KE-NRB-2015-00279,2015,43,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,3.4,moderate_burden
KE-NRB-2012-00280,2012,32,25-34,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,30.8,moderate_burden
KE-NRB-2015-00281,2015,74,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,12.7,moderate_burden
KE-NRB-2009-00282,2009,35,35-44,Female,Breast,Sarcoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-00283,2018,46,45-54,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-00284,2013,44,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,29.2,moderate_burden
KE-NRB-2017-00285,2017,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.0,moderate_burden
KE-NRB-2012-00286,2012,53,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.8,moderate_burden
KE-NRB-2015-00287,2015,68,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-00288,2018,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,5.9,moderate_burden
KE-NRB-2018-00289,2018,42,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,14.4,moderate_burden
KE-NRB-2012-00290,2012,53,45-54,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.3,moderate_burden
KE-NRB-2017-00291,2017,25,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,28.4,moderate_burden
KE-NRB-2010-00292,2010,44,35-44,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,19.2,moderate_burden
KE-NRB-2012-00293,2012,65,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,21.4,moderate_burden
KE-NRB-2015-00294,2015,66,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2014-00295,2014,44,35-44,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,29.8,moderate_burden
KE-NRB-2011-00296,2011,33,25-34,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.6,moderate_burden
KE-NRB-2016-00297,2016,57,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,24.6,moderate_burden
KE-NRB-2011-00298,2011,69,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,24.1,moderate_burden
KE-NRB-2017-00299,2017,70,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-00300,2012,40,35-44,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,47.9,moderate_burden
KE-NRB-2017-00301,2017,73,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00302,2017,25,25-34,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.9,moderate_burden
KE-NRB-2015-00303,2015,72,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,31.6,moderate_burden
KE-NRB-2015-00304,2015,52,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00305,2017,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.5,moderate_burden
KE-NRB-2013-00306,2013,24,15-24,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,40.2,moderate_burden
KE-NRB-2014-00307,2014,70,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery only,Lost to follow-up,0.4,moderate_burden
KE-NRB-2010-00308,2010,72,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,38.3,moderate_burden
KE-NRB-2013-00309,2013,63,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,11.7,moderate_burden
KE-NRB-2012-00310,2012,60,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,19.3,moderate_burden
KE-NRB-2017-00311,2017,61,55-64,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-00312,2015,56,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.4,moderate_burden
KE-NRB-2013-00313,2013,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.9,moderate_burden
KE-NRB-2014-00314,2014,50,45-54,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,23.3,moderate_burden
KE-NRB-2016-00315,2016,48,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Dead,12.0,moderate_burden
KE-NRB-2012-00316,2012,74,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,9.5,moderate_burden
KE-NRB-2018-00317,2018,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,50.0,moderate_burden
KE-NRB-2016-00318,2016,30,25-34,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,21.5,moderate_burden
KE-NRB-2016-00319,2016,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,31.3,moderate_burden
KE-NRB-2018-00320,2018,47,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,35.6,moderate_burden
KE-NRB-2013-00321,2013,61,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.7,moderate_burden
KE-NRB-2012-00322,2012,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.7,moderate_burden
KE-NRB-2009-00323,2009,47,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,1.4,moderate_burden
KE-NRB-2012-00324,2012,64,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.4,moderate_burden
KE-NRB-2011-00325,2011,53,45-54,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00326,2016,69,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00327,2011,37,35-44,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.4,moderate_burden
KE-NRB-2013-00328,2013,56,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,moderate_burden
KE-NRB-2015-00329,2015,32,25-34,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.2,moderate_burden
KE-NRB-2016-00330,2016,31,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.6,moderate_burden
KE-NRB-2011-00331,2011,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.2,moderate_burden
KE-NRB-2018-00332,2018,46,45-54,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.8,moderate_burden
KE-NRB-2016-00333,2016,68,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,38.1,moderate_burden
KE-NRB-2018-00334,2018,56,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,7.6,moderate_burden
KE-NRB-2016-00335,2016,47,45-54,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,2.9,moderate_burden
KE-NRB-2015-00336,2015,38,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,24.5,moderate_burden
KE-NRB-2014-00337,2014,72,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,22.9,moderate_burden
KE-NRB-2017-00338,2017,31,25-34,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,9.9,moderate_burden
KE-NRB-2012-00339,2012,84,75+,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,20.3,moderate_burden
KE-NRB-2012-00340,2012,45,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,16.2,moderate_burden
KE-NRB-2011-00341,2011,33,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-00342,2017,49,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,16.7,moderate_burden
KE-NRB-2013-00343,2013,44,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00344,2012,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Alive,11.8,moderate_burden
KE-NRB-2011-00345,2011,72,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,34.2,moderate_burden
KE-NRB-2010-00346,2010,61,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,54.5,moderate_burden
KE-NRB-2010-00347,2010,63,55-64,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,11.3,moderate_burden
KE-NRB-2011-00348,2011,54,45-54,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Alive,50.2,moderate_burden
KE-NRB-2016-00349,2016,44,35-44,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,50.3,moderate_burden
KE-NRB-2016-00350,2016,37,35-44,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,5.1,moderate_burden
KE-NRB-2018-00351,2018,93,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,52.6,moderate_burden
KE-NRB-2018-00352,2018,61,55-64,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.6,moderate_burden
KE-NRB-2014-00353,2014,60,55-64,Male,Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,6.8,moderate_burden
KE-NRB-2013-00354,2013,41,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.7,moderate_burden
KE-NRB-2016-00355,2016,32,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.0,moderate_burden
KE-NRB-2009-00356,2009,41,35-44,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-00357,2014,63,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.6,moderate_burden
KE-NRB-2009-00358,2009,77,75+,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,14.2,moderate_burden
KE-NRB-2016-00359,2016,86,75+,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,8.0,moderate_burden
KE-NRB-2014-00360,2014,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.5,moderate_burden
KE-NRB-2011-00361,2011,42,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.1,moderate_burden
KE-NRB-2018-00362,2018,45,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,53.9,moderate_burden
KE-NRB-2017-00363,2017,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.2,moderate_burden
KE-NRB-2015-00364,2015,72,65-74,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,2.1,moderate_burden
KE-NRB-2016-00365,2016,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Alive,10.1,moderate_burden
KE-NRB-2015-00366,2015,62,55-64,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,31.1,moderate_burden
KE-NRB-2011-00367,2011,44,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,1.9,moderate_burden
KE-NRB-2016-00368,2016,58,55-64,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-00369,2009,70,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.6,moderate_burden
KE-NRB-2018-00370,2018,71,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.9,moderate_burden
KE-NRB-2011-00371,2011,56,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,4.4,moderate_burden
KE-NRB-2013-00372,2013,49,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Radiotherapy,Dead,33.0,moderate_burden
KE-NRB-2014-00373,2014,45,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.0,moderate_burden
KE-NRB-2015-00374,2015,59,55-64,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00375,2018,21,15-24,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,36.1,moderate_burden
KE-NRB-2013-00376,2013,75,75+,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,8.2,moderate_burden
KE-NRB-2014-00377,2014,56,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,7.8,moderate_burden
KE-NRB-2014-00378,2014,52,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,37.4,moderate_burden
KE-NRB-2012-00379,2012,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-00380,2018,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,15.4,moderate_burden
KE-NRB-2013-00381,2013,38,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,4.8,moderate_burden
KE-NRB-2015-00382,2015,15,15-24,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,13.3,moderate_burden
KE-NRB-2011-00383,2011,65,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.7,moderate_burden
KE-NRB-2016-00384,2016,24,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,8.0,moderate_burden
KE-NRB-2009-00385,2009,34,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2014-00386,2014,49,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,18.7,moderate_burden
KE-NRB-2016-00387,2016,25,25-34,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.5,moderate_burden
KE-NRB-2011-00388,2011,33,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.9,moderate_burden
KE-NRB-2014-00389,2014,41,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Dead,3.0,moderate_burden
KE-NRB-2017-00390,2017,74,65-74,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.2,moderate_burden
KE-NRB-2009-00391,2009,45,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,17.3,moderate_burden
KE-NRB-2015-00392,2015,66,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.1,moderate_burden
KE-NRB-2009-00393,2009,59,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.6,moderate_burden
KE-NRB-2010-00394,2010,84,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00395,2017,74,65-74,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-00396,2014,73,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2010-00397,2010,63,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,44.2,moderate_burden
KE-NRB-2010-00398,2010,66,65-74,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,23.1,moderate_burden
KE-NRB-2018-00399,2018,57,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2016-00400,2016,0,0-14,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.6,moderate_burden
KE-NRB-2015-00401,2015,48,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.3,moderate_burden
KE-NRB-2018-00402,2018,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-00403,2012,50,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,5.7,moderate_burden
KE-NRB-2016-00404,2016,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,40.8,moderate_burden
KE-NRB-2014-00405,2014,26,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,11.5,moderate_burden
KE-NRB-2016-00406,2016,35,35-44,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.5,moderate_burden
KE-NRB-2017-00407,2017,44,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,33.9,moderate_burden
KE-NRB-2013-00408,2013,25,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.2,moderate_burden
KE-NRB-2014-00409,2014,53,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,1.5,moderate_burden
KE-NRB-2018-00410,2018,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.6,moderate_burden
KE-NRB-2011-00411,2011,36,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00412,2018,51,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.9,moderate_burden
KE-NRB-2017-00413,2017,94,75+,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.8,moderate_burden
KE-NRB-2016-00414,2016,62,55-64,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2011-00415,2011,56,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,31.0,moderate_burden
KE-NRB-2014-00416,2014,57,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,39.4,moderate_burden
KE-NRB-2015-00417,2015,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,51.3,moderate_burden
KE-NRB-2011-00418,2011,59,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Dead,26.4,moderate_burden
KE-NRB-2010-00419,2010,45,45-54,Male,Pancreas,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,28.2,moderate_burden
KE-NRB-2009-00420,2009,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,23.3,moderate_burden
KE-NRB-2018-00421,2018,42,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2016-00422,2016,27,25-34,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,46.0,moderate_burden
KE-NRB-2018-00423,2018,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,29.7,moderate_burden
KE-NRB-2018-00424,2018,71,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.7,moderate_burden
KE-NRB-2014-00425,2014,36,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,30.6,moderate_burden
KE-NRB-2017-00426,2017,51,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.7,moderate_burden
KE-NRB-2016-00427,2016,42,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.9,moderate_burden
KE-NRB-2009-00428,2009,55,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2017-00429,2017,45,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-00430,2011,58,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-00431,2009,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.2,moderate_burden
KE-NRB-2013-00432,2013,27,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,29.8,moderate_burden
KE-NRB-2009-00433,2009,69,65-74,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,50.1,moderate_burden
KE-NRB-2013-00434,2013,73,65-74,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,49.7,moderate_burden
KE-NRB-2013-00435,2013,34,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.9,moderate_burden
KE-NRB-2010-00436,2010,42,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.5,moderate_burden
KE-NRB-2015-00437,2015,37,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-00438,2009,32,25-34,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,9.6,moderate_burden
KE-NRB-2013-00439,2013,45,45-54,Female,Thyroid,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.9,moderate_burden
KE-NRB-2014-00440,2014,36,35-44,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-00441,2016,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,26.8,moderate_burden
KE-NRB-2012-00442,2012,60,55-64,Male,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,51.7,moderate_burden
KE-NRB-2010-00443,2010,74,65-74,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.9,moderate_burden
KE-NRB-2014-00444,2014,37,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,33.7,moderate_burden
KE-NRB-2015-00445,2015,32,25-34,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,19.2,moderate_burden
KE-NRB-2017-00446,2017,37,35-44,Female,Other,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.4,moderate_burden
KE-NRB-2014-00447,2014,66,65-74,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,49.0,moderate_burden
KE-NRB-2009-00448,2009,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00449,2011,72,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,34.0,moderate_burden
KE-NRB-2017-00450,2017,53,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,42.3,moderate_burden
KE-NRB-2015-00451,2015,69,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,27.6,moderate_burden
KE-NRB-2018-00452,2018,59,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,4.4,moderate_burden
KE-NRB-2014-00453,2014,35,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,40.1,moderate_burden
KE-NRB-2018-00454,2018,38,35-44,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.8,moderate_burden
KE-NRB-2015-00455,2015,53,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00456,2015,85,75+,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,59.8,moderate_burden
KE-NRB-2013-00457,2013,28,25-34,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,7.8,moderate_burden
KE-NRB-2016-00458,2016,52,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,29.2,moderate_burden
KE-NRB-2017-00459,2017,35,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00460,2018,39,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.8,moderate_burden
KE-NRB-2015-00461,2015,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.3,moderate_burden
KE-NRB-2017-00462,2017,31,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,33.0,moderate_burden
KE-NRB-2017-00463,2017,55,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.3,moderate_burden
KE-NRB-2016-00464,2016,62,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.0,moderate_burden
KE-NRB-2018-00465,2018,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,55.7,moderate_burden
KE-NRB-2018-00466,2018,54,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,2.4,moderate_burden
KE-NRB-2013-00467,2013,53,45-54,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Palliative care only,Dead,3.9,moderate_burden
KE-NRB-2017-00468,2017,52,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-00469,2013,52,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-00470,2010,60,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-00471,2016,48,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,34.1,moderate_burden
KE-NRB-2012-00472,2012,61,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,18.0,moderate_burden
KE-NRB-2012-00473,2012,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.9,moderate_burden
KE-NRB-2011-00474,2011,95,75+,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,21.1,moderate_burden
KE-NRB-2014-00475,2014,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.3,moderate_burden
KE-NRB-2016-00476,2016,74,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,13.8,moderate_burden
KE-NRB-2018-00477,2018,51,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,44.8,moderate_burden
KE-NRB-2014-00478,2014,42,35-44,Female,Ovary,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.7,moderate_burden
KE-NRB-2011-00479,2011,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Dead,1.6,moderate_burden
KE-NRB-2014-00480,2014,57,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.1,moderate_burden
KE-NRB-2012-00481,2012,48,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,21.9,moderate_burden
KE-NRB-2014-00482,2014,50,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.0,moderate_burden
KE-NRB-2018-00483,2018,49,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,37.0,moderate_burden
KE-NRB-2009-00484,2009,16,15-24,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.3,moderate_burden
KE-NRB-2013-00485,2013,57,55-64,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.1,moderate_burden
KE-NRB-2017-00486,2017,24,15-24,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,35.8,moderate_burden
KE-NRB-2016-00487,2016,47,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-00488,2014,71,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,48.7,moderate_burden
KE-NRB-2018-00489,2018,17,15-24,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.7,moderate_burden
KE-NRB-2018-00490,2018,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,moderate_burden
KE-NRB-2009-00491,2009,70,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-00492,2015,60,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00493,2015,59,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Rural,Surgery only,Dead,11.9,moderate_burden
KE-NRB-2017-00494,2017,25,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.0,moderate_burden
KE-NRB-2016-00495,2016,73,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,41.9,moderate_burden
KE-NRB-2017-00496,2017,66,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.9,moderate_burden
KE-NRB-2018-00497,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,0.7,moderate_burden
KE-NRB-2010-00498,2010,65,65-74,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,17.6,moderate_burden
KE-NRB-2009-00499,2009,52,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.3,moderate_burden
KE-NRB-2013-00500,2013,63,55-64,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,14.7,moderate_burden
KE-NRB-2011-00501,2011,47,45-54,Male,Pancreas,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,44.6,moderate_burden
KE-NRB-2014-00502,2014,34,25-34,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-00503,2015,24,15-24,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,15.8,moderate_burden
KE-NRB-2011-00504,2011,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,16.2,moderate_burden
KE-NRB-2014-00505,2014,60,55-64,Male,Liver,Adenocarcinoma,Unknown,Death certificate only,In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-00506,2016,29,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,27.5,moderate_burden
KE-NRB-2017-00507,2017,29,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.2,moderate_burden
KE-NRB-2014-00508,2014,70,65-74,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-00509,2014,49,45-54,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,54.1,moderate_burden
KE-NRB-2016-00510,2016,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Palliative care only,Dead,8.8,moderate_burden
KE-NRB-2018-00511,2018,43,35-44,Male,Pancreas,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00512,2016,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.9,moderate_burden
KE-NRB-2018-00513,2018,69,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,46.8,moderate_burden
KE-NRB-2010-00514,2010,56,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,3.0,moderate_burden
KE-NRB-2012-00515,2012,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.1,moderate_burden
KE-NRB-2010-00516,2010,50,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,47.7,moderate_burden
KE-NRB-2015-00517,2015,66,65-74,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,2.6,moderate_burden
KE-NRB-2015-00518,2015,48,45-54,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,47.6,moderate_burden
KE-NRB-2015-00519,2015,64,55-64,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.7,moderate_burden
KE-NRB-2016-00520,2016,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,10.6,moderate_burden
KE-NRB-2013-00521,2013,67,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.4,moderate_burden
KE-NRB-2018-00522,2018,39,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.9,moderate_burden
KE-NRB-2013-00523,2013,59,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,17.6,moderate_burden
KE-NRB-2015-00524,2015,55,55-64,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,15.1,moderate_burden
KE-NRB-2016-00525,2016,39,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,51.4,moderate_burden
KE-NRB-2015-00526,2015,30,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,22.8,moderate_burden
KE-NRB-2018-00527,2018,26,25-34,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.2,moderate_burden
KE-NRB-2013-00528,2013,56,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Palliative care only,Dead,1.0,moderate_burden
KE-NRB-2013-00529,2013,53,45-54,Male,Stomach,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.7,moderate_burden
KE-NRB-2018-00530,2018,66,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.0,moderate_burden
KE-NRB-2014-00531,2014,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00532,2013,58,55-64,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.3,moderate_burden
KE-NRB-2014-00533,2014,61,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,10.7,moderate_burden
KE-NRB-2014-00534,2014,47,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,31.4,moderate_burden
KE-NRB-2018-00535,2018,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,28.5,moderate_burden
KE-NRB-2017-00536,2017,63,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,13.8,moderate_burden
KE-NRB-2010-00537,2010,72,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,7.1,moderate_burden
KE-NRB-2015-00538,2015,81,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.8,moderate_burden
KE-NRB-2015-00539,2015,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.6,moderate_burden
KE-NRB-2010-00540,2010,58,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.9,moderate_burden
KE-NRB-2011-00541,2011,63,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.8,moderate_burden
KE-NRB-2011-00542,2011,37,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-00543,2012,1,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,57.7,moderate_burden
KE-NRB-2016-00544,2016,65,65-74,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,41.7,moderate_burden
KE-NRB-2017-00545,2017,48,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,2.9,moderate_burden
KE-NRB-2018-00546,2018,94,75+,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.6,moderate_burden
KE-NRB-2013-00547,2013,61,55-64,Male,Lung,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,51.9,moderate_burden
KE-NRB-2011-00548,2011,70,65-74,Male,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,51.5,moderate_burden
KE-NRB-2016-00549,2016,28,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,31.6,moderate_burden
KE-NRB-2011-00550,2011,57,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,6.0,moderate_burden
KE-NRB-2014-00551,2014,66,65-74,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.7,moderate_burden
KE-NRB-2014-00552,2014,61,55-64,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.1,moderate_burden
KE-NRB-2015-00553,2015,51,45-54,Male,Pancreas,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,3.3,moderate_burden
KE-NRB-2015-00554,2015,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,24.8,moderate_burden
KE-NRB-2013-00555,2013,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00556,2012,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,19.4,moderate_burden
KE-NRB-2015-00557,2015,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-00558,2016,44,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,6.0,moderate_burden
KE-NRB-2012-00559,2012,65,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.4,moderate_burden
KE-NRB-2012-00560,2012,44,35-44,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.4,moderate_burden
KE-NRB-2011-00561,2011,75,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,23.1,moderate_burden
KE-NRB-2014-00562,2014,64,55-64,Female,Cervix uteri,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,18.9,moderate_burden
KE-NRB-2014-00563,2014,37,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,18.0,moderate_burden
KE-NRB-2016-00564,2016,56,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,53.9,moderate_burden
KE-NRB-2018-00565,2018,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00566,2015,47,45-54,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.5,moderate_burden
KE-NRB-2016-00567,2016,47,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,0.7,moderate_burden
KE-NRB-2010-00568,2010,37,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,8.2,moderate_burden
KE-NRB-2015-00569,2015,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Alive,22.0,moderate_burden
KE-NRB-2017-00570,2017,35,35-44,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,55.3,moderate_burden
KE-NRB-2015-00571,2015,36,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,31.9,moderate_burden
KE-NRB-2014-00572,2014,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,3.7,moderate_burden
KE-NRB-2014-00573,2014,80,75+,Female,Other,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,5.8,moderate_burden
KE-NRB-2012-00574,2012,53,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,5.5,moderate_burden
KE-NRB-2014-00575,2014,9,0-14,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.6,moderate_burden
KE-NRB-2015-00576,2015,49,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.4,moderate_burden
KE-NRB-2015-00577,2015,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.2,moderate_burden
KE-NRB-2010-00578,2010,71,65-74,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.2,moderate_burden
KE-NRB-2014-00579,2014,64,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,40.5,moderate_burden
KE-NRB-2017-00580,2017,33,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,6.6,moderate_burden
KE-NRB-2018-00581,2018,62,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,14.0,moderate_burden
KE-NRB-2014-00582,2014,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,11.0,moderate_burden
KE-NRB-2010-00583,2010,57,55-64,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Dead,25.9,moderate_burden
KE-NRB-2016-00584,2016,81,75+,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00585,2013,23,15-24,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,38.7,moderate_burden
KE-NRB-2017-00586,2017,61,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-00587,2010,35,35-44,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.1,moderate_burden
KE-NRB-2010-00588,2010,83,75+,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,6.1,moderate_burden
KE-NRB-2013-00589,2013,49,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,12.3,moderate_burden
KE-NRB-2009-00590,2009,44,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,26.1,moderate_burden
KE-NRB-2015-00591,2015,62,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-00592,2017,51,45-54,Male,Pancreas,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,40.9,moderate_burden
KE-NRB-2013-00593,2013,54,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.9,moderate_burden
KE-NRB-2013-00594,2013,76,75+,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.4,moderate_burden
KE-NRB-2013-00595,2013,36,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,4.2,moderate_burden
KE-NRB-2015-00596,2015,64,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,37.9,moderate_burden
KE-NRB-2013-00597,2013,44,35-44,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,4.9,moderate_burden
KE-NRB-2016-00598,2016,41,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,47.8,moderate_burden
KE-NRB-2012-00599,2012,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00600,2016,28,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,40.7,moderate_burden
KE-NRB-2018-00601,2018,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,0.0,moderate_burden
KE-NRB-2009-00602,2009,73,65-74,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00603,2016,49,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,26.2,moderate_burden
KE-NRB-2012-00604,2012,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.8,moderate_burden
KE-NRB-2009-00605,2009,48,45-54,Male,Pancreas,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2015-00606,2015,81,75+,Male,Non-Hodgkin lymphoma,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,33.3,moderate_burden
KE-NRB-2013-00607,2013,66,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,17.1,moderate_burden
KE-NRB-2011-00608,2011,3,0-14,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.7,moderate_burden
KE-NRB-2015-00609,2015,23,15-24,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,29.8,moderate_burden
KE-NRB-2009-00610,2009,19,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-00611,2017,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,29.5,moderate_burden
KE-NRB-2010-00612,2010,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.1,moderate_burden
KE-NRB-2009-00613,2009,46,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,moderate_burden
KE-NRB-2015-00614,2015,63,55-64,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00615,2018,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.6,moderate_burden
KE-NRB-2011-00616,2011,11,0-14,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,29.5,moderate_burden
KE-NRB-2015-00617,2015,24,15-24,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.3,moderate_burden
KE-NRB-2011-00618,2011,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,21.7,moderate_burden
KE-NRB-2010-00619,2010,70,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.4,moderate_burden
KE-NRB-2009-00620,2009,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,10.2,moderate_burden
KE-NRB-2014-00621,2014,43,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-00622,2018,12,0-14,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00623,2017,57,55-64,Male,Prostate,Leukemia,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Alive,2.1,moderate_burden
KE-NRB-2015-00624,2015,71,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,18.7,moderate_burden
KE-NRB-2013-00625,2013,85,75+,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-00626,2011,52,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,8.7,moderate_burden
KE-NRB-2017-00627,2017,72,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.8,moderate_burden
KE-NRB-2012-00628,2012,86,75+,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-00629,2013,55,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,42.0,moderate_burden
KE-NRB-2015-00630,2015,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Alive,15.7,moderate_burden
KE-NRB-2015-00631,2015,53,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Dead,7.3,moderate_burden
KE-NRB-2017-00632,2017,69,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,6.2,moderate_burden
KE-NRB-2015-00633,2015,1,0-14,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,58.3,moderate_burden
KE-NRB-2015-00634,2015,68,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,0.2,moderate_burden
KE-NRB-2016-00635,2016,55,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,47.8,moderate_burden
KE-NRB-2016-00636,2016,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.2,moderate_burden
KE-NRB-2018-00637,2018,47,45-54,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,23.3,moderate_burden
KE-NRB-2014-00638,2014,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,36.7,moderate_burden
KE-NRB-2017-00639,2017,66,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Alive,56.0,moderate_burden
KE-NRB-2011-00640,2011,68,65-74,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,52.8,moderate_burden
KE-NRB-2010-00641,2010,51,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,10.0,moderate_burden
KE-NRB-2015-00642,2015,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,13.1,moderate_burden
KE-NRB-2011-00643,2011,63,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,39.3,moderate_burden
KE-NRB-2009-00644,2009,11,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.1,moderate_burden
KE-NRB-2014-00645,2014,56,55-64,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.4,moderate_burden
KE-NRB-2014-00646,2014,70,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.5,moderate_burden
KE-NRB-2015-00647,2015,71,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Alive,31.6,moderate_burden
KE-NRB-2012-00648,2012,46,45-54,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,51.8,moderate_burden
KE-NRB-2014-00649,2014,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,39.3,moderate_burden
KE-NRB-2010-00650,2010,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Lost to follow-up,58.3,moderate_burden
KE-NRB-2016-00651,2016,74,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,18.4,moderate_burden
KE-NRB-2011-00652,2011,59,55-64,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,57.3,moderate_burden
KE-NRB-2017-00653,2017,83,75+,Male,Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,moderate_burden
KE-NRB-2016-00654,2016,39,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00655,2017,62,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Alive,24.1,moderate_burden
KE-NRB-2013-00656,2013,59,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,41.2,moderate_burden
KE-NRB-2015-00657,2015,66,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,41.7,moderate_burden
KE-NRB-2015-00658,2015,35,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Alive,39.5,moderate_burden
KE-NRB-2016-00659,2016,71,65-74,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,18.3,moderate_burden
KE-NRB-2011-00660,2011,88,75+,Female,Ovary,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,29.4,moderate_burden
KE-NRB-2015-00661,2015,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,10.0,moderate_burden
KE-NRB-2009-00662,2009,33,25-34,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.3,moderate_burden
KE-NRB-2014-00663,2014,57,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Dead,0.8,moderate_burden
KE-NRB-2018-00664,2018,28,25-34,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,43.5,moderate_burden
KE-NRB-2010-00665,2010,54,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00666,2015,39,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,19.1,moderate_burden
KE-NRB-2015-00667,2015,37,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,13.0,moderate_burden
KE-NRB-2012-00668,2012,48,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.9,moderate_burden
KE-NRB-2015-00669,2015,65,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,6.3,moderate_burden
KE-NRB-2016-00670,2016,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,40.3,moderate_burden
KE-NRB-2013-00671,2013,26,25-34,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.1,moderate_burden
KE-NRB-2010-00672,2010,31,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,19.1,moderate_burden
KE-NRB-2013-00673,2013,43,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,21.6,moderate_burden
KE-NRB-2012-00674,2012,53,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.5,moderate_burden
KE-NRB-2016-00675,2016,73,65-74,Male,Skin (melanoma),Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.6,moderate_burden
KE-NRB-2017-00676,2017,59,55-64,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.3,moderate_burden
KE-NRB-2017-00677,2017,56,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.8,moderate_burden
KE-NRB-2017-00678,2017,28,25-34,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,39.6,moderate_burden
KE-NRB-2017-00679,2017,34,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00680,2011,68,65-74,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-00681,2014,53,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,35.1,moderate_burden
KE-NRB-2016-00682,2016,40,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.4,moderate_burden
KE-NRB-2017-00683,2017,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-00684,2011,30,25-34,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.3,moderate_burden
KE-NRB-2016-00685,2016,57,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,28.9,moderate_burden
KE-NRB-2016-00686,2016,74,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,56.5,moderate_burden
KE-NRB-2011-00687,2011,36,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,3.4,moderate_burden
KE-NRB-2012-00688,2012,24,15-24,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.5,moderate_burden
KE-NRB-2014-00689,2014,57,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,31.8,moderate_burden
KE-NRB-2015-00690,2015,40,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.1,moderate_burden
KE-NRB-2016-00691,2016,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.0,moderate_burden
KE-NRB-2010-00692,2010,39,35-44,Male,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.6,moderate_burden
KE-NRB-2018-00693,2018,32,25-34,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,43.5,moderate_burden
KE-NRB-2012-00694,2012,73,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.0,moderate_burden
KE-NRB-2016-00695,2016,58,55-64,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.1,moderate_burden
KE-NRB-2013-00696,2013,84,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,26.0,moderate_burden
KE-NRB-2015-00697,2015,70,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.2,moderate_burden
KE-NRB-2014-00698,2014,40,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,16.0,moderate_burden
KE-NRB-2012-00699,2012,55,55-64,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.8,moderate_burden
KE-NRB-2016-00700,2016,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.1,moderate_burden
KE-NRB-2011-00701,2011,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00702,2015,67,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.1,moderate_burden
KE-NRB-2018-00703,2018,70,65-74,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-00704,2014,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,6.7,moderate_burden
KE-NRB-2018-00705,2018,74,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,21.1,moderate_burden
KE-NRB-2009-00706,2009,30,25-34,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.5,moderate_burden
KE-NRB-2016-00707,2016,38,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.5,moderate_burden
KE-NRB-2012-00708,2012,67,65-74,Female,Corpus uteri,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,37.1,moderate_burden
KE-NRB-2017-00709,2017,73,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.0,moderate_burden
KE-NRB-2017-00710,2017,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,40.4,moderate_burden
KE-NRB-2014-00711,2014,38,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-00712,2014,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-00713,2015,29,25-34,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,54.6,moderate_burden
KE-NRB-2015-00714,2015,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,30.9,moderate_burden
KE-NRB-2010-00715,2010,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,13.6,moderate_burden
KE-NRB-2013-00716,2013,60,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.1,moderate_burden
KE-NRB-2014-00717,2014,65,65-74,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,6.9,moderate_burden
KE-NRB-2015-00718,2015,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,12.7,moderate_burden
KE-NRB-2017-00719,2017,64,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-00720,2012,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00721,2017,86,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,55.1,moderate_burden
KE-NRB-2014-00722,2014,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,moderate_burden
KE-NRB-2015-00723,2015,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,0.1,moderate_burden
KE-NRB-2012-00724,2012,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,5.9,moderate_burden
KE-NRB-2015-00725,2015,69,65-74,Male,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,19.1,moderate_burden
KE-NRB-2009-00726,2009,35,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,35.3,moderate_burden
KE-NRB-2018-00727,2018,60,55-64,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,2.0,moderate_burden
KE-NRB-2018-00728,2018,21,15-24,Male,Colorectum,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00729,2012,74,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,moderate_burden
KE-NRB-2018-00730,2018,68,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2014-00731,2014,39,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-00732,2011,67,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,16.1,moderate_burden
KE-NRB-2012-00733,2012,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,60.0,moderate_burden
KE-NRB-2013-00734,2013,73,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Lost to follow-up,35.6,moderate_burden
KE-NRB-2012-00735,2012,56,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00736,2011,58,55-64,Male,Prostate,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00737,2012,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2014-00738,2014,41,35-44,Female,Ovary,Adenocarcinoma,Unknown,Clinical only,Benign/uncertain,Urban,N/A,Alive,21.9,moderate_burden
KE-NRB-2015-00739,2015,33,25-34,Female,Breast,Other specified,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-00740,2013,47,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,55.9,moderate_burden
KE-NRB-2013-00741,2013,51,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.5,moderate_burden
KE-NRB-2016-00742,2016,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-00743,2018,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.5,moderate_burden
KE-NRB-2017-00744,2017,48,45-54,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-00745,2013,56,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,36.4,moderate_burden
KE-NRB-2016-00746,2016,35,35-44,Male,Stomach,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.6,moderate_burden
KE-NRB-2012-00747,2012,30,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Radiotherapy only,Alive,45.0,moderate_burden
KE-NRB-2017-00748,2017,32,25-34,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00749,2018,74,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.9,moderate_burden
KE-NRB-2015-00750,2015,78,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,7.8,moderate_burden
KE-NRB-2013-00751,2013,28,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-00752,2011,69,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,16.6,moderate_burden
KE-NRB-2018-00753,2018,69,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.7,moderate_burden
KE-NRB-2014-00754,2014,30,25-34,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,1.9,moderate_burden
KE-NRB-2017-00755,2017,58,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.0,moderate_burden
KE-NRB-2018-00756,2018,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-00757,2010,74,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Dead,8.2,moderate_burden
KE-NRB-2009-00758,2009,68,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,51.8,moderate_burden
KE-NRB-2017-00759,2017,36,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-00760,2011,67,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,14.6,moderate_burden
KE-NRB-2013-00761,2013,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,54.1,moderate_burden
KE-NRB-2014-00762,2014,72,65-74,Male,Bladder,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,6.8,moderate_burden
KE-NRB-2017-00763,2017,91,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00764,2018,72,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,23.8,moderate_burden
KE-NRB-2017-00765,2017,60,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.0,moderate_burden
KE-NRB-2017-00766,2017,61,55-64,Male,Colorectum,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-00767,2018,46,45-54,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.7,moderate_burden
KE-NRB-2018-00768,2018,82,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-00769,2017,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,56.5,moderate_burden
KE-NRB-2015-00770,2015,30,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.7,moderate_burden
KE-NRB-2014-00771,2014,46,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.0,moderate_burden
KE-NRB-2011-00772,2011,38,35-44,Male,Skin (melanoma),Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.2,moderate_burden
KE-NRB-2018-00773,2018,69,65-74,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,49.9,moderate_burden
KE-NRB-2014-00774,2014,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,14.6,moderate_burden
KE-NRB-2011-00775,2011,52,45-54,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.2,moderate_burden
KE-NRB-2015-00776,2015,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,2.0,moderate_burden
KE-NRB-2016-00777,2016,67,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,29.6,moderate_burden
KE-NRB-2016-00778,2016,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,30.3,moderate_burden
KE-NRB-2014-00779,2014,72,65-74,Male,Bladder,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.5,moderate_burden
KE-NRB-2015-00780,2015,41,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,56.1,moderate_burden
KE-NRB-2014-00781,2014,63,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.1,moderate_burden
KE-NRB-2016-00782,2016,43,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,36.4,moderate_burden
KE-NRB-2010-00783,2010,38,35-44,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.2,moderate_burden
KE-NRB-2017-00784,2017,24,15-24,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.2,moderate_burden
KE-NRB-2010-00785,2010,61,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.3,moderate_burden
KE-NRB-2010-00786,2010,59,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.4,moderate_burden
KE-NRB-2016-00787,2016,33,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.3,moderate_burden
KE-NRB-2017-00788,2017,69,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,41.0,moderate_burden
KE-NRB-2010-00789,2010,45,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-00790,2014,66,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.0,moderate_burden
KE-NRB-2015-00791,2015,74,65-74,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,38.2,moderate_burden
KE-NRB-2017-00792,2017,59,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,28.4,moderate_burden
KE-NRB-2018-00793,2018,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-00794,2013,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,5.4,moderate_burden
KE-NRB-2015-00795,2015,71,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.8,moderate_burden
KE-NRB-2012-00796,2012,63,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-00797,2018,31,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-00798,2018,35,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.4,moderate_burden
KE-NRB-2009-00799,2009,67,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-00800,2011,64,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,44.9,moderate_burden
KE-NRB-2016-00801,2016,50,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,53.8,moderate_burden
KE-NRB-2018-00802,2018,36,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-00803,2018,72,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-00804,2014,58,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,34.6,moderate_burden
KE-NRB-2018-00805,2018,49,45-54,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,17.7,moderate_burden
KE-NRB-2014-00806,2014,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,34.1,moderate_burden
KE-NRB-2017-00807,2017,77,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.1,moderate_burden
KE-NRB-2014-00808,2014,56,55-64,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,24.3,moderate_burden
KE-NRB-2013-00809,2013,65,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.3,moderate_burden
KE-NRB-2010-00810,2010,57,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.1,moderate_burden
KE-NRB-2011-00811,2011,71,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,54.1,moderate_burden
KE-NRB-2010-00812,2010,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,26.3,moderate_burden
KE-NRB-2010-00813,2010,66,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,23.7,moderate_burden
KE-NRB-2018-00814,2018,32,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.1,moderate_burden
KE-NRB-2009-00815,2009,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.7,moderate_burden
KE-NRB-2018-00816,2018,40,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.6,moderate_burden
KE-NRB-2012-00817,2012,50,45-54,Female,Other,Other specified,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,27.4,moderate_burden
KE-NRB-2018-00818,2018,48,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,22.1,moderate_burden
KE-NRB-2013-00819,2013,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-00820,2014,69,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-00821,2017,10,0-14,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,10.6,moderate_burden
KE-NRB-2018-00822,2018,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,11.3,moderate_burden
KE-NRB-2016-00823,2016,61,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,10.4,moderate_burden
KE-NRB-2011-00824,2011,45,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,7.7,moderate_burden
KE-NRB-2018-00825,2018,32,25-34,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.5,moderate_burden
KE-NRB-2012-00826,2012,71,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,43.1,moderate_burden
KE-NRB-2009-00827,2009,70,65-74,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-00828,2015,42,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,18.2,moderate_burden
KE-NRB-2018-00829,2018,66,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,30.2,moderate_burden
KE-NRB-2016-00830,2016,50,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.4,moderate_burden
KE-NRB-2016-00831,2016,71,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.4,moderate_burden
KE-NRB-2017-00832,2017,42,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-00833,2014,92,75+,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,36.3,moderate_burden
KE-NRB-2013-00834,2013,65,65-74,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.9,moderate_burden
KE-NRB-2014-00835,2014,74,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,34.4,moderate_burden
KE-NRB-2017-00836,2017,27,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.3,moderate_burden
KE-NRB-2014-00837,2014,59,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.7,moderate_burden
KE-NRB-2017-00838,2017,57,55-64,Male,Stomach,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,30.7,moderate_burden
KE-NRB-2017-00839,2017,41,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,39.4,moderate_burden
KE-NRB-2017-00840,2017,51,45-54,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.3,moderate_burden
KE-NRB-2018-00841,2018,66,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Palliative care only,Alive,32.3,moderate_burden
KE-NRB-2014-00842,2014,60,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,23.0,moderate_burden
KE-NRB-2013-00843,2013,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,54.7,moderate_burden
KE-NRB-2016-00844,2016,53,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-00845,2018,27,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-00846,2016,54,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.2,moderate_burden
KE-NRB-2011-00847,2011,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-00848,2012,62,55-64,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,40.2,moderate_burden
KE-NRB-2014-00849,2014,29,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.1,moderate_burden
KE-NRB-2018-00850,2018,68,65-74,Male,Kidney,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,31.7,moderate_burden
KE-NRB-2013-00851,2013,61,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,No treatment,Alive,14.4,moderate_burden
KE-NRB-2015-00852,2015,33,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,12.0,moderate_burden
KE-NRB-2013-00853,2013,73,65-74,Male,Skin (melanoma),Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.2,moderate_burden
KE-NRB-2017-00854,2017,71,65-74,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.7,moderate_burden
KE-NRB-2018-00855,2018,67,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,7.1,moderate_burden
KE-NRB-2018-00856,2018,72,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2018-00857,2018,49,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.4,moderate_burden
KE-NRB-2016-00858,2016,59,55-64,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00859,2013,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.2,moderate_burden
KE-NRB-2016-00860,2016,67,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,38.2,moderate_burden
KE-NRB-2014-00861,2014,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-00862,2015,51,45-54,Male,Kidney,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.3,moderate_burden
KE-NRB-2018-00863,2018,71,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,45.3,moderate_burden
KE-NRB-2015-00864,2015,48,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,6.1,moderate_burden
KE-NRB-2013-00865,2013,41,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-00866,2016,61,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-00867,2016,63,55-64,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.5,moderate_burden
KE-NRB-2016-00868,2016,95,75+,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,1.5,moderate_burden
KE-NRB-2016-00869,2016,57,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.9,moderate_burden
KE-NRB-2014-00870,2014,56,55-64,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,4.4,moderate_burden
KE-NRB-2012-00871,2012,23,15-24,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,3.0,moderate_burden
KE-NRB-2016-00872,2016,89,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.7,moderate_burden
KE-NRB-2017-00873,2017,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-00874,2013,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,39.1,moderate_burden
KE-NRB-2012-00875,2012,58,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-00876,2013,43,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.3,moderate_burden
KE-NRB-2018-00877,2018,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,8.1,moderate_burden
KE-NRB-2013-00878,2013,66,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,40.2,moderate_burden
KE-NRB-2018-00879,2018,41,35-44,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.7,moderate_burden
KE-NRB-2012-00880,2012,35,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,10.7,moderate_burden
KE-NRB-2017-00881,2017,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-00882,2015,38,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.5,moderate_burden
KE-NRB-2011-00883,2011,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00884,2012,69,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.0,moderate_burden
KE-NRB-2018-00885,2018,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,31.9,moderate_burden
KE-NRB-2015-00886,2015,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-00887,2017,74,65-74,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,8.4,moderate_burden
KE-NRB-2013-00888,2013,71,65-74,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.3,moderate_burden
KE-NRB-2012-00889,2012,80,75+,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.2,moderate_burden
KE-NRB-2016-00890,2016,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2013-00891,2013,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,42.6,moderate_burden
KE-NRB-2014-00892,2014,40,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.1,moderate_burden
KE-NRB-2017-00893,2017,55,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-00894,2013,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,7.2,moderate_burden
KE-NRB-2015-00895,2015,60,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.7,moderate_burden
KE-NRB-2015-00896,2015,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.1,moderate_burden
KE-NRB-2011-00897,2011,47,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,11.0,moderate_burden
KE-NRB-2011-00898,2011,60,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,28.8,moderate_burden
KE-NRB-2018-00899,2018,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,30.7,moderate_burden
KE-NRB-2014-00900,2014,37,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,1.2,moderate_burden
KE-NRB-2018-00901,2018,21,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,48.2,moderate_burden
KE-NRB-2010-00902,2010,51,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,10.0,moderate_burden
KE-NRB-2015-00903,2015,46,45-54,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.6,moderate_burden
KE-NRB-2016-00904,2016,54,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.8,moderate_burden
KE-NRB-2011-00905,2011,72,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,32.4,moderate_burden
KE-NRB-2016-00906,2016,39,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-00907,2012,51,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.6,moderate_burden
KE-NRB-2018-00908,2018,68,65-74,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.7,moderate_burden
KE-NRB-2017-00909,2017,66,65-74,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Dead,0.1,moderate_burden
KE-NRB-2013-00910,2013,69,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,54.3,moderate_burden
KE-NRB-2012-00911,2012,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-00912,2017,68,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,21.0,moderate_burden
KE-NRB-2011-00913,2011,90,75+,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,13.3,moderate_burden
KE-NRB-2009-00914,2009,29,25-34,Male,Stomach,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Alive,14.9,moderate_burden
KE-NRB-2012-00915,2012,57,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-00916,2016,9,0-14,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.7,moderate_burden
KE-NRB-2012-00917,2012,72,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.6,moderate_burden
KE-NRB-2017-00918,2017,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,0.2,moderate_burden
KE-NRB-2015-00919,2015,58,55-64,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,30.6,moderate_burden
KE-NRB-2017-00920,2017,26,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,57.1,moderate_burden
KE-NRB-2014-00921,2014,70,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.7,moderate_burden
KE-NRB-2015-00922,2015,35,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,59.0,moderate_burden
KE-NRB-2012-00923,2012,56,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-00924,2009,64,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.2,moderate_burden
KE-NRB-2015-00925,2015,42,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.1,moderate_burden
KE-NRB-2012-00926,2012,59,55-64,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.3,moderate_burden
KE-NRB-2013-00927,2013,49,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,45.7,moderate_burden
KE-NRB-2015-00928,2015,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.4,moderate_burden
KE-NRB-2009-00929,2009,50,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,6.0,moderate_burden
KE-NRB-2016-00930,2016,44,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-00931,2013,32,25-34,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,22.4,moderate_burden
KE-NRB-2010-00932,2010,37,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,21.7,moderate_burden
KE-NRB-2014-00933,2014,70,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,7.6,moderate_burden
KE-NRB-2018-00934,2018,33,25-34,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-00935,2010,50,45-54,Male,Prostate,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,0.5,moderate_burden
KE-NRB-2015-00936,2015,27,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,18.5,moderate_burden
KE-NRB-2016-00937,2016,23,15-24,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.1,moderate_burden
KE-NRB-2016-00938,2016,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,6.5,moderate_burden
KE-NRB-2017-00939,2017,62,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,0.7,moderate_burden
KE-NRB-2009-00940,2009,38,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-00941,2011,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.9,moderate_burden
KE-NRB-2015-00942,2015,56,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.5,moderate_burden
KE-NRB-2017-00943,2017,61,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,53.6,moderate_burden
KE-NRB-2012-00944,2012,51,45-54,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.8,moderate_burden
KE-NRB-2010-00945,2010,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Lost to follow-up,6.0,moderate_burden
KE-NRB-2010-00946,2010,55,55-64,Male,Oesophagus,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.9,moderate_burden
KE-NRB-2016-00947,2016,9,0-14,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.7,moderate_burden
KE-NRB-2017-00948,2017,65,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.8,moderate_burden
KE-NRB-2017-00949,2017,54,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,15.1,moderate_burden
KE-NRB-2012-00950,2012,31,25-34,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-00951,2013,70,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,7.0,moderate_burden
KE-NRB-2012-00952,2012,60,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-00953,2016,85,75+,Male,Kidney,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,0.9,moderate_burden
KE-NRB-2012-00954,2012,57,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.3,moderate_burden
KE-NRB-2017-00955,2017,70,65-74,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,42.9,moderate_burden
KE-NRB-2013-00956,2013,56,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,13.6,moderate_burden
KE-NRB-2017-00957,2017,43,35-44,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2018-00958,2018,44,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,20.1,moderate_burden
KE-NRB-2016-00959,2016,26,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,35.8,moderate_burden
KE-NRB-2009-00960,2009,28,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Palliative care only,Dead,27.9,moderate_burden
KE-NRB-2018-00961,2018,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,7.7,moderate_burden
KE-NRB-2016-00962,2016,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,7.5,moderate_burden
KE-NRB-2013-00963,2013,49,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-00964,2015,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Dead,14.6,moderate_burden
KE-NRB-2009-00965,2009,39,35-44,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,13.4,moderate_burden
KE-NRB-2013-00966,2013,91,75+,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.2,moderate_burden
KE-NRB-2012-00967,2012,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,39.2,moderate_burden
KE-NRB-2011-00968,2011,38,35-44,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.7,moderate_burden
KE-NRB-2014-00969,2014,41,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,57.5,moderate_burden
KE-NRB-2012-00970,2012,30,25-34,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,38.1,moderate_burden
KE-NRB-2014-00971,2014,37,35-44,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.1,moderate_burden
KE-NRB-2012-00972,2012,62,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,60.0,moderate_burden
KE-NRB-2012-00973,2012,67,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,41.3,moderate_burden
KE-NRB-2010-00974,2010,43,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.2,moderate_burden
KE-NRB-2017-00975,2017,45,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,No treatment,Alive,7.5,moderate_burden
KE-NRB-2014-00976,2014,62,55-64,Male,Prostate,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,14.3,moderate_burden
KE-NRB-2011-00977,2011,69,65-74,Male,Colorectum,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,47.0,moderate_burden
KE-NRB-2012-00978,2012,30,25-34,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,18.6,moderate_burden
KE-NRB-2009-00979,2009,63,55-64,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Alive,33.5,moderate_burden
KE-NRB-2018-00980,2018,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,20.8,moderate_burden
KE-NRB-2018-00981,2018,50,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-00982,2012,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Benign/uncertain,Urban,N/A,Dead,18.0,moderate_burden
KE-NRB-2010-00983,2010,71,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,56.9,moderate_burden
KE-NRB-2018-00984,2018,67,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-00985,2013,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,42.0,moderate_burden
KE-NRB-2010-00986,2010,29,25-34,Female,Other,Unspecified,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,4.3,moderate_burden
KE-NRB-2011-00987,2011,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,22.2,moderate_burden
KE-NRB-2014-00988,2014,66,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,34.5,moderate_burden
KE-NRB-2016-00989,2016,42,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.3,moderate_burden
KE-NRB-2014-00990,2014,95,75+,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-00991,2011,49,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.9,moderate_burden
KE-NRB-2017-00992,2017,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,22.1,moderate_burden
KE-NRB-2010-00993,2010,47,45-54,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,9.9,moderate_burden
KE-NRB-2012-00994,2012,37,35-44,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.8,moderate_burden
KE-NRB-2016-00995,2016,31,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,18.8,moderate_burden
KE-NRB-2016-00996,2016,50,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.7,moderate_burden
KE-NRB-2016-00997,2016,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.7,moderate_burden
KE-NRB-2011-00998,2011,45,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,26.6,moderate_burden
KE-NRB-2018-00999,2018,52,45-54,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,41.3,moderate_burden
KE-NRB-2017-01000,2017,73,65-74,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.8,moderate_burden
KE-NRB-2011-01001,2011,49,45-54,Male,Kidney,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,30.6,moderate_burden
KE-NRB-2018-01002,2018,55,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,23.5,moderate_burden
KE-NRB-2014-01003,2014,52,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-01004,2018,36,35-44,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-01005,2009,45,45-54,Male,Liver,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,20.4,moderate_burden
KE-NRB-2018-01006,2018,63,55-64,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,21.7,moderate_burden
KE-NRB-2012-01007,2012,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,44.4,moderate_burden
KE-NRB-2014-01008,2014,47,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,35.7,moderate_burden
KE-NRB-2009-01009,2009,42,35-44,Male,Bladder,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,42.2,moderate_burden
KE-NRB-2014-01010,2014,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.3,moderate_burden
KE-NRB-2017-01011,2017,56,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.2,moderate_burden
KE-NRB-2010-01012,2010,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,13.8,moderate_burden
KE-NRB-2016-01013,2016,47,45-54,Male,Pancreas,Non-keratinizing carcinoma,Unknown,Clinical only,In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-01014,2016,49,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-01015,2012,46,45-54,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.1,moderate_burden
KE-NRB-2015-01016,2015,38,35-44,Male,Colorectum,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.5,moderate_burden
KE-NRB-2014-01017,2014,29,25-34,Female,Other,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.2,moderate_burden
KE-NRB-2017-01018,2017,90,75+,Male,Kaposi sarcoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2017-01019,2017,83,75+,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-01020,2011,28,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,moderate_burden
KE-NRB-2012-01021,2012,24,15-24,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.8,moderate_burden
KE-NRB-2016-01022,2016,28,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,6.3,moderate_burden
KE-NRB-2015-01023,2015,55,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.8,moderate_burden
KE-NRB-2010-01024,2010,59,55-64,Male,Multiple myeloma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.7,moderate_burden
KE-NRB-2009-01025,2009,32,25-34,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-01026,2009,52,45-54,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01027,2014,50,45-54,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.5,moderate_burden
KE-NRB-2011-01028,2011,36,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.3,moderate_burden
KE-NRB-2012-01029,2012,64,55-64,Male,Colorectum,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01030,2016,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2009-01031,2009,58,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,1.7,moderate_burden
KE-NRB-2012-01032,2012,80,75+,Female,Ovary,Lymphoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-01033,2016,29,25-34,Male,Kidney,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.0,moderate_burden
KE-NRB-2012-01034,2012,54,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.4,moderate_burden
KE-NRB-2012-01035,2012,35,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-01036,2014,89,75+,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.9,moderate_burden
KE-NRB-2011-01037,2011,59,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.9,moderate_burden
KE-NRB-2017-01038,2017,57,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-01039,2010,28,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.1,moderate_burden
KE-NRB-2014-01040,2014,73,65-74,Male,Stomach,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,7.0,moderate_burden
KE-NRB-2015-01041,2015,65,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,60.0,moderate_burden
KE-NRB-2014-01042,2014,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.0,moderate_burden
KE-NRB-2010-01043,2010,34,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,34.5,moderate_burden
KE-NRB-2011-01044,2011,27,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Palliative care only,Alive,32.5,moderate_burden
KE-NRB-2016-01045,2016,75,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-01046,2018,62,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2014-01047,2014,88,75+,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.6,moderate_burden
KE-NRB-2014-01048,2014,63,55-64,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,6.4,moderate_burden
KE-NRB-2013-01049,2013,68,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Lost to follow-up,15.8,moderate_burden
KE-NRB-2014-01050,2014,20,15-24,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.0,moderate_burden
KE-NRB-2015-01051,2015,45,45-54,Male,Kaposi sarcoma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.5,moderate_burden
KE-NRB-2017-01052,2017,64,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01053,2016,67,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,17.1,moderate_burden
KE-NRB-2018-01054,2018,70,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,35.4,moderate_burden
KE-NRB-2013-01055,2013,60,55-64,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-01056,2013,8,0-14,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.9,moderate_burden
KE-NRB-2013-01057,2013,66,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,No treatment,Dead,9.4,moderate_burden
KE-NRB-2017-01058,2017,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,12.3,moderate_burden
KE-NRB-2011-01059,2011,49,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,42.3,moderate_burden
KE-NRB-2018-01060,2018,21,15-24,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,44.8,moderate_burden
KE-NRB-2010-01061,2010,34,25-34,Male,Kaposi sarcoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.2,moderate_burden
KE-NRB-2011-01062,2011,42,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.6,moderate_burden
KE-NRB-2010-01063,2010,36,35-44,Male,Stomach,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.8,moderate_burden
KE-NRB-2010-01064,2010,51,45-54,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.6,moderate_burden
KE-NRB-2015-01065,2015,48,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,21.9,moderate_burden
KE-NRB-2017-01066,2017,82,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.2,moderate_burden
KE-NRB-2016-01067,2016,92,75+,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-01068,2009,34,25-34,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.2,moderate_burden
KE-NRB-2013-01069,2013,53,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,1.2,moderate_burden
KE-NRB-2014-01070,2014,40,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,58.1,moderate_burden
KE-NRB-2016-01071,2016,49,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01072,2015,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,18.1,moderate_burden
KE-NRB-2018-01073,2018,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01074,2013,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.0,moderate_burden
KE-NRB-2015-01075,2015,60,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.1,moderate_burden
KE-NRB-2015-01076,2015,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,50.5,moderate_burden
KE-NRB-2010-01077,2010,87,75+,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Benign/uncertain,Rural,N/A,Dead,27.2,moderate_burden
KE-NRB-2018-01078,2018,36,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,41.8,moderate_burden
KE-NRB-2014-01079,2014,43,35-44,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,8.4,moderate_burden
KE-NRB-2011-01080,2011,31,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,0.9,moderate_burden
KE-NRB-2012-01081,2012,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.3,moderate_burden
KE-NRB-2016-01082,2016,62,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-01083,2014,53,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,28.8,moderate_burden
KE-NRB-2016-01084,2016,64,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Benign/uncertain,Urban,N/A,Alive,29.0,moderate_burden
KE-NRB-2018-01085,2018,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,In situ,Urban,N/A,Alive,31.6,moderate_burden
KE-NRB-2016-01086,2016,53,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery only,Alive,6.3,moderate_burden
KE-NRB-2018-01087,2018,62,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-01088,2014,64,55-64,Male,Kidney,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.7,moderate_burden
KE-NRB-2010-01089,2010,73,65-74,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.1,moderate_burden
KE-NRB-2018-01090,2018,80,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,2.3,moderate_burden
KE-NRB-2016-01091,2016,56,55-64,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.3,moderate_burden
KE-NRB-2013-01092,2013,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.5,moderate_burden
KE-NRB-2014-01093,2014,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,28.3,moderate_burden
KE-NRB-2018-01094,2018,42,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-01095,2018,76,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-01096,2014,64,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,30.7,moderate_burden
KE-NRB-2011-01097,2011,25,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-01098,2011,89,75+,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,25.0,moderate_burden
KE-NRB-2017-01099,2017,73,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-01100,2012,67,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.5,moderate_burden
KE-NRB-2009-01101,2009,44,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.9,moderate_burden
KE-NRB-2009-01102,2009,40,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,24.6,moderate_burden
KE-NRB-2016-01103,2016,53,45-54,Male,Colorectum,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.8,moderate_burden
KE-NRB-2012-01104,2012,57,55-64,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2012-01105,2012,44,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Other,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-01106,2016,58,55-64,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,32.7,moderate_burden
KE-NRB-2016-01107,2016,74,65-74,Male,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-01108,2013,48,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,33.1,moderate_burden
KE-NRB-2016-01109,2016,45,45-54,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01110,2017,71,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,51.6,moderate_burden
KE-NRB-2018-01111,2018,53,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-01112,2009,51,45-54,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,8.4,moderate_burden
KE-NRB-2011-01113,2011,62,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2012-01114,2012,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,24.1,moderate_burden
KE-NRB-2016-01115,2016,34,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,17.4,moderate_burden
KE-NRB-2016-01116,2016,60,55-64,Female,Corpus uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,6.4,moderate_burden
KE-NRB-2014-01117,2014,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,33.7,moderate_burden
KE-NRB-2017-01118,2017,60,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.2,moderate_burden
KE-NRB-2016-01119,2016,65,65-74,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,48.8,moderate_burden
KE-NRB-2017-01120,2017,70,65-74,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,4.8,moderate_burden
KE-NRB-2015-01121,2015,47,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.4,moderate_burden
KE-NRB-2016-01122,2016,69,65-74,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,59.7,moderate_burden
KE-NRB-2015-01123,2015,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,5.0,moderate_burden
KE-NRB-2014-01124,2014,16,15-24,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,47.2,moderate_burden
KE-NRB-2017-01125,2017,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,31.4,moderate_burden
KE-NRB-2015-01126,2015,41,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,44.1,moderate_burden
KE-NRB-2013-01127,2013,63,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-01128,2016,73,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,11.2,moderate_burden
KE-NRB-2012-01129,2012,72,65-74,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,1.9,moderate_burden
KE-NRB-2009-01130,2009,94,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Dead,5.5,moderate_burden
KE-NRB-2011-01131,2011,56,55-64,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,moderate_burden
KE-NRB-2015-01132,2015,28,25-34,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,48.0,moderate_burden
KE-NRB-2018-01133,2018,70,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-01134,2015,73,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,30.9,moderate_burden
KE-NRB-2018-01135,2018,63,55-64,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,3.2,moderate_burden
KE-NRB-2018-01136,2018,60,55-64,Male,Oesophagus,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,31.8,moderate_burden
KE-NRB-2017-01137,2017,50,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01138,2013,73,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.5,moderate_burden
KE-NRB-2015-01139,2015,57,55-64,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01140,2016,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,10.4,moderate_burden
KE-NRB-2015-01141,2015,73,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,3.0,moderate_burden
KE-NRB-2018-01142,2018,88,75+,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,2.7,moderate_burden
KE-NRB-2017-01143,2017,77,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,45.8,moderate_burden
KE-NRB-2014-01144,2014,75,75+,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-01145,2017,62,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,46.3,moderate_burden
KE-NRB-2010-01146,2010,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.7,moderate_burden
KE-NRB-2011-01147,2011,66,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,1.7,moderate_burden
KE-NRB-2014-01148,2014,94,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.6,moderate_burden
KE-NRB-2016-01149,2016,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.9,moderate_burden
KE-NRB-2014-01150,2014,70,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,In situ,Peri-urban,N/A,Alive,45.5,moderate_burden
KE-NRB-2013-01151,2013,47,45-54,Male,Prostate,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,7.2,moderate_burden
KE-NRB-2014-01152,2014,62,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.1,moderate_burden
KE-NRB-2017-01153,2017,55,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01154,2017,62,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,36.2,moderate_burden
KE-NRB-2018-01155,2018,49,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.3,moderate_burden
KE-NRB-2014-01156,2014,73,65-74,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-01157,2012,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,1.3,moderate_burden
KE-NRB-2012-01158,2012,62,55-64,Male,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.1,moderate_burden
KE-NRB-2017-01159,2017,40,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,48.6,moderate_burden
KE-NRB-2012-01160,2012,14,0-14,Male,Prostate,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,18.1,moderate_burden
KE-NRB-2015-01161,2015,62,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01162,2016,32,25-34,Female,Ovary,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,23.3,moderate_burden
KE-NRB-2018-01163,2018,59,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01164,2014,50,45-54,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.7,moderate_burden
KE-NRB-2016-01165,2016,52,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-01166,2018,55,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,13.7,moderate_burden
KE-NRB-2010-01167,2010,36,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-01168,2013,44,35-44,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,21.3,moderate_burden
KE-NRB-2011-01169,2011,34,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2016-01170,2016,41,35-44,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Palliative care only,Dead,9.7,moderate_burden
KE-NRB-2014-01171,2014,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,31.8,moderate_burden
KE-NRB-2016-01172,2016,51,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,14.2,moderate_burden
KE-NRB-2018-01173,2018,31,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery only,Alive,40.5,moderate_burden
KE-NRB-2018-01174,2018,48,45-54,Female,Breast,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01175,2015,67,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,36.9,moderate_burden
KE-NRB-2014-01176,2014,58,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,3.5,moderate_burden
KE-NRB-2015-01177,2015,56,55-64,Male,Liver,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,31.8,moderate_burden
KE-NRB-2017-01178,2017,28,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-01179,2015,51,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-01180,2015,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.9,moderate_burden
KE-NRB-2011-01181,2011,48,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01182,2013,45,45-54,Female,Ovary,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,35.1,moderate_burden
KE-NRB-2011-01183,2011,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.2,moderate_burden
KE-NRB-2018-01184,2018,35,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,7.1,moderate_burden
KE-NRB-2010-01185,2010,74,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,13.5,moderate_burden
KE-NRB-2011-01186,2011,71,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.7,moderate_burden
KE-NRB-2017-01187,2017,62,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-01188,2015,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01189,2015,44,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.5,moderate_burden
KE-NRB-2013-01190,2013,54,45-54,Male,Skin (melanoma),Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.2,moderate_burden
KE-NRB-2011-01191,2011,95,75+,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.8,moderate_burden
KE-NRB-2011-01192,2011,62,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,19.5,moderate_burden
KE-NRB-2017-01193,2017,51,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,59.6,moderate_burden
KE-NRB-2015-01194,2015,31,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,45.7,moderate_burden
KE-NRB-2015-01195,2015,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,2.4,moderate_burden
KE-NRB-2014-01196,2014,55,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,15.1,moderate_burden
KE-NRB-2015-01197,2015,51,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.6,moderate_burden
KE-NRB-2012-01198,2012,55,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,46.7,moderate_burden
KE-NRB-2015-01199,2015,37,35-44,Female,Ovary,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,26.2,moderate_burden
KE-NRB-2016-01200,2016,71,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,21.5,moderate_burden
KE-NRB-2018-01201,2018,59,55-64,Female,Ovary,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,19.5,moderate_burden
KE-NRB-2016-01202,2016,59,55-64,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.7,moderate_burden
KE-NRB-2011-01203,2011,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,52.7,moderate_burden
KE-NRB-2018-01204,2018,48,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.4,moderate_burden
KE-NRB-2013-01205,2013,57,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,51.6,moderate_burden
KE-NRB-2016-01206,2016,33,25-34,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.0,moderate_burden
KE-NRB-2016-01207,2016,51,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.4,moderate_burden
KE-NRB-2016-01208,2016,52,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,59.2,moderate_burden
KE-NRB-2015-01209,2015,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.1,moderate_burden
KE-NRB-2012-01210,2012,45,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,49.6,moderate_burden
KE-NRB-2013-01211,2013,69,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,34.9,moderate_burden
KE-NRB-2014-01212,2014,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,8.3,moderate_burden
KE-NRB-2012-01213,2012,45,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2009-01214,2009,72,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.3,moderate_burden
KE-NRB-2018-01215,2018,35,35-44,Male,Multiple myeloma,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Alive,11.8,moderate_burden
KE-NRB-2015-01216,2015,72,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.8,moderate_burden
KE-NRB-2010-01217,2010,82,75+,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-01218,2010,62,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,40.3,moderate_burden
KE-NRB-2012-01219,2012,44,35-44,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,55.0,moderate_burden
KE-NRB-2014-01220,2014,72,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,2.2,moderate_burden
KE-NRB-2014-01221,2014,27,25-34,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,56.6,moderate_burden
KE-NRB-2018-01222,2018,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-01223,2011,49,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,22.0,moderate_burden
KE-NRB-2009-01224,2009,44,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.1,moderate_burden
KE-NRB-2015-01225,2015,48,45-54,Male,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.0,moderate_burden
KE-NRB-2016-01226,2016,36,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2018-01227,2018,32,25-34,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,4.1,moderate_burden
KE-NRB-2018-01228,2018,54,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,6.8,moderate_burden
KE-NRB-2017-01229,2017,35,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,12.7,moderate_burden
KE-NRB-2015-01230,2015,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.0,moderate_burden
KE-NRB-2015-01231,2015,71,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,6.4,moderate_burden
KE-NRB-2013-01232,2013,47,45-54,Male,Pancreas,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,5.2,moderate_burden
KE-NRB-2015-01233,2015,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.3,moderate_burden
KE-NRB-2014-01234,2014,53,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,0.7,moderate_burden
KE-NRB-2017-01235,2017,59,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,14.7,moderate_burden
KE-NRB-2015-01236,2015,29,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.8,moderate_burden
KE-NRB-2014-01237,2014,48,45-54,Female,Ovary,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,55.7,moderate_burden
KE-NRB-2009-01238,2009,46,45-54,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.9,moderate_burden
KE-NRB-2013-01239,2013,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-01240,2014,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.4,moderate_burden
KE-NRB-2017-01241,2017,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Alive,58.3,moderate_burden
KE-NRB-2011-01242,2011,28,25-34,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.6,moderate_burden
KE-NRB-2018-01243,2018,62,55-64,Male,Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,10.2,moderate_burden
KE-NRB-2012-01244,2012,89,75+,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,46.0,moderate_burden
KE-NRB-2010-01245,2010,66,65-74,Male,Multiple myeloma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01246,2017,51,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,10.7,moderate_burden
KE-NRB-2012-01247,2012,63,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,22.8,moderate_burden
KE-NRB-2013-01248,2013,69,65-74,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.8,moderate_burden
KE-NRB-2010-01249,2010,69,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,2.6,moderate_burden
KE-NRB-2015-01250,2015,72,65-74,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-01251,2011,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.0,moderate_burden
KE-NRB-2014-01252,2014,69,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.7,moderate_burden
KE-NRB-2017-01253,2017,45,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.8,moderate_burden
KE-NRB-2017-01254,2017,82,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.8,moderate_burden
KE-NRB-2013-01255,2013,33,25-34,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.2,moderate_burden
KE-NRB-2016-01256,2016,60,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.1,moderate_burden
KE-NRB-2012-01257,2012,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,4.3,moderate_burden
KE-NRB-2013-01258,2013,63,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.4,moderate_burden
KE-NRB-2010-01259,2010,67,65-74,Male,Stomach,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,44.3,moderate_burden
KE-NRB-2016-01260,2016,48,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.0,moderate_burden
KE-NRB-2013-01261,2013,62,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2015-01262,2015,40,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.3,moderate_burden
KE-NRB-2012-01263,2012,22,15-24,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,18.3,moderate_burden
KE-NRB-2010-01264,2010,45,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,2.7,moderate_burden
KE-NRB-2015-01265,2015,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemotherapy only,Alive,10.4,moderate_burden
KE-NRB-2010-01266,2010,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,49.9,moderate_burden
KE-NRB-2016-01267,2016,69,65-74,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.1,moderate_burden
KE-NRB-2011-01268,2011,53,45-54,Female,Thyroid,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,5.5,moderate_burden
KE-NRB-2010-01269,2010,70,65-74,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-01270,2012,68,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.8,moderate_burden
KE-NRB-2017-01271,2017,55,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,41.9,moderate_burden
KE-NRB-2009-01272,2009,48,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,36.2,moderate_burden
KE-NRB-2016-01273,2016,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.1,moderate_burden
KE-NRB-2014-01274,2014,48,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,12.8,moderate_burden
KE-NRB-2018-01275,2018,62,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,5.4,moderate_burden
KE-NRB-2018-01276,2018,36,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,49.3,moderate_burden
KE-NRB-2012-01277,2012,55,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,0.6,moderate_burden
KE-NRB-2010-01278,2010,56,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,14.3,moderate_burden
KE-NRB-2014-01279,2014,39,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.5,moderate_burden
KE-NRB-2018-01280,2018,40,35-44,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,moderate_burden
KE-NRB-2018-01281,2018,20,15-24,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.4,moderate_burden
KE-NRB-2018-01282,2018,47,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01283,2015,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,39.1,moderate_burden
KE-NRB-2013-01284,2013,38,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,57.6,moderate_burden
KE-NRB-2016-01285,2016,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,moderate_burden
KE-NRB-2016-01286,2016,25,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Lost to follow-up,13.1,moderate_burden
KE-NRB-2011-01287,2011,57,55-64,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.5,moderate_burden
KE-NRB-2016-01288,2016,68,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,53.9,moderate_burden
KE-NRB-2014-01289,2014,73,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,29.1,moderate_burden
KE-NRB-2018-01290,2018,62,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.6,moderate_burden
KE-NRB-2018-01291,2018,49,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.3,moderate_burden
KE-NRB-2010-01292,2010,75,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.6,moderate_burden
KE-NRB-2012-01293,2012,62,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.8,moderate_burden
KE-NRB-2012-01294,2012,62,55-64,Male,Colorectum,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.7,moderate_burden
KE-NRB-2017-01295,2017,45,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,56.3,moderate_burden
KE-NRB-2017-01296,2017,51,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.7,moderate_burden
KE-NRB-2011-01297,2011,62,55-64,Female,Breast,Adenocarcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,36.0,moderate_burden
KE-NRB-2017-01298,2017,72,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,45.5,moderate_burden
KE-NRB-2013-01299,2013,50,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2018-01300,2018,35,35-44,Male,Liver,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.4,moderate_burden
KE-NRB-2017-01301,2017,24,15-24,Male,Prostate,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,55.5,moderate_burden
KE-NRB-2012-01302,2012,54,45-54,Male,Kidney,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,4.4,moderate_burden
KE-NRB-2014-01303,2014,43,35-44,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,43.0,moderate_burden
KE-NRB-2017-01304,2017,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,25.7,moderate_burden
KE-NRB-2010-01305,2010,55,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,44.1,moderate_burden
KE-NRB-2015-01306,2015,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,9.3,moderate_burden
KE-NRB-2012-01307,2012,76,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Dead,18.8,moderate_burden
KE-NRB-2010-01308,2010,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,16.7,moderate_burden
KE-NRB-2018-01309,2018,59,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,9.0,moderate_burden
KE-NRB-2012-01310,2012,66,65-74,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.3,moderate_burden
KE-NRB-2014-01311,2014,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.6,moderate_burden
KE-NRB-2014-01312,2014,27,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-01313,2013,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.9,moderate_burden
KE-NRB-2009-01314,2009,51,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.4,moderate_burden
KE-NRB-2011-01315,2011,28,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.9,moderate_burden
KE-NRB-2009-01316,2009,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,11.5,moderate_burden
KE-NRB-2011-01317,2011,54,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01318,2017,46,45-54,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.1,moderate_burden
KE-NRB-2016-01319,2016,21,15-24,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Dead,2.8,moderate_burden
KE-NRB-2010-01320,2010,48,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,34.1,moderate_burden
KE-NRB-2016-01321,2016,60,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-01322,2012,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,0.8,moderate_burden
KE-NRB-2011-01323,2011,74,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,4.2,moderate_burden
KE-NRB-2013-01324,2013,50,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-01325,2014,38,35-44,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,7.6,moderate_burden
KE-NRB-2018-01326,2018,95,75+,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01327,2015,36,35-44,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,19.1,moderate_burden
KE-NRB-2014-01328,2014,29,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.3,moderate_burden
KE-NRB-2016-01329,2016,32,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-01330,2009,50,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,28.3,moderate_burden
KE-NRB-2017-01331,2017,60,55-64,Male,Colorectum,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-01332,2011,30,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-01333,2017,46,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.1,moderate_burden
KE-NRB-2016-01334,2016,35,35-44,Male,Pancreas,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.4,moderate_burden
KE-NRB-2010-01335,2010,51,45-54,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-01336,2017,41,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,31.7,moderate_burden
KE-NRB-2016-01337,2016,37,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,55.7,moderate_burden
KE-NRB-2009-01338,2009,46,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,41.8,moderate_burden
KE-NRB-2017-01339,2017,45,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,18.4,moderate_burden
KE-NRB-2014-01340,2014,37,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,43.0,moderate_burden
KE-NRB-2017-01341,2017,69,65-74,Male,Kidney,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,14.0,moderate_burden
KE-NRB-2016-01342,2016,36,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.4,moderate_burden
KE-NRB-2013-01343,2013,83,75+,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01344,2015,30,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-01345,2018,60,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01346,2016,37,35-44,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,12.1,moderate_burden
KE-NRB-2015-01347,2015,60,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,40.9,moderate_burden
KE-NRB-2012-01348,2012,70,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-01349,2014,56,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,37.0,moderate_burden
KE-NRB-2014-01350,2014,62,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.1,moderate_burden
KE-NRB-2013-01351,2013,49,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,3.6,moderate_burden
KE-NRB-2018-01352,2018,30,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01353,2013,39,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,47.8,moderate_burden
KE-NRB-2016-01354,2016,30,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,39.3,moderate_burden
KE-NRB-2016-01355,2016,60,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,15.9,moderate_burden
KE-NRB-2017-01356,2017,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,45.3,moderate_burden
KE-NRB-2014-01357,2014,76,75+,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.3,moderate_burden
KE-NRB-2018-01358,2018,61,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,3.7,moderate_burden
KE-NRB-2011-01359,2011,53,45-54,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,8.1,moderate_burden
KE-NRB-2017-01360,2017,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,In situ,Rural,N/A,Dead,43.1,moderate_burden
KE-NRB-2010-01361,2010,83,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,3.5,moderate_burden
KE-NRB-2015-01362,2015,53,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.5,moderate_burden
KE-NRB-2010-01363,2010,87,75+,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2018-01364,2018,66,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-01365,2012,49,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01366,2015,50,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.3,moderate_burden
KE-NRB-2010-01367,2010,65,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,16.7,moderate_burden
KE-NRB-2012-01368,2012,45,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,14.2,moderate_burden
KE-NRB-2016-01369,2016,71,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.7,moderate_burden
KE-NRB-2016-01370,2016,54,45-54,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.8,moderate_burden
KE-NRB-2011-01371,2011,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,33.5,moderate_burden
KE-NRB-2014-01372,2014,28,25-34,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,11.4,moderate_burden
KE-NRB-2011-01373,2011,58,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2017-01374,2017,64,55-64,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.3,moderate_burden
KE-NRB-2014-01375,2014,56,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,40.7,moderate_burden
KE-NRB-2009-01376,2009,31,25-34,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,41.1,moderate_burden
KE-NRB-2012-01377,2012,63,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,8.2,moderate_burden
KE-NRB-2011-01378,2011,84,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,27.0,moderate_burden
KE-NRB-2018-01379,2018,67,65-74,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,58.8,moderate_burden
KE-NRB-2012-01380,2012,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-01381,2011,28,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2017-01382,2017,43,35-44,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.7,moderate_burden
KE-NRB-2017-01383,2017,57,55-64,Male,Leukemia,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2016-01384,2016,38,35-44,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2016-01385,2016,53,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,0.4,moderate_burden
KE-NRB-2012-01386,2012,63,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,58.1,moderate_burden
KE-NRB-2013-01387,2013,66,65-74,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.1,moderate_burden
KE-NRB-2013-01388,2013,54,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,29.1,moderate_burden
KE-NRB-2016-01389,2016,33,25-34,Male,Multiple myeloma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,4.3,moderate_burden
KE-NRB-2010-01390,2010,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,4.8,moderate_burden
KE-NRB-2017-01391,2017,70,65-74,Male,Kidney,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.0,moderate_burden
KE-NRB-2010-01392,2010,68,65-74,Female,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Lost to follow-up,50.6,moderate_burden
KE-NRB-2014-01393,2014,45,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.1,moderate_burden
KE-NRB-2013-01394,2013,72,65-74,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,29.5,moderate_burden
KE-NRB-2018-01395,2018,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.9,moderate_burden
KE-NRB-2017-01396,2017,60,55-64,Male,Skin (melanoma),Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-01397,2012,54,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,11.8,moderate_burden
KE-NRB-2011-01398,2011,42,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.2,moderate_burden
KE-NRB-2016-01399,2016,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,6.5,moderate_burden
KE-NRB-2017-01400,2017,40,35-44,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,12.5,moderate_burden
KE-NRB-2017-01401,2017,72,65-74,Male,Brain and CNS,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,28.8,moderate_burden
KE-NRB-2009-01402,2009,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,43.6,moderate_burden
KE-NRB-2013-01403,2013,48,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.0,moderate_burden
KE-NRB-2015-01404,2015,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,35.9,moderate_burden
KE-NRB-2015-01405,2015,26,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-01406,2016,56,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01407,2015,62,55-64,Male,Leukemia,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.8,moderate_burden
KE-NRB-2013-01408,2013,58,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2016-01409,2016,72,65-74,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.5,moderate_burden
KE-NRB-2013-01410,2013,94,75+,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01411,2015,64,55-64,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.1,moderate_burden
KE-NRB-2014-01412,2014,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.4,moderate_burden
KE-NRB-2012-01413,2012,59,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.5,moderate_burden
KE-NRB-2010-01414,2010,49,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Peri-urban,N/A,Dead,29.8,moderate_burden
KE-NRB-2014-01415,2014,53,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Alive,15.9,moderate_burden
KE-NRB-2012-01416,2012,71,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Chemo + Radiotherapy,Dead,12.1,moderate_burden
KE-NRB-2010-01417,2010,68,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.6,moderate_burden
KE-NRB-2010-01418,2010,58,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01419,2013,28,25-34,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.1,moderate_burden
KE-NRB-2012-01420,2012,57,55-64,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,36.5,moderate_burden
KE-NRB-2016-01421,2016,64,55-64,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Dead,4.1,moderate_burden
KE-NRB-2018-01422,2018,25,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,5.7,moderate_burden
KE-NRB-2016-01423,2016,66,65-74,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,13.7,moderate_burden
KE-NRB-2017-01424,2017,52,45-54,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,26.1,moderate_burden
KE-NRB-2014-01425,2014,51,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.8,moderate_burden
KE-NRB-2015-01426,2015,42,35-44,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.8,moderate_burden
KE-NRB-2014-01427,2014,49,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,7.4,moderate_burden
KE-NRB-2013-01428,2013,72,65-74,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.5,moderate_burden
KE-NRB-2015-01429,2015,62,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,50.6,moderate_burden
KE-NRB-2014-01430,2014,27,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,1.5,moderate_burden
KE-NRB-2015-01431,2015,32,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.0,moderate_burden
KE-NRB-2017-01432,2017,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-01433,2013,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.4,moderate_burden
KE-NRB-2014-01434,2014,54,45-54,Male,Bladder,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Dead,18.4,moderate_burden
KE-NRB-2012-01435,2012,91,75+,Female,Corpus uteri,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,48.8,moderate_burden
KE-NRB-2017-01436,2017,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,3.2,moderate_burden
KE-NRB-2014-01437,2014,26,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.6,moderate_burden
KE-NRB-2018-01438,2018,33,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,13.7,moderate_burden
KE-NRB-2014-01439,2014,52,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.9,moderate_burden
KE-NRB-2011-01440,2011,68,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,23.4,moderate_burden
KE-NRB-2016-01441,2016,80,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,42.3,moderate_burden
KE-NRB-2011-01442,2011,40,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.5,moderate_burden
KE-NRB-2015-01443,2015,55,55-64,Male,Non-Hodgkin lymphoma,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01444,2013,48,45-54,Male,Colorectum,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,17.1,moderate_burden
KE-NRB-2016-01445,2016,4,0-14,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,17.8,moderate_burden
KE-NRB-2015-01446,2015,41,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.9,moderate_burden
KE-NRB-2017-01447,2017,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,4.8,moderate_burden
KE-NRB-2018-01448,2018,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.4,moderate_burden
KE-NRB-2018-01449,2018,22,15-24,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,0.5,moderate_burden
KE-NRB-2012-01450,2012,17,15-24,Female,Breast,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,5.8,moderate_burden
KE-NRB-2011-01451,2011,46,45-54,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,25.8,moderate_burden
KE-NRB-2015-01452,2015,64,55-64,Female,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Alive,18.9,moderate_burden
KE-NRB-2015-01453,2015,41,35-44,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,11.2,moderate_burden
KE-NRB-2013-01454,2013,37,35-44,Male,Kaposi sarcoma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.0,moderate_burden
KE-NRB-2018-01455,2018,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.0,moderate_burden
KE-NRB-2011-01456,2011,19,15-24,Male,Multiple myeloma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.8,moderate_burden
KE-NRB-2016-01457,2016,59,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,42.8,moderate_burden
KE-NRB-2011-01458,2011,49,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,19.8,moderate_burden
KE-NRB-2018-01459,2018,52,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,40.4,moderate_burden
KE-NRB-2012-01460,2012,55,55-64,Female,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.9,moderate_burden
KE-NRB-2016-01461,2016,54,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,5.8,moderate_burden
KE-NRB-2015-01462,2015,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2009-01463,2009,54,45-54,Female,Corpus uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2016-01464,2016,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.6,moderate_burden
KE-NRB-2014-01465,2014,40,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-01466,2010,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,33.4,moderate_burden
KE-NRB-2009-01467,2009,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,45.1,moderate_burden
KE-NRB-2015-01468,2015,69,65-74,Male,Brain and CNS,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.6,moderate_burden
KE-NRB-2015-01469,2015,56,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.9,moderate_burden
KE-NRB-2015-01470,2015,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,4.8,moderate_burden
KE-NRB-2017-01471,2017,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,30.7,moderate_burden
KE-NRB-2010-01472,2010,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-01473,2012,8,0-14,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,50.8,moderate_burden
KE-NRB-2012-01474,2012,74,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,11.8,moderate_burden
KE-NRB-2014-01475,2014,39,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.5,moderate_burden
KE-NRB-2015-01476,2015,36,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.0,moderate_burden
KE-NRB-2016-01477,2016,52,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,40.8,moderate_burden
KE-NRB-2011-01478,2011,63,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,32.3,moderate_burden
KE-NRB-2014-01479,2014,46,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.7,moderate_burden
KE-NRB-2013-01480,2013,52,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2011-01481,2011,0,0-14,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,33.2,moderate_burden
KE-NRB-2012-01482,2012,67,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,6.0,moderate_burden
KE-NRB-2018-01483,2018,22,15-24,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,28.0,moderate_burden
KE-NRB-2016-01484,2016,87,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,16.8,moderate_burden
KE-NRB-2011-01485,2011,26,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,1.5,moderate_burden
KE-NRB-2011-01486,2011,51,45-54,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.0,moderate_burden
KE-NRB-2016-01487,2016,68,65-74,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.1,moderate_burden
KE-NRB-2014-01488,2014,40,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,47.8,moderate_burden
KE-NRB-2016-01489,2016,87,75+,Male,Kidney,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,6.1,moderate_burden
KE-NRB-2010-01490,2010,45,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,5.0,moderate_burden
KE-NRB-2010-01491,2010,55,55-64,Male,Bladder,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-01492,2011,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-01493,2014,51,45-54,Male,Stomach,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,43.8,moderate_burden
KE-NRB-2017-01494,2017,50,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-01495,2018,26,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01496,2013,49,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01497,2013,69,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,26.6,moderate_burden
KE-NRB-2009-01498,2009,55,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2012-01499,2012,82,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,14.2,moderate_burden
KE-NRB-2017-01500,2017,30,25-34,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,5.7,moderate_burden
KE-NRB-2017-01501,2017,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,12.3,moderate_burden
KE-NRB-2014-01502,2014,47,45-54,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.4,moderate_burden
KE-NRB-2012-01503,2012,49,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.0,moderate_burden
KE-NRB-2015-01504,2015,47,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,39.3,moderate_burden
KE-NRB-2015-01505,2015,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,19.2,moderate_burden
KE-NRB-2015-01506,2015,70,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,No treatment,Dead,0.8,moderate_burden
KE-NRB-2009-01507,2009,70,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.3,moderate_burden
KE-NRB-2014-01508,2014,74,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.4,moderate_burden
KE-NRB-2018-01509,2018,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,21.7,moderate_burden
KE-NRB-2011-01510,2011,59,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.2,moderate_burden
KE-NRB-2018-01511,2018,47,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-01512,2011,63,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-01513,2015,30,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Lost to follow-up,13.5,moderate_burden
KE-NRB-2018-01514,2018,46,45-54,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,53.6,moderate_burden
KE-NRB-2014-01515,2014,48,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2014-01516,2014,58,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.6,moderate_burden
KE-NRB-2011-01517,2011,38,35-44,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Other,Benign/uncertain,Urban,N/A,Lost to follow-up,17.1,moderate_burden
KE-NRB-2014-01518,2014,62,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.4,moderate_burden
KE-NRB-2013-01519,2013,36,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.5,moderate_burden
KE-NRB-2009-01520,2009,73,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,8.7,moderate_burden
KE-NRB-2013-01521,2013,89,75+,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,5.8,moderate_burden
KE-NRB-2009-01522,2009,57,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,26.8,moderate_burden
KE-NRB-2015-01523,2015,95,75+,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,46.3,moderate_burden
KE-NRB-2010-01524,2010,45,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,29.5,moderate_burden
KE-NRB-2018-01525,2018,55,55-64,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery + Radiotherapy,Dead,24.4,moderate_burden
KE-NRB-2012-01526,2012,40,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,9.1,moderate_burden
KE-NRB-2017-01527,2017,58,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Lost to follow-up,34.3,moderate_burden
KE-NRB-2016-01528,2016,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,18.4,moderate_burden
KE-NRB-2018-01529,2018,62,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.3,moderate_burden
KE-NRB-2018-01530,2018,39,35-44,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.5,moderate_burden
KE-NRB-2010-01531,2010,59,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01532,2014,49,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,48.2,moderate_burden
KE-NRB-2015-01533,2015,52,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,44.8,moderate_burden
KE-NRB-2013-01534,2013,66,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,12.7,moderate_burden
KE-NRB-2016-01535,2016,92,75+,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.7,moderate_burden
KE-NRB-2017-01536,2017,71,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,0.1,moderate_burden
KE-NRB-2015-01537,2015,33,25-34,Male,Brain and CNS,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.3,moderate_burden
KE-NRB-2017-01538,2017,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,12.0,moderate_burden
KE-NRB-2012-01539,2012,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,22.0,moderate_burden
KE-NRB-2013-01540,2013,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,38.5,moderate_burden
KE-NRB-2013-01541,2013,21,15-24,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,33.2,moderate_burden
KE-NRB-2009-01542,2009,37,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,53.5,moderate_burden
KE-NRB-2014-01543,2014,47,45-54,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-01544,2009,68,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.6,moderate_burden
KE-NRB-2010-01545,2010,62,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,12.5,moderate_burden
KE-NRB-2011-01546,2011,36,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,28.7,moderate_burden
KE-NRB-2015-01547,2015,85,75+,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,14.8,moderate_burden
KE-NRB-2012-01548,2012,31,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.5,moderate_burden
KE-NRB-2013-01549,2013,68,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,0.3,moderate_burden
KE-NRB-2011-01550,2011,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.9,moderate_burden
KE-NRB-2011-01551,2011,75,75+,Male,Leukemia,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,25.3,moderate_burden
KE-NRB-2013-01552,2013,49,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,25.6,moderate_burden
KE-NRB-2015-01553,2015,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.9,moderate_burden
KE-NRB-2018-01554,2018,55,55-64,Male,Colorectum,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,24.6,moderate_burden
KE-NRB-2017-01555,2017,49,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01556,2015,85,75+,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-01557,2014,67,65-74,Female,Thyroid,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.2,moderate_burden
KE-NRB-2014-01558,2014,59,55-64,Male,Brain and CNS,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-01559,2017,52,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Rural,N/A,Dead,22.2,moderate_burden
KE-NRB-2017-01560,2017,72,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.3,moderate_burden
KE-NRB-2012-01561,2012,27,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2014-01562,2014,58,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,23.1,moderate_burden
KE-NRB-2010-01563,2010,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2011-01564,2011,49,45-54,Male,Multiple myeloma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,16.1,moderate_burden
KE-NRB-2017-01565,2017,27,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,49.2,moderate_burden
KE-NRB-2009-01566,2009,48,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,19.7,moderate_burden
KE-NRB-2016-01567,2016,47,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-01568,2018,55,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.4,moderate_burden
KE-NRB-2014-01569,2014,47,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,20.1,moderate_burden
KE-NRB-2012-01570,2012,44,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.8,moderate_burden
KE-NRB-2015-01571,2015,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.2,moderate_burden
KE-NRB-2014-01572,2014,71,65-74,Male,Prostate,Squamous cell carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,10.9,moderate_burden
KE-NRB-2018-01573,2018,85,75+,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,4.4,moderate_burden
KE-NRB-2018-01574,2018,62,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.5,moderate_burden
KE-NRB-2016-01575,2016,59,55-64,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-01576,2012,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.0,moderate_burden
KE-NRB-2016-01577,2016,36,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.8,moderate_burden
KE-NRB-2013-01578,2013,66,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-01579,2013,92,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-01580,2011,74,65-74,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-01581,2011,56,55-64,Female,Ovary,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.3,moderate_burden
KE-NRB-2013-01582,2013,36,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.9,moderate_burden
KE-NRB-2016-01583,2016,40,35-44,Male,Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.7,moderate_burden
KE-NRB-2018-01584,2018,39,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.2,moderate_burden
KE-NRB-2017-01585,2017,53,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Dead,51.2,moderate_burden
KE-NRB-2016-01586,2016,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.5,moderate_burden
KE-NRB-2018-01587,2018,71,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,30.4,moderate_burden
KE-NRB-2016-01588,2016,25,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,6.0,moderate_burden
KE-NRB-2018-01589,2018,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,23.0,moderate_burden
KE-NRB-2011-01590,2011,25,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,42.7,moderate_burden
KE-NRB-2012-01591,2012,29,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,20.9,moderate_burden
KE-NRB-2014-01592,2014,28,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.0,moderate_burden
KE-NRB-2018-01593,2018,48,45-54,Male,Oesophagus,Unspecified,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,32.1,moderate_burden
KE-NRB-2010-01594,2010,65,65-74,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,23.0,moderate_burden
KE-NRB-2018-01595,2018,74,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-01596,2015,50,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,27.4,moderate_burden
KE-NRB-2017-01597,2017,53,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,9.6,moderate_burden
KE-NRB-2018-01598,2018,71,65-74,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.4,moderate_burden
KE-NRB-2011-01599,2011,31,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.5,moderate_burden
KE-NRB-2016-01600,2016,30,25-34,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.8,moderate_burden
KE-NRB-2012-01601,2012,46,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,19.7,moderate_burden
KE-NRB-2016-01602,2016,68,65-74,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,16.4,moderate_burden
KE-NRB-2009-01603,2009,41,35-44,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,12.4,moderate_burden
KE-NRB-2016-01604,2016,56,55-64,Male,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.1,moderate_burden
KE-NRB-2014-01605,2014,64,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,14.9,moderate_burden
KE-NRB-2009-01606,2009,57,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,14.0,moderate_burden
KE-NRB-2018-01607,2018,72,65-74,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.3,moderate_burden
KE-NRB-2012-01608,2012,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.0,moderate_burden
KE-NRB-2014-01609,2014,32,25-34,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,34.3,moderate_burden
KE-NRB-2010-01610,2010,32,25-34,Male,Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,51.2,moderate_burden
KE-NRB-2018-01611,2018,51,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-01612,2011,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-01613,2013,46,45-54,Male,Lung,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,8.6,moderate_burden
KE-NRB-2011-01614,2011,54,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,4.8,moderate_burden
KE-NRB-2013-01615,2013,62,55-64,Female,Ovary,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,38.2,moderate_burden
KE-NRB-2014-01616,2014,51,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,21.2,moderate_burden
KE-NRB-2016-01617,2016,66,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.6,moderate_burden
KE-NRB-2011-01618,2011,65,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,15.9,moderate_burden
KE-NRB-2013-01619,2013,61,55-64,Male,Oesophagus,Unspecified,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,54.8,moderate_burden
KE-NRB-2018-01620,2018,55,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.3,moderate_burden
KE-NRB-2017-01621,2017,46,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.3,moderate_burden
KE-NRB-2017-01622,2017,52,45-54,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,14.5,moderate_burden
KE-NRB-2018-01623,2018,2,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-01624,2018,66,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,17.4,moderate_burden
KE-NRB-2016-01625,2016,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.0,moderate_burden
KE-NRB-2010-01626,2010,34,25-34,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.0,moderate_burden
KE-NRB-2017-01627,2017,18,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,19.6,moderate_burden
KE-NRB-2018-01628,2018,29,25-34,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,56.6,moderate_burden
KE-NRB-2016-01629,2016,70,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,7.3,moderate_burden
KE-NRB-2014-01630,2014,71,65-74,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,31.5,moderate_burden
KE-NRB-2018-01631,2018,37,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,20.9,moderate_burden
KE-NRB-2010-01632,2010,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01633,2015,71,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.0,moderate_burden
KE-NRB-2013-01634,2013,67,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,22.8,moderate_burden
KE-NRB-2010-01635,2010,42,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,35.1,moderate_burden
KE-NRB-2018-01636,2018,54,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,22.6,moderate_burden
KE-NRB-2012-01637,2012,70,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-01638,2012,23,15-24,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01639,2016,40,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,42.3,moderate_burden
KE-NRB-2016-01640,2016,45,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.1,moderate_burden
KE-NRB-2016-01641,2016,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-01642,2013,32,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,17.8,moderate_burden
KE-NRB-2009-01643,2009,35,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.0,moderate_burden
KE-NRB-2017-01644,2017,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,25.8,moderate_burden
KE-NRB-2013-01645,2013,53,45-54,Female,Ovary,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,36.4,moderate_burden
KE-NRB-2012-01646,2012,59,55-64,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.9,moderate_burden
KE-NRB-2016-01647,2016,54,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-01648,2014,60,55-64,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,12.5,moderate_burden
KE-NRB-2011-01649,2011,58,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,2.1,moderate_burden
KE-NRB-2015-01650,2015,68,65-74,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Peri-urban,Palliative care only,Alive,42.9,moderate_burden
KE-NRB-2012-01651,2012,87,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,31.0,moderate_burden
KE-NRB-2016-01652,2016,71,65-74,Male,Bladder,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,2.3,moderate_burden
KE-NRB-2015-01653,2015,30,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-01654,2009,64,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-01655,2017,48,45-54,Male,Prostate,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2015-01656,2015,88,75+,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,14.7,moderate_burden
KE-NRB-2012-01657,2012,74,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,10.2,moderate_burden
KE-NRB-2016-01658,2016,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,18.7,moderate_burden
KE-NRB-2010-01659,2010,45,45-54,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,38.6,moderate_burden
KE-NRB-2018-01660,2018,66,65-74,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,8.6,moderate_burden
KE-NRB-2017-01661,2017,79,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,41.6,moderate_burden
KE-NRB-2017-01662,2017,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-01663,2018,57,55-64,Female,Ovary,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,28.4,moderate_burden
KE-NRB-2014-01664,2014,28,25-34,Female,Corpus uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,24.5,moderate_burden
KE-NRB-2010-01665,2010,59,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,48.8,moderate_burden
KE-NRB-2015-01666,2015,35,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,35.2,moderate_burden
KE-NRB-2016-01667,2016,36,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,4.9,moderate_burden
KE-NRB-2014-01668,2014,46,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01669,2017,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,12.4,moderate_burden
KE-NRB-2017-01670,2017,54,45-54,Male,Stomach,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,51.2,moderate_burden
KE-NRB-2018-01671,2018,65,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,8.1,moderate_burden
KE-NRB-2010-01672,2010,53,45-54,Male,Lung,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.1,moderate_burden
KE-NRB-2009-01673,2009,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,1.4,moderate_burden
KE-NRB-2009-01674,2009,93,75+,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,12.8,moderate_burden
KE-NRB-2015-01675,2015,87,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.8,moderate_burden
KE-NRB-2012-01676,2012,88,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-01677,2011,34,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Other,In situ,Urban,N/A,Alive,0.5,moderate_burden
KE-NRB-2010-01678,2010,73,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.6,moderate_burden
KE-NRB-2017-01679,2017,44,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,28.0,moderate_burden
KE-NRB-2017-01680,2017,89,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2016-01681,2016,70,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-01682,2017,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.7,moderate_burden
KE-NRB-2018-01683,2018,61,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.1,moderate_burden
KE-NRB-2012-01684,2012,74,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-01685,2010,86,75+,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.7,moderate_burden
KE-NRB-2018-01686,2018,69,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,21.4,moderate_burden
KE-NRB-2014-01687,2014,86,75+,Male,Skin (melanoma),Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.5,moderate_burden
KE-NRB-2009-01688,2009,28,25-34,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,56.7,moderate_burden
KE-NRB-2016-01689,2016,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.9,moderate_burden
KE-NRB-2011-01690,2011,51,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.5,moderate_burden
KE-NRB-2016-01691,2016,44,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,57.4,moderate_burden
KE-NRB-2018-01692,2018,57,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,12.9,moderate_burden
KE-NRB-2018-01693,2018,61,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,13.5,moderate_burden
KE-NRB-2013-01694,2013,30,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.0,moderate_burden
KE-NRB-2013-01695,2013,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.2,moderate_burden
KE-NRB-2009-01696,2009,38,35-44,Male,Stomach,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,36.2,moderate_burden
KE-NRB-2018-01697,2018,66,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,23.6,moderate_burden
KE-NRB-2009-01698,2009,44,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.0,moderate_burden
KE-NRB-2014-01699,2014,60,55-64,Female,Other,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,1.1,moderate_burden
KE-NRB-2015-01700,2015,35,35-44,Male,Multiple myeloma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,19.2,moderate_burden
KE-NRB-2012-01701,2012,60,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,18.3,moderate_burden
KE-NRB-2010-01702,2010,7,0-14,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,41.6,moderate_burden
KE-NRB-2016-01703,2016,53,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,25.4,moderate_burden
KE-NRB-2009-01704,2009,53,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,7.8,moderate_burden
KE-NRB-2011-01705,2011,48,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-01706,2011,50,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Rural,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-01707,2013,64,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,11.8,moderate_burden
KE-NRB-2015-01708,2015,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.1,moderate_burden
KE-NRB-2015-01709,2015,41,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.9,moderate_burden
KE-NRB-2017-01710,2017,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,18.5,moderate_burden
KE-NRB-2018-01711,2018,60,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,1.6,moderate_burden
KE-NRB-2013-01712,2013,41,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,9.8,moderate_burden
KE-NRB-2011-01713,2011,49,45-54,Male,Bladder,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.9,moderate_burden
KE-NRB-2018-01714,2018,44,35-44,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01715,2016,88,75+,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,28.4,moderate_burden
KE-NRB-2014-01716,2014,47,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,29.3,moderate_burden
KE-NRB-2010-01717,2010,65,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,2.6,moderate_burden
KE-NRB-2015-01718,2015,37,35-44,Female,Ovary,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,37.3,moderate_burden
KE-NRB-2018-01719,2018,76,75+,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,39.0,moderate_burden
KE-NRB-2016-01720,2016,49,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,53.4,moderate_burden
KE-NRB-2016-01721,2016,28,25-34,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-01722,2016,42,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,5.8,moderate_burden
KE-NRB-2016-01723,2016,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.2,moderate_burden
KE-NRB-2011-01724,2011,38,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,24.1,moderate_burden
KE-NRB-2017-01725,2017,61,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Lost to follow-up,14.6,moderate_burden
KE-NRB-2017-01726,2017,72,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-01727,2012,60,55-64,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01728,2016,11,0-14,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,20.0,moderate_burden
KE-NRB-2013-01729,2013,71,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.4,moderate_burden
KE-NRB-2018-01730,2018,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.6,moderate_burden
KE-NRB-2017-01731,2017,37,35-44,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-01732,2010,55,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,46.2,moderate_burden
KE-NRB-2013-01733,2013,66,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.0,moderate_burden
KE-NRB-2017-01734,2017,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,1.5,moderate_burden
KE-NRB-2018-01735,2018,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.9,moderate_burden
KE-NRB-2012-01736,2012,56,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-01737,2013,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-01738,2018,19,15-24,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,14.5,moderate_burden
KE-NRB-2010-01739,2010,64,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,23.1,moderate_burden
KE-NRB-2016-01740,2016,52,45-54,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-01741,2018,41,35-44,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.4,moderate_burden
KE-NRB-2011-01742,2011,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,13.1,moderate_burden
KE-NRB-2016-01743,2016,94,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,9.2,moderate_burden
KE-NRB-2017-01744,2017,76,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.3,moderate_burden
KE-NRB-2010-01745,2010,64,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2016-01746,2016,41,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,34.0,moderate_burden
KE-NRB-2010-01747,2010,25,25-34,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,35.9,moderate_burden
KE-NRB-2012-01748,2012,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,5.2,moderate_burden
KE-NRB-2015-01749,2015,62,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.6,moderate_burden
KE-NRB-2018-01750,2018,69,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,7.5,moderate_burden
KE-NRB-2017-01751,2017,63,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,2.0,moderate_burden
KE-NRB-2011-01752,2011,51,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,30.3,moderate_burden
KE-NRB-2010-01753,2010,10,0-14,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2011-01754,2011,29,25-34,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,15.6,moderate_burden
KE-NRB-2012-01755,2012,48,45-54,Male,Kidney,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,35.4,moderate_burden
KE-NRB-2018-01756,2018,59,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,21.0,moderate_burden
KE-NRB-2009-01757,2009,67,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,39.5,moderate_burden
KE-NRB-2016-01758,2016,60,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,52.7,moderate_burden
KE-NRB-2011-01759,2011,65,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,17.7,moderate_burden
KE-NRB-2015-01760,2015,50,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.6,moderate_burden
KE-NRB-2018-01761,2018,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.9,moderate_burden
KE-NRB-2016-01762,2016,54,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,4.5,moderate_burden
KE-NRB-2017-01763,2017,51,45-54,Male,Oesophagus,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,17.4,moderate_burden
KE-NRB-2014-01764,2014,37,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,45.4,moderate_burden
KE-NRB-2013-01765,2013,37,35-44,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,0.1,moderate_burden
KE-NRB-2015-01766,2015,42,35-44,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,41.0,moderate_burden
KE-NRB-2018-01767,2018,59,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,5.6,moderate_burden
KE-NRB-2010-01768,2010,95,75+,Male,Prostate,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Dead,22.7,moderate_burden
KE-NRB-2012-01769,2012,74,65-74,Male,Leukemia,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.2,moderate_burden
KE-NRB-2012-01770,2012,43,35-44,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,58.1,moderate_burden
KE-NRB-2017-01771,2017,94,75+,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,36.6,moderate_burden
KE-NRB-2011-01772,2011,47,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,24.8,moderate_burden
KE-NRB-2009-01773,2009,32,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.3,moderate_burden
KE-NRB-2018-01774,2018,54,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01775,2017,57,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,12.1,moderate_burden
KE-NRB-2017-01776,2017,51,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,26.9,moderate_burden
KE-NRB-2009-01777,2009,21,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,38.2,moderate_burden
KE-NRB-2017-01778,2017,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,9.5,moderate_burden
KE-NRB-2009-01779,2009,58,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-01780,2015,44,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.5,moderate_burden
KE-NRB-2009-01781,2009,54,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,50.2,moderate_burden
KE-NRB-2012-01782,2012,29,25-34,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,58.9,moderate_burden
KE-NRB-2012-01783,2012,38,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,19.9,moderate_burden
KE-NRB-2014-01784,2014,6,0-14,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-01785,2015,89,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,3.4,moderate_burden
KE-NRB-2016-01786,2016,45,45-54,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-01787,2010,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,17.4,moderate_burden
KE-NRB-2010-01788,2010,44,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.7,moderate_burden
KE-NRB-2009-01789,2009,51,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01790,2015,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,24.0,moderate_burden
KE-NRB-2011-01791,2011,48,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Rural,N/A,Dead,8.5,moderate_burden
KE-NRB-2009-01792,2009,9,0-14,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.0,moderate_burden
KE-NRB-2016-01793,2016,42,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,3.7,moderate_burden
KE-NRB-2015-01794,2015,64,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-01795,2013,43,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,6.0,moderate_burden
KE-NRB-2014-01796,2014,65,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,47.4,moderate_burden
KE-NRB-2009-01797,2009,61,55-64,Male,Kaposi sarcoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2013-01798,2013,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,18.0,moderate_burden
KE-NRB-2016-01799,2016,6,0-14,Male,Other,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemotherapy only,Alive,20.4,moderate_burden
KE-NRB-2016-01800,2016,36,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.6,moderate_burden
KE-NRB-2016-01801,2016,47,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,0.2,moderate_burden
KE-NRB-2009-01802,2009,70,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,15.5,moderate_burden
KE-NRB-2018-01803,2018,50,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.0,moderate_burden
KE-NRB-2014-01804,2014,50,45-54,Female,Corpus uteri,Sarcoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery only,Dead,1.2,moderate_burden
KE-NRB-2013-01805,2013,62,55-64,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-01806,2009,66,65-74,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,51.7,moderate_burden
KE-NRB-2014-01807,2014,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.8,moderate_burden
KE-NRB-2009-01808,2009,63,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,13.2,moderate_burden
KE-NRB-2011-01809,2011,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.3,moderate_burden
KE-NRB-2013-01810,2013,38,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,53.3,moderate_burden
KE-NRB-2013-01811,2013,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,27.8,moderate_burden
KE-NRB-2018-01812,2018,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01813,2014,36,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,9.6,moderate_burden
KE-NRB-2010-01814,2010,73,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,8.1,moderate_burden
KE-NRB-2010-01815,2010,17,15-24,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-01816,2011,56,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.3,moderate_burden
KE-NRB-2017-01817,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2018-01818,2018,74,65-74,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,9.6,moderate_burden
KE-NRB-2014-01819,2014,95,75+,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,26.6,moderate_burden
KE-NRB-2013-01820,2013,63,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,23.0,moderate_burden
KE-NRB-2011-01821,2011,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-01822,2012,55,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.5,moderate_burden
KE-NRB-2017-01823,2017,37,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,19.7,moderate_burden
KE-NRB-2010-01824,2010,41,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,4.2,moderate_burden
KE-NRB-2018-01825,2018,46,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,1.4,moderate_burden
KE-NRB-2009-01826,2009,67,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,10.9,moderate_burden
KE-NRB-2009-01827,2009,73,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.4,moderate_burden
KE-NRB-2015-01828,2015,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,40.9,moderate_burden
KE-NRB-2014-01829,2014,24,15-24,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Urban,N/A,Dead,18.2,moderate_burden
KE-NRB-2011-01830,2011,42,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,0.1,moderate_burden
KE-NRB-2017-01831,2017,53,45-54,Male,Leukemia,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-01832,2015,38,35-44,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,26.3,moderate_burden
KE-NRB-2014-01833,2014,76,75+,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01834,2015,30,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.2,moderate_burden
KE-NRB-2017-01835,2017,25,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,37.2,moderate_burden
KE-NRB-2013-01836,2013,54,45-54,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.8,moderate_burden
KE-NRB-2011-01837,2011,57,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.8,moderate_burden
KE-NRB-2010-01838,2010,48,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.2,moderate_burden
KE-NRB-2013-01839,2013,34,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.3,moderate_burden
KE-NRB-2012-01840,2012,19,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,22.5,moderate_burden
KE-NRB-2017-01841,2017,73,65-74,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.2,moderate_burden
KE-NRB-2013-01842,2013,58,55-64,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-01843,2011,71,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.8,moderate_burden
KE-NRB-2015-01844,2015,52,45-54,Male,Leukemia,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-01845,2018,60,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-01846,2015,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.7,moderate_burden
KE-NRB-2018-01847,2018,55,55-64,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.1,moderate_burden
KE-NRB-2018-01848,2018,57,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,14.4,moderate_burden
KE-NRB-2015-01849,2015,44,35-44,Male,Colorectum,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.9,moderate_burden
KE-NRB-2009-01850,2009,37,35-44,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.9,moderate_burden
KE-NRB-2015-01851,2015,88,75+,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-01852,2009,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.6,moderate_burden
KE-NRB-2009-01853,2009,33,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,7.8,moderate_burden
KE-NRB-2017-01854,2017,69,65-74,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01855,2014,44,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Palliative care only,Dead,0.5,moderate_burden
KE-NRB-2015-01856,2015,37,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,48.3,moderate_burden
KE-NRB-2011-01857,2011,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.6,moderate_burden
KE-NRB-2012-01858,2012,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,9.7,moderate_burden
KE-NRB-2018-01859,2018,53,45-54,Male,Oesophagus,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,11.1,moderate_burden
KE-NRB-2014-01860,2014,44,35-44,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,17.0,moderate_burden
KE-NRB-2013-01861,2013,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,23.8,moderate_burden
KE-NRB-2017-01862,2017,52,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-01863,2013,41,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,27.5,moderate_burden
KE-NRB-2016-01864,2016,55,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.8,moderate_burden
KE-NRB-2016-01865,2016,73,65-74,Male,Bladder,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,6.2,moderate_burden
KE-NRB-2011-01866,2011,51,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.0,moderate_burden
KE-NRB-2010-01867,2010,21,15-24,Male,Multiple myeloma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-01868,2018,58,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,21.3,moderate_burden
KE-NRB-2015-01869,2015,30,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.7,moderate_burden
KE-NRB-2018-01870,2018,44,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,43.0,moderate_burden
KE-NRB-2018-01871,2018,28,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,3.7,moderate_burden
KE-NRB-2009-01872,2009,32,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-01873,2017,84,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,22.0,moderate_burden
KE-NRB-2016-01874,2016,31,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2014-01875,2014,30,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.3,moderate_burden
KE-NRB-2018-01876,2018,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.8,moderate_burden
KE-NRB-2017-01877,2017,67,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,60.0,moderate_burden
KE-NRB-2018-01878,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,20.5,moderate_burden
KE-NRB-2012-01879,2012,54,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,1.2,moderate_burden
KE-NRB-2017-01880,2017,94,75+,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,7.4,moderate_burden
KE-NRB-2015-01881,2015,69,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,42.0,moderate_burden
KE-NRB-2017-01882,2017,20,15-24,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,18.6,moderate_burden
KE-NRB-2010-01883,2010,63,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,30.9,moderate_burden
KE-NRB-2013-01884,2013,91,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.0,moderate_burden
KE-NRB-2011-01885,2011,75,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,44.1,moderate_burden
KE-NRB-2015-01886,2015,42,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2009-01887,2009,62,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,6.2,moderate_burden
KE-NRB-2010-01888,2010,55,55-64,Male,Non-Hodgkin lymphoma,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-01889,2016,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Lost to follow-up,56.0,moderate_burden
KE-NRB-2017-01890,2017,53,45-54,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,23.5,moderate_burden
KE-NRB-2016-01891,2016,49,45-54,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,No treatment,Dead,8.6,moderate_burden
KE-NRB-2018-01892,2018,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,9.0,moderate_burden
KE-NRB-2017-01893,2017,26,25-34,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,31.1,moderate_burden
KE-NRB-2013-01894,2013,76,75+,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,1.1,moderate_burden
KE-NRB-2010-01895,2010,67,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2012-01896,2012,71,65-74,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.0,moderate_burden
KE-NRB-2017-01897,2017,56,55-64,Female,Corpus uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.2,moderate_burden
KE-NRB-2010-01898,2010,60,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,27.1,moderate_burden
KE-NRB-2010-01899,2010,61,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-01900,2011,60,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.5,moderate_burden
KE-NRB-2014-01901,2014,62,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-01902,2015,26,25-34,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,22.4,moderate_burden
KE-NRB-2009-01903,2009,70,65-74,Male,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,0.4,moderate_burden
KE-NRB-2010-01904,2010,32,25-34,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-01905,2018,44,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-01906,2016,67,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.3,moderate_burden
KE-NRB-2014-01907,2014,53,45-54,Female,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Rural,Surgery + Radiotherapy,Alive,21.6,moderate_burden
KE-NRB-2016-01908,2016,56,55-64,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,19.6,moderate_burden
KE-NRB-2011-01909,2011,50,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2010-01910,2010,51,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.0,moderate_burden
KE-NRB-2011-01911,2011,66,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,24.7,moderate_burden
KE-NRB-2012-01912,2012,76,75+,Male,Non-Hodgkin lymphoma,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,23.8,moderate_burden
KE-NRB-2018-01913,2018,47,45-54,Male,Stomach,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01914,2014,65,65-74,Female,Other,Leukemia,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-01915,2014,67,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,37.3,moderate_burden
KE-NRB-2014-01916,2014,64,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,48.9,moderate_burden
KE-NRB-2016-01917,2016,49,45-54,Male,Lung,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,33.5,moderate_burden
KE-NRB-2018-01918,2018,53,45-54,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-01919,2017,42,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,53.2,moderate_burden
KE-NRB-2017-01920,2017,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Other,In situ,Peri-urban,N/A,Dead,3.4,moderate_burden
KE-NRB-2016-01921,2016,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01922,2017,66,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-01923,2016,36,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,28.8,moderate_burden
KE-NRB-2017-01924,2017,68,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,5.6,moderate_burden
KE-NRB-2013-01925,2013,47,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.3,moderate_burden
KE-NRB-2016-01926,2016,59,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-01927,2012,69,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2013-01928,2013,55,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-01929,2013,56,55-64,Male,Liver,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,0.5,moderate_burden
KE-NRB-2010-01930,2010,54,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,18.4,moderate_burden
KE-NRB-2011-01931,2011,70,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,32.3,moderate_burden
KE-NRB-2018-01932,2018,29,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,45.6,moderate_burden
KE-NRB-2015-01933,2015,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.5,moderate_burden
KE-NRB-2011-01934,2011,47,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,2.6,moderate_burden
KE-NRB-2016-01935,2016,42,35-44,Male,Colorectum,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.9,moderate_burden
KE-NRB-2014-01936,2014,64,55-64,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-01937,2013,42,35-44,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,0.5,moderate_burden
KE-NRB-2012-01938,2012,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-01939,2017,51,45-54,Male,Other,Other specified,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,54.5,moderate_burden
KE-NRB-2014-01940,2014,35,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-01941,2016,64,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,13.6,moderate_burden
KE-NRB-2016-01942,2016,42,35-44,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,15.9,moderate_burden
KE-NRB-2017-01943,2017,41,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,0.4,moderate_burden
KE-NRB-2017-01944,2017,47,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,42.8,moderate_burden
KE-NRB-2016-01945,2016,59,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,20.5,moderate_burden
KE-NRB-2010-01946,2010,15,15-24,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-01947,2013,73,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.2,moderate_burden
KE-NRB-2014-01948,2014,24,15-24,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,30.4,moderate_burden
KE-NRB-2011-01949,2011,31,25-34,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.7,moderate_burden
KE-NRB-2017-01950,2017,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.5,moderate_burden
KE-NRB-2018-01951,2018,41,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-01952,2016,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.1,moderate_burden
KE-NRB-2010-01953,2010,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,9.9,moderate_burden
KE-NRB-2014-01954,2014,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,52.4,moderate_burden
KE-NRB-2018-01955,2018,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.0,moderate_burden
KE-NRB-2010-01956,2010,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,No treatment,Dead,7.1,moderate_burden
KE-NRB-2011-01957,2011,68,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,3.4,moderate_burden
KE-NRB-2014-01958,2014,80,75+,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.2,moderate_burden
KE-NRB-2014-01959,2014,26,25-34,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.3,moderate_burden
KE-NRB-2014-01960,2014,62,55-64,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,18.8,moderate_burden
KE-NRB-2018-01961,2018,39,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,7.8,moderate_burden
KE-NRB-2011-01962,2011,67,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-01963,2012,73,65-74,Male,Leukemia,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.3,moderate_burden
KE-NRB-2011-01964,2011,28,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,10.5,moderate_burden
KE-NRB-2009-01965,2009,31,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-01966,2009,39,35-44,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,15.2,moderate_burden
KE-NRB-2017-01967,2017,42,35-44,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01968,2015,55,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-01969,2017,42,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01970,2017,44,35-44,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,28.7,moderate_burden
KE-NRB-2016-01971,2016,44,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,30.3,moderate_burden
KE-NRB-2014-01972,2014,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,16.7,moderate_burden
KE-NRB-2018-01973,2018,53,45-54,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.8,moderate_burden
KE-NRB-2018-01974,2018,31,25-34,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.3,moderate_burden
KE-NRB-2010-01975,2010,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.1,moderate_burden
KE-NRB-2011-01976,2011,61,55-64,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,31.3,moderate_burden
KE-NRB-2015-01977,2015,12,0-14,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.1,moderate_burden
KE-NRB-2018-01978,2018,60,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.8,moderate_burden
KE-NRB-2012-01979,2012,47,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,5.3,moderate_burden
KE-NRB-2014-01980,2014,56,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01981,2015,41,35-44,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.9,moderate_burden
KE-NRB-2010-01982,2010,65,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,49.8,moderate_burden
KE-NRB-2018-01983,2018,4,0-14,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.9,moderate_burden
KE-NRB-2012-01984,2012,54,45-54,Male,Leukemia,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Alive,13.6,moderate_burden
KE-NRB-2017-01985,2017,43,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.8,moderate_burden
KE-NRB-2017-01986,2017,67,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-01987,2017,44,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-01988,2018,62,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery only,Dead,8.7,moderate_burden
KE-NRB-2015-01989,2015,61,55-64,Male,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-01990,2012,56,55-64,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-01991,2015,66,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,19.2,moderate_burden
KE-NRB-2017-01992,2017,45,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.3,moderate_burden
KE-NRB-2011-01993,2011,38,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,12.9,moderate_burden
KE-NRB-2018-01994,2018,53,45-54,Male,Bladder,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Rural,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-01995,2011,61,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.4,moderate_burden
KE-NRB-2013-01996,2013,25,25-34,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.9,moderate_burden
KE-NRB-2010-01997,2010,49,45-54,Male,Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,37.5,moderate_burden
KE-NRB-2016-01998,2016,84,75+,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,0.7,moderate_burden
KE-NRB-2014-01999,2014,69,65-74,Female,Cervix uteri,Unspecified,Undifferentiated (Grade IV),Clinical only,Benign/uncertain,Urban,N/A,Alive,32.0,moderate_burden
KE-NRB-2017-02000,2017,94,75+,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,8.3,moderate_burden
KE-NRB-2018-02001,2018,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2011-02002,2011,25,25-34,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.7,moderate_burden
KE-NRB-2017-02003,2017,59,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2013-02004,2013,55,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,28.3,moderate_burden
KE-NRB-2016-02005,2016,45,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-02006,2018,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.2,moderate_burden
KE-NRB-2014-02007,2014,90,75+,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-02008,2018,60,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.1,moderate_burden
KE-NRB-2015-02009,2015,64,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,8.5,moderate_burden
KE-NRB-2018-02010,2018,52,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-02011,2013,57,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.7,moderate_burden
KE-NRB-2011-02012,2011,40,35-44,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.5,moderate_burden
KE-NRB-2013-02013,2013,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02014,2017,86,75+,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02015,2018,29,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.5,moderate_burden
KE-NRB-2013-02016,2013,50,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.4,moderate_burden
KE-NRB-2017-02017,2017,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,26.8,moderate_burden
KE-NRB-2017-02018,2017,66,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-02019,2017,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,44.3,moderate_burden
KE-NRB-2016-02020,2016,68,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.9,moderate_burden
KE-NRB-2018-02021,2018,70,65-74,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,56.8,moderate_burden
KE-NRB-2012-02022,2012,53,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,3.0,moderate_burden
KE-NRB-2013-02023,2013,63,55-64,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,38.1,moderate_burden
KE-NRB-2016-02024,2016,52,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,7.8,moderate_burden
KE-NRB-2009-02025,2009,68,65-74,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,20.9,moderate_burden
KE-NRB-2017-02026,2017,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,59.7,moderate_burden
KE-NRB-2016-02027,2016,79,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02028,2017,62,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,24.0,moderate_burden
KE-NRB-2013-02029,2013,54,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.5,moderate_burden
KE-NRB-2018-02030,2018,81,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-02031,2016,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.2,moderate_burden
KE-NRB-2017-02032,2017,77,75+,Female,Thyroid,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,24.1,moderate_burden
KE-NRB-2017-02033,2017,47,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-02034,2017,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,48.4,moderate_burden
KE-NRB-2011-02035,2011,78,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.9,moderate_burden
KE-NRB-2015-02036,2015,43,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,21.1,moderate_burden
KE-NRB-2011-02037,2011,37,35-44,Female,Ovary,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.1,moderate_burden
KE-NRB-2013-02038,2013,55,55-64,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.7,moderate_burden
KE-NRB-2009-02039,2009,70,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,46.4,moderate_burden
KE-NRB-2014-02040,2014,67,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,43.3,moderate_burden
KE-NRB-2015-02041,2015,2,0-14,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.6,moderate_burden
KE-NRB-2016-02042,2016,35,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,34.5,moderate_burden
KE-NRB-2009-02043,2009,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,12.3,moderate_burden
KE-NRB-2018-02044,2018,35,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02045,2014,67,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,46.6,moderate_burden
KE-NRB-2009-02046,2009,66,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Dead,20.2,moderate_burden
KE-NRB-2016-02047,2016,51,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,36.9,moderate_burden
KE-NRB-2016-02048,2016,35,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,45.1,moderate_burden
KE-NRB-2013-02049,2013,28,25-34,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,47.5,moderate_burden
KE-NRB-2016-02050,2016,48,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.7,moderate_burden
KE-NRB-2018-02051,2018,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.2,moderate_burden
KE-NRB-2016-02052,2016,2,0-14,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,3.4,moderate_burden
KE-NRB-2014-02053,2014,56,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.6,moderate_burden
KE-NRB-2010-02054,2010,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,4.7,moderate_burden
KE-NRB-2012-02055,2012,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.7,moderate_burden
KE-NRB-2012-02056,2012,44,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02057,2014,38,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.4,moderate_burden
KE-NRB-2016-02058,2016,53,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,23.4,moderate_burden
KE-NRB-2013-02059,2013,71,65-74,Female,Other,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,29.8,moderate_burden
KE-NRB-2017-02060,2017,44,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,moderate_burden
KE-NRB-2017-02061,2017,29,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,24.7,moderate_burden
KE-NRB-2016-02062,2016,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,4.9,moderate_burden
KE-NRB-2009-02063,2009,68,65-74,Male,Prostate,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-02064,2017,38,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,39.4,moderate_burden
KE-NRB-2017-02065,2017,27,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,10.2,moderate_burden
KE-NRB-2016-02066,2016,62,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-02067,2009,65,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.7,moderate_burden
KE-NRB-2017-02068,2017,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,44.5,moderate_burden
KE-NRB-2016-02069,2016,4,0-14,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,3.6,moderate_burden
KE-NRB-2017-02070,2017,52,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02071,2014,29,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,2.1,moderate_burden
KE-NRB-2009-02072,2009,54,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,6.9,moderate_burden
KE-NRB-2016-02073,2016,37,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02074,2017,50,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,5.1,moderate_burden
KE-NRB-2016-02075,2016,46,45-54,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.4,moderate_burden
KE-NRB-2011-02076,2011,57,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02077,2017,68,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.8,moderate_burden
KE-NRB-2018-02078,2018,94,75+,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.6,moderate_burden
KE-NRB-2013-02079,2013,63,55-64,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.9,moderate_burden
KE-NRB-2016-02080,2016,34,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,36.8,moderate_burden
KE-NRB-2018-02081,2018,45,45-54,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,23.6,moderate_burden
KE-NRB-2011-02082,2011,59,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,1.4,moderate_burden
KE-NRB-2015-02083,2015,51,45-54,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,8.1,moderate_burden
KE-NRB-2013-02084,2013,60,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,6.2,moderate_burden
KE-NRB-2010-02085,2010,39,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.1,moderate_burden
KE-NRB-2012-02086,2012,58,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,34.4,moderate_burden
KE-NRB-2011-02087,2011,60,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.6,moderate_burden
KE-NRB-2015-02088,2015,81,75+,Male,Liver,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,50.2,moderate_burden
KE-NRB-2014-02089,2014,88,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.6,moderate_burden
KE-NRB-2017-02090,2017,45,45-54,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.5,moderate_burden
KE-NRB-2014-02091,2014,51,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,36.7,moderate_burden
KE-NRB-2012-02092,2012,37,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,11.4,moderate_burden
KE-NRB-2013-02093,2013,61,55-64,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,42.2,moderate_burden
KE-NRB-2013-02094,2013,36,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,41.5,moderate_burden
KE-NRB-2010-02095,2010,51,45-54,Male,Stomach,Other specified,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.8,moderate_burden
KE-NRB-2017-02096,2017,53,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,14.9,moderate_burden
KE-NRB-2015-02097,2015,15,15-24,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.6,moderate_burden
KE-NRB-2011-02098,2011,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.7,moderate_burden
KE-NRB-2013-02099,2013,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,9.1,moderate_burden
KE-NRB-2018-02100,2018,64,55-64,Female,Breast,Unspecified,Unknown,Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-02101,2014,42,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,11.4,moderate_burden
KE-NRB-2011-02102,2011,39,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.0,moderate_burden
KE-NRB-2018-02103,2018,52,45-54,Female,Other,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-02104,2017,81,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,8.1,moderate_burden
KE-NRB-2018-02105,2018,56,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,37.9,moderate_burden
KE-NRB-2012-02106,2012,17,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,25.5,moderate_burden
KE-NRB-2016-02107,2016,54,45-54,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.4,moderate_burden
KE-NRB-2017-02108,2017,69,65-74,Female,Breast,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,11.5,moderate_burden
KE-NRB-2011-02109,2011,53,45-54,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.8,moderate_burden
KE-NRB-2017-02110,2017,33,25-34,Female,Corpus uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-02111,2015,41,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2018-02112,2018,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,1.8,moderate_burden
KE-NRB-2013-02113,2013,71,65-74,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Dead,10.1,moderate_burden
KE-NRB-2014-02114,2014,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.2,moderate_burden
KE-NRB-2018-02115,2018,60,55-64,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,50.0,moderate_burden
KE-NRB-2011-02116,2011,54,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2011-02117,2011,30,25-34,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.2,moderate_burden
KE-NRB-2017-02118,2017,61,55-64,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,44.7,moderate_burden
KE-NRB-2015-02119,2015,51,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,40.1,moderate_burden
KE-NRB-2015-02120,2015,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.4,moderate_burden
KE-NRB-2016-02121,2016,48,45-54,Female,Ovary,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-02122,2013,10,0-14,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-02123,2018,42,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Dead,29.9,moderate_burden
KE-NRB-2018-02124,2018,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,19.1,moderate_burden
KE-NRB-2015-02125,2015,48,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,11.3,moderate_burden
KE-NRB-2016-02126,2016,44,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.7,moderate_burden
KE-NRB-2017-02127,2017,52,45-54,Male,Kidney,Squamous cell carcinoma,Unknown,Death certificate only,Benign/uncertain,Urban,N/A,Alive,6.7,moderate_burden
KE-NRB-2014-02128,2014,29,25-34,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.6,moderate_burden
KE-NRB-2016-02129,2016,94,75+,Female,Ovary,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.1,moderate_burden
KE-NRB-2015-02130,2015,22,15-24,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02131,2017,50,45-54,Female,Breast,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,28.0,moderate_burden
KE-NRB-2013-02132,2013,69,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.3,moderate_burden
KE-NRB-2009-02133,2009,44,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,47.2,moderate_burden
KE-NRB-2011-02134,2011,51,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,6.2,moderate_burden
KE-NRB-2017-02135,2017,34,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,53.4,moderate_burden
KE-NRB-2013-02136,2013,56,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.6,moderate_burden
KE-NRB-2011-02137,2011,2,0-14,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-02138,2013,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,7.1,moderate_burden
KE-NRB-2013-02139,2013,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,51.7,moderate_burden
KE-NRB-2012-02140,2012,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,33.1,moderate_burden
KE-NRB-2015-02141,2015,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2009-02142,2009,44,35-44,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-02143,2016,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,28.6,moderate_burden
KE-NRB-2014-02144,2014,56,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,42.9,moderate_burden
KE-NRB-2018-02145,2018,30,25-34,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.2,moderate_burden
KE-NRB-2016-02146,2016,62,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.6,moderate_burden
KE-NRB-2014-02147,2014,64,55-64,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,16.9,moderate_burden
KE-NRB-2013-02148,2013,62,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02149,2015,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-02150,2012,27,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.6,moderate_burden
KE-NRB-2016-02151,2016,29,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,10.2,moderate_burden
KE-NRB-2018-02152,2018,7,0-14,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.2,moderate_burden
KE-NRB-2016-02153,2016,68,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.4,moderate_burden
KE-NRB-2014-02154,2014,35,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,44.9,moderate_burden
KE-NRB-2016-02155,2016,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.2,moderate_burden
KE-NRB-2010-02156,2010,70,65-74,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,3.7,moderate_burden
KE-NRB-2011-02157,2011,32,25-34,Female,Breast,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,3.0,moderate_burden
KE-NRB-2016-02158,2016,45,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.2,moderate_burden
KE-NRB-2011-02159,2011,43,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,36.9,moderate_burden
KE-NRB-2014-02160,2014,72,65-74,Male,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.1,moderate_burden
KE-NRB-2014-02161,2014,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-02162,2012,48,45-54,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,5.2,moderate_burden
KE-NRB-2013-02163,2013,81,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02164,2014,41,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,3.1,moderate_burden
KE-NRB-2011-02165,2011,82,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,58.8,moderate_burden
KE-NRB-2011-02166,2011,50,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Palliative care only,Alive,2.7,moderate_burden
KE-NRB-2018-02167,2018,41,35-44,Male,Colorectum,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,19.1,moderate_burden
KE-NRB-2014-02168,2014,68,65-74,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2016-02169,2016,73,65-74,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,2.5,moderate_burden
KE-NRB-2018-02170,2018,37,35-44,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2010-02171,2010,43,35-44,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,11.0,moderate_burden
KE-NRB-2010-02172,2010,50,45-54,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,32.4,moderate_burden
KE-NRB-2016-02173,2016,36,35-44,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-02174,2015,58,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-02175,2012,45,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,14.8,moderate_burden
KE-NRB-2015-02176,2015,72,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02177,2017,39,35-44,Female,Breast,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,7.7,moderate_burden
KE-NRB-2015-02178,2015,52,45-54,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,0.1,moderate_burden
KE-NRB-2012-02179,2012,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.5,moderate_burden
KE-NRB-2009-02180,2009,91,75+,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,0.3,moderate_burden
KE-NRB-2011-02181,2011,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02182,2018,35,35-44,Female,Ovary,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,55.8,moderate_burden
KE-NRB-2012-02183,2012,48,45-54,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,18.9,moderate_burden
KE-NRB-2012-02184,2012,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,6.8,moderate_burden
KE-NRB-2010-02185,2010,85,75+,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,6.5,moderate_burden
KE-NRB-2014-02186,2014,77,75+,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-02187,2016,65,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02188,2018,53,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.3,moderate_burden
KE-NRB-2012-02189,2012,60,55-64,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,39.8,moderate_burden
KE-NRB-2016-02190,2016,35,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Alive,10.7,moderate_burden
KE-NRB-2015-02191,2015,29,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,22.7,moderate_burden
KE-NRB-2012-02192,2012,66,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-02193,2011,59,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.4,moderate_burden
KE-NRB-2012-02194,2012,72,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.5,moderate_burden
KE-NRB-2018-02195,2018,44,35-44,Male,Leukemia,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,57.9,moderate_burden
KE-NRB-2012-02196,2012,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.5,moderate_burden
KE-NRB-2015-02197,2015,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.6,moderate_burden
KE-NRB-2014-02198,2014,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,22.2,moderate_burden
KE-NRB-2015-02199,2015,51,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,2.7,moderate_burden
KE-NRB-2015-02200,2015,29,25-34,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.6,moderate_burden
KE-NRB-2013-02201,2013,54,45-54,Male,Hodgkin lymphoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.1,moderate_burden
KE-NRB-2014-02202,2014,57,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2011-02203,2011,38,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.7,moderate_burden
KE-NRB-2018-02204,2018,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.2,moderate_burden
KE-NRB-2009-02205,2009,78,75+,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.8,moderate_burden
KE-NRB-2016-02206,2016,47,45-54,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,18.9,moderate_burden
KE-NRB-2014-02207,2014,65,65-74,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,2.6,moderate_burden
KE-NRB-2011-02208,2011,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,51.3,moderate_burden
KE-NRB-2018-02209,2018,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,4.4,moderate_burden
KE-NRB-2015-02210,2015,36,35-44,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.0,moderate_burden
KE-NRB-2012-02211,2012,69,65-74,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2011-02212,2011,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,28.2,moderate_burden
KE-NRB-2011-02213,2011,51,45-54,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,49.8,moderate_burden
KE-NRB-2011-02214,2011,63,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,18.2,moderate_burden
KE-NRB-2010-02215,2010,82,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2017-02216,2017,25,25-34,Male,Stomach,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.7,moderate_burden
KE-NRB-2016-02217,2016,41,35-44,Male,Skin (melanoma),Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.1,moderate_burden
KE-NRB-2015-02218,2015,35,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,49.3,moderate_burden
KE-NRB-2013-02219,2013,37,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,14.2,moderate_burden
KE-NRB-2018-02220,2018,48,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.1,moderate_burden
KE-NRB-2013-02221,2013,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2015-02222,2015,41,35-44,Male,Other,Non-keratinizing carcinoma,Unknown,Clinical only,In situ,Urban,N/A,Dead,28.0,moderate_burden
KE-NRB-2013-02223,2013,38,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,3.2,moderate_burden
KE-NRB-2017-02224,2017,32,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02225,2015,23,15-24,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.2,moderate_burden
KE-NRB-2009-02226,2009,30,25-34,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,20.7,moderate_burden
KE-NRB-2016-02227,2016,52,45-54,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02228,2017,4,0-14,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.3,moderate_burden
KE-NRB-2014-02229,2014,44,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.8,moderate_burden
KE-NRB-2014-02230,2014,37,35-44,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.0,moderate_burden
KE-NRB-2015-02231,2015,71,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,8.5,moderate_burden
KE-NRB-2011-02232,2011,55,55-64,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.6,moderate_burden
KE-NRB-2017-02233,2017,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,15.6,moderate_burden
KE-NRB-2012-02234,2012,1,0-14,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.7,moderate_burden
KE-NRB-2018-02235,2018,48,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,25.5,moderate_burden
KE-NRB-2012-02236,2012,86,75+,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.0,moderate_burden
KE-NRB-2013-02237,2013,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,36.9,moderate_burden
KE-NRB-2014-02238,2014,27,25-34,Male,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,6.0,moderate_burden
KE-NRB-2018-02239,2018,62,55-64,Male,Liver,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02240,2015,39,35-44,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-02241,2013,62,55-64,Male,Liver,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.0,moderate_burden
KE-NRB-2018-02242,2018,51,45-54,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,0.9,moderate_burden
KE-NRB-2009-02243,2009,56,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2011-02244,2011,36,35-44,Male,Stomach,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.0,moderate_burden
KE-NRB-2017-02245,2017,42,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.1,moderate_burden
KE-NRB-2018-02246,2018,47,45-54,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,33.8,moderate_burden
KE-NRB-2013-02247,2013,12,0-14,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,4.6,moderate_burden
KE-NRB-2017-02248,2017,41,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,13.6,moderate_burden
KE-NRB-2015-02249,2015,32,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Alive,44.4,moderate_burden
KE-NRB-2013-02250,2013,37,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,8.0,moderate_burden
KE-NRB-2011-02251,2011,90,75+,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02252,2017,70,65-74,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,30.0,moderate_burden
KE-NRB-2018-02253,2018,57,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,42.1,moderate_burden
KE-NRB-2013-02254,2013,1,0-14,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.4,moderate_burden
KE-NRB-2016-02255,2016,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,2.5,moderate_burden
KE-NRB-2011-02256,2011,26,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,10.0,moderate_burden
KE-NRB-2013-02257,2013,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-02258,2016,17,15-24,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.1,moderate_burden
KE-NRB-2017-02259,2017,43,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.0,moderate_burden
KE-NRB-2009-02260,2009,59,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,15.4,moderate_burden
KE-NRB-2015-02261,2015,1,0-14,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2011-02262,2011,27,25-34,Female,Thyroid,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,3.3,moderate_burden
KE-NRB-2015-02263,2015,52,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,19.6,moderate_burden
KE-NRB-2011-02264,2011,91,75+,Female,Other,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,1.5,moderate_burden
KE-NRB-2013-02265,2013,82,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,2.6,moderate_burden
KE-NRB-2014-02266,2014,71,65-74,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02267,2017,60,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,38.3,moderate_burden
KE-NRB-2018-02268,2018,47,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,9.9,moderate_burden
KE-NRB-2014-02269,2014,85,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02270,2014,29,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.3,moderate_burden
KE-NRB-2012-02271,2012,50,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.9,moderate_burden
KE-NRB-2015-02272,2015,52,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,8.8,moderate_burden
KE-NRB-2013-02273,2013,36,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-02274,2009,59,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,31.0,moderate_burden
KE-NRB-2015-02275,2015,74,65-74,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,21.6,moderate_burden
KE-NRB-2016-02276,2016,64,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,9.6,moderate_burden
KE-NRB-2015-02277,2015,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02278,2017,36,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-02279,2013,59,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.3,moderate_burden
KE-NRB-2013-02280,2013,55,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,36.9,moderate_burden
KE-NRB-2014-02281,2014,83,75+,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,1.4,moderate_burden
KE-NRB-2017-02282,2017,52,45-54,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,3.8,moderate_burden
KE-NRB-2017-02283,2017,28,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.1,moderate_burden
KE-NRB-2012-02284,2012,45,45-54,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.4,moderate_burden
KE-NRB-2016-02285,2016,63,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,moderate_burden
KE-NRB-2016-02286,2016,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.7,moderate_burden
KE-NRB-2013-02287,2013,57,55-64,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,16.4,moderate_burden
KE-NRB-2014-02288,2014,21,15-24,Male,Liver,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.7,moderate_burden
KE-NRB-2015-02289,2015,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,4.9,moderate_burden
KE-NRB-2013-02290,2013,45,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,15.2,moderate_burden
KE-NRB-2016-02291,2016,74,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,12.3,moderate_burden
KE-NRB-2015-02292,2015,34,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.1,moderate_burden
KE-NRB-2012-02293,2012,55,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemotherapy only,Alive,27.5,moderate_burden
KE-NRB-2016-02294,2016,52,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,39.7,moderate_burden
KE-NRB-2012-02295,2012,54,45-54,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.0,moderate_burden
KE-NRB-2011-02296,2011,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2014-02297,2014,70,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,58.8,moderate_burden
KE-NRB-2016-02298,2016,41,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,31.4,moderate_burden
KE-NRB-2018-02299,2018,63,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,52.6,moderate_burden
KE-NRB-2016-02300,2016,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,10.1,moderate_burden
KE-NRB-2012-02301,2012,75,75+,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.9,moderate_burden
KE-NRB-2014-02302,2014,64,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.1,moderate_burden
KE-NRB-2016-02303,2016,60,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,29.9,moderate_burden
KE-NRB-2014-02304,2014,66,65-74,Male,Oesophagus,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.1,moderate_burden
KE-NRB-2012-02305,2012,49,45-54,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.6,moderate_burden
KE-NRB-2013-02306,2013,33,25-34,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Clinical only,Malignant,Rural,Palliative care only,Dead,40.6,moderate_burden
KE-NRB-2013-02307,2013,59,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Dead,0.4,moderate_burden
KE-NRB-2010-02308,2010,0,0-14,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemotherapy only,Alive,26.8,moderate_burden
KE-NRB-2016-02309,2016,36,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.6,moderate_burden
KE-NRB-2015-02310,2015,72,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,9.3,moderate_burden
KE-NRB-2014-02311,2014,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,58.7,moderate_burden
KE-NRB-2009-02312,2009,69,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-02313,2010,95,75+,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,34.5,moderate_burden
KE-NRB-2015-02314,2015,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-02315,2018,95,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,35.0,moderate_burden
KE-NRB-2015-02316,2015,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,35.3,moderate_burden
KE-NRB-2016-02317,2016,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,13.4,moderate_burden
KE-NRB-2018-02318,2018,49,45-54,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,16.6,moderate_burden
KE-NRB-2018-02319,2018,17,15-24,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,37.0,moderate_burden
KE-NRB-2014-02320,2014,42,35-44,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,33.9,moderate_burden
KE-NRB-2015-02321,2015,38,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,16.3,moderate_burden
KE-NRB-2014-02322,2014,62,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-02323,2013,63,55-64,Female,Ovary,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,No treatment,Alive,9.1,moderate_burden
KE-NRB-2015-02324,2015,71,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.3,moderate_burden
KE-NRB-2015-02325,2015,70,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,9.2,moderate_burden
KE-NRB-2014-02326,2014,28,25-34,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02327,2012,74,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.6,moderate_burden
KE-NRB-2011-02328,2011,65,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Dead,11.4,moderate_burden
KE-NRB-2014-02329,2014,35,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,0.5,moderate_burden
KE-NRB-2018-02330,2018,41,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,41.6,moderate_burden
KE-NRB-2011-02331,2011,42,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,5.7,moderate_burden
KE-NRB-2015-02332,2015,64,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,0.5,moderate_burden
KE-NRB-2016-02333,2016,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,23.4,moderate_burden
KE-NRB-2013-02334,2013,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.7,moderate_burden
KE-NRB-2016-02335,2016,63,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,12.5,moderate_burden
KE-NRB-2012-02336,2012,52,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.5,moderate_burden
KE-NRB-2016-02337,2016,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-02338,2014,46,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,0.3,moderate_burden
KE-NRB-2016-02339,2016,64,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.7,moderate_burden
KE-NRB-2015-02340,2015,31,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,21.9,moderate_burden
KE-NRB-2012-02341,2012,65,65-74,Female,Ovary,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemotherapy only,Lost to follow-up,52.1,moderate_burden
KE-NRB-2016-02342,2016,43,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.0,moderate_burden
KE-NRB-2017-02343,2017,68,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,23.4,moderate_burden
KE-NRB-2014-02344,2014,62,55-64,Male,Liver,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,7.6,moderate_burden
KE-NRB-2017-02345,2017,37,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,3.9,moderate_burden
KE-NRB-2014-02346,2014,79,75+,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.9,moderate_burden
KE-NRB-2014-02347,2014,72,65-74,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,9.0,moderate_burden
KE-NRB-2018-02348,2018,56,55-64,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-02349,2011,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,46.4,moderate_burden
KE-NRB-2012-02350,2012,28,25-34,Male,Colorectum,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.7,moderate_burden
KE-NRB-2010-02351,2010,27,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2014-02352,2014,49,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.5,moderate_burden
KE-NRB-2017-02353,2017,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Radiotherapy only,Alive,18.4,moderate_burden
KE-NRB-2012-02354,2012,26,25-34,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02355,2015,35,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,21.7,moderate_burden
KE-NRB-2013-02356,2013,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,51.9,moderate_burden
KE-NRB-2017-02357,2017,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-02358,2009,71,65-74,Male,Prostate,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,22.9,moderate_burden
KE-NRB-2017-02359,2017,48,45-54,Female,Other,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,6.8,moderate_burden
KE-NRB-2012-02360,2012,48,45-54,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02361,2012,35,35-44,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-02362,2015,28,25-34,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.3,moderate_burden
KE-NRB-2010-02363,2010,43,35-44,Female,Breast,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,11.8,moderate_burden
KE-NRB-2013-02364,2013,65,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-02365,2009,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,33.4,moderate_burden
KE-NRB-2013-02366,2013,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,8.2,moderate_burden
KE-NRB-2016-02367,2016,51,45-54,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,28.8,moderate_burden
KE-NRB-2018-02368,2018,44,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,36.9,moderate_burden
KE-NRB-2013-02369,2013,94,75+,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.3,moderate_burden
KE-NRB-2015-02370,2015,73,65-74,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.1,moderate_burden
KE-NRB-2018-02371,2018,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,3.3,moderate_burden
KE-NRB-2011-02372,2011,46,45-54,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,18.5,moderate_burden
KE-NRB-2018-02373,2018,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-02374,2012,48,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,43.5,moderate_burden
KE-NRB-2014-02375,2014,60,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,25.9,moderate_burden
KE-NRB-2018-02376,2018,38,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.9,moderate_burden
KE-NRB-2018-02377,2018,48,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,22.7,moderate_burden
KE-NRB-2016-02378,2016,52,45-54,Male,Other,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,55.0,moderate_burden
KE-NRB-2009-02379,2009,47,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,59.9,moderate_burden
KE-NRB-2017-02380,2017,74,65-74,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-02381,2011,51,45-54,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,14.1,moderate_burden
KE-NRB-2016-02382,2016,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,26.2,moderate_burden
KE-NRB-2017-02383,2017,40,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Chemo + Radiotherapy,Alive,11.4,moderate_burden
KE-NRB-2009-02384,2009,90,75+,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-02385,2016,46,45-54,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,56.4,moderate_burden
KE-NRB-2013-02386,2013,48,45-54,Female,Corpus uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.3,moderate_burden
KE-NRB-2012-02387,2012,89,75+,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,25.1,moderate_burden
KE-NRB-2015-02388,2015,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,19.6,moderate_burden
KE-NRB-2012-02389,2012,38,35-44,Female,Corpus uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,28.8,moderate_burden
KE-NRB-2017-02390,2017,48,45-54,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,2.0,moderate_burden
KE-NRB-2016-02391,2016,34,25-34,Male,Other,Unspecified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,20.4,moderate_burden
KE-NRB-2009-02392,2009,52,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,2.6,moderate_burden
KE-NRB-2011-02393,2011,59,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.2,moderate_burden
KE-NRB-2017-02394,2017,62,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Other,Malignant,Peri-urban,Chemotherapy only,Alive,21.8,moderate_burden
KE-NRB-2011-02395,2011,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,13.0,moderate_burden
KE-NRB-2015-02396,2015,34,25-34,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,3.3,moderate_burden
KE-NRB-2015-02397,2015,88,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,6.4,moderate_burden
KE-NRB-2012-02398,2012,80,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,21.8,moderate_burden
KE-NRB-2014-02399,2014,47,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Lost to follow-up,52.5,moderate_burden
KE-NRB-2018-02400,2018,71,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,18.1,moderate_burden
KE-NRB-2015-02401,2015,52,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,51.7,moderate_burden
KE-NRB-2015-02402,2015,44,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.4,moderate_burden
KE-NRB-2016-02403,2016,58,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-02404,2015,41,35-44,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,31.5,moderate_burden
KE-NRB-2016-02405,2016,37,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,55.3,moderate_burden
KE-NRB-2010-02406,2010,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,10.3,moderate_burden
KE-NRB-2018-02407,2018,84,75+,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,42.7,moderate_burden
KE-NRB-2016-02408,2016,42,35-44,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.7,moderate_burden
KE-NRB-2009-02409,2009,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,12.8,moderate_burden
KE-NRB-2010-02410,2010,60,55-64,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,moderate_burden
KE-NRB-2018-02411,2018,45,45-54,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.5,moderate_burden
KE-NRB-2018-02412,2018,26,25-34,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,15.2,moderate_burden
KE-NRB-2012-02413,2012,76,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.0,moderate_burden
KE-NRB-2012-02414,2012,73,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.6,moderate_burden
KE-NRB-2016-02415,2016,44,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,49.2,moderate_burden
KE-NRB-2014-02416,2014,10,0-14,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,51.9,moderate_burden
KE-NRB-2009-02417,2009,55,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,5.6,moderate_burden
KE-NRB-2010-02418,2010,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Alive,4.3,moderate_burden
KE-NRB-2015-02419,2015,75,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-02420,2018,90,75+,Male,Oesophagus,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,31.1,moderate_burden
KE-NRB-2009-02421,2009,58,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,5.5,moderate_burden
KE-NRB-2014-02422,2014,62,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,40.2,moderate_burden
KE-NRB-2010-02423,2010,57,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,39.4,moderate_burden
KE-NRB-2016-02424,2016,13,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,20.0,moderate_burden
KE-NRB-2013-02425,2013,42,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2010-02426,2010,65,65-74,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.6,moderate_burden
KE-NRB-2017-02427,2017,80,75+,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.2,moderate_burden
KE-NRB-2014-02428,2014,27,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2016-02429,2016,88,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02430,2018,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.9,moderate_burden
KE-NRB-2013-02431,2013,70,65-74,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,53.0,moderate_burden
KE-NRB-2018-02432,2018,39,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,49.7,moderate_burden
KE-NRB-2018-02433,2018,47,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,19.9,moderate_burden
KE-NRB-2016-02434,2016,56,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.7,moderate_burden
KE-NRB-2018-02435,2018,40,35-44,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,39.7,moderate_burden
KE-NRB-2018-02436,2018,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,5.0,moderate_burden
KE-NRB-2018-02437,2018,57,55-64,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.9,moderate_burden
KE-NRB-2014-02438,2014,54,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,25.5,moderate_burden
KE-NRB-2015-02439,2015,74,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.7,moderate_burden
KE-NRB-2014-02440,2014,68,65-74,Female,Breast,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.4,moderate_burden
KE-NRB-2014-02441,2014,34,25-34,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-02442,2016,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,30.1,moderate_burden
KE-NRB-2013-02443,2013,60,55-64,Female,Other,Sarcoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Dead,14.3,moderate_burden
KE-NRB-2017-02444,2017,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,0.8,moderate_burden
KE-NRB-2009-02445,2009,89,75+,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,1.2,moderate_burden
KE-NRB-2014-02446,2014,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,9.0,moderate_burden
KE-NRB-2011-02447,2011,51,45-54,Female,Ovary,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.2,moderate_burden
KE-NRB-2013-02448,2013,70,65-74,Male,Bladder,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,25.0,moderate_burden
KE-NRB-2018-02449,2018,70,65-74,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,56.9,moderate_burden
KE-NRB-2018-02450,2018,60,55-64,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.8,moderate_burden
KE-NRB-2016-02451,2016,57,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,51.0,moderate_burden
KE-NRB-2013-02452,2013,48,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-02453,2010,39,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.6,moderate_burden
KE-NRB-2015-02454,2015,56,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.5,moderate_burden
KE-NRB-2016-02455,2016,69,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,28.5,moderate_burden
KE-NRB-2016-02456,2016,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,58.0,moderate_burden
KE-NRB-2017-02457,2017,60,55-64,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-02458,2017,22,15-24,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,14.8,moderate_burden
KE-NRB-2017-02459,2017,43,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02460,2012,43,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.8,moderate_burden
KE-NRB-2013-02461,2013,20,15-24,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,2.5,moderate_burden
KE-NRB-2016-02462,2016,42,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,24.8,moderate_burden
KE-NRB-2017-02463,2017,55,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.1,moderate_burden
KE-NRB-2013-02464,2013,73,65-74,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,13.0,moderate_burden
KE-NRB-2016-02465,2016,15,15-24,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.3,moderate_burden
KE-NRB-2017-02466,2017,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2017-02467,2017,56,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.6,moderate_burden
KE-NRB-2011-02468,2011,50,45-54,Female,Corpus uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.8,moderate_burden
KE-NRB-2013-02469,2013,2,0-14,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Lost to follow-up,20.4,moderate_burden
KE-NRB-2010-02470,2010,44,35-44,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,58.4,moderate_burden
KE-NRB-2011-02471,2011,15,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,29.5,moderate_burden
KE-NRB-2010-02472,2010,46,45-54,Female,Other,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,38.1,moderate_burden
KE-NRB-2011-02473,2011,57,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,13.6,moderate_burden
KE-NRB-2015-02474,2015,21,15-24,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02475,2017,36,35-44,Male,Pancreas,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,23.7,moderate_burden
KE-NRB-2012-02476,2012,39,35-44,Female,Breast,Non-keratinizing carcinoma,Unknown,Other,In situ,Peri-urban,N/A,Alive,26.3,moderate_burden
KE-NRB-2010-02477,2010,49,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,5.4,moderate_burden
KE-NRB-2016-02478,2016,39,35-44,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,12.8,moderate_burden
KE-NRB-2012-02479,2012,61,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Dead,3.8,moderate_burden
KE-NRB-2015-02480,2015,70,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,30.8,moderate_burden
KE-NRB-2018-02481,2018,57,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,3.9,moderate_burden
KE-NRB-2016-02482,2016,72,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,38.3,moderate_burden
KE-NRB-2011-02483,2011,19,15-24,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,55.2,moderate_burden
KE-NRB-2016-02484,2016,21,15-24,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,16.9,moderate_burden
KE-NRB-2018-02485,2018,58,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.4,moderate_burden
KE-NRB-2018-02486,2018,91,75+,Male,Stomach,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,22.5,moderate_burden
KE-NRB-2018-02487,2018,22,15-24,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,10.5,moderate_burden
KE-NRB-2015-02488,2015,46,45-54,Male,Pancreas,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.0,moderate_burden
KE-NRB-2016-02489,2016,28,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.7,moderate_burden
KE-NRB-2016-02490,2016,5,0-14,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02491,2015,52,45-54,Male,Other,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02492,2018,51,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,31.3,moderate_burden
KE-NRB-2011-02493,2011,69,65-74,Male,Bladder,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.4,moderate_burden
KE-NRB-2010-02494,2010,61,55-64,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,9.5,moderate_burden
KE-NRB-2011-02495,2011,56,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.2,moderate_burden
KE-NRB-2014-02496,2014,5,0-14,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.3,moderate_burden
KE-NRB-2016-02497,2016,50,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,21.9,moderate_burden
KE-NRB-2014-02498,2014,53,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,20.2,moderate_burden
KE-NRB-2016-02499,2016,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.5,moderate_burden
KE-NRB-2011-02500,2011,60,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.8,moderate_burden
KE-NRB-2012-02501,2012,68,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,40.9,moderate_burden
KE-NRB-2016-02502,2016,38,35-44,Female,Thyroid,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,56.9,moderate_burden
KE-NRB-2012-02503,2012,58,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.8,moderate_burden
KE-NRB-2010-02504,2010,68,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.5,moderate_burden
KE-NRB-2010-02505,2010,37,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,6.5,moderate_burden
KE-NRB-2015-02506,2015,54,45-54,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-02507,2012,60,55-64,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,21.1,moderate_burden
KE-NRB-2011-02508,2011,23,15-24,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.7,moderate_burden
KE-NRB-2017-02509,2017,38,35-44,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,23.3,moderate_burden
KE-NRB-2017-02510,2017,23,15-24,Female,Other,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.2,moderate_burden
KE-NRB-2016-02511,2016,54,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,40.5,moderate_burden
KE-NRB-2017-02512,2017,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,55.1,moderate_burden
KE-NRB-2009-02513,2009,46,45-54,Female,Corpus uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Rural,No treatment,Alive,0.4,moderate_burden
KE-NRB-2010-02514,2010,27,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,17.8,moderate_burden
KE-NRB-2018-02515,2018,76,75+,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,55.6,moderate_burden
KE-NRB-2015-02516,2015,74,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,33.9,moderate_burden
KE-NRB-2010-02517,2010,70,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,28.4,moderate_burden
KE-NRB-2013-02518,2013,49,45-54,Female,Cervix uteri,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,moderate_burden
KE-NRB-2017-02519,2017,64,55-64,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.3,moderate_burden
KE-NRB-2009-02520,2009,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Palliative care only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-02521,2012,58,55-64,Male,Stomach,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Dead,6.8,moderate_burden
KE-NRB-2009-02522,2009,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02523,2015,52,45-54,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.2,moderate_burden
KE-NRB-2014-02524,2014,41,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,5.6,moderate_burden
KE-NRB-2017-02525,2017,46,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,31.6,moderate_burden
KE-NRB-2016-02526,2016,60,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,40.8,moderate_burden
KE-NRB-2012-02527,2012,12,0-14,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,57.2,moderate_burden
KE-NRB-2011-02528,2011,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,44.9,moderate_burden
KE-NRB-2010-02529,2010,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,55.9,moderate_burden
KE-NRB-2015-02530,2015,37,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.9,moderate_burden
KE-NRB-2015-02531,2015,63,55-64,Male,Leukemia,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,9.0,moderate_burden
KE-NRB-2010-02532,2010,33,25-34,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,19.3,moderate_burden
KE-NRB-2015-02533,2015,49,45-54,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,10.3,moderate_burden
KE-NRB-2018-02534,2018,62,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,29.4,moderate_burden
KE-NRB-2014-02535,2014,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-02536,2013,32,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-02537,2017,52,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,57.9,moderate_burden
KE-NRB-2017-02538,2017,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02539,2014,46,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-02540,2015,85,75+,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.8,moderate_burden
KE-NRB-2016-02541,2016,47,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,22.0,moderate_burden
KE-NRB-2018-02542,2018,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,12.9,moderate_burden
KE-NRB-2017-02543,2017,71,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,34.2,moderate_burden
KE-NRB-2013-02544,2013,50,45-54,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.3,moderate_burden
KE-NRB-2009-02545,2009,73,65-74,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,37.8,moderate_burden
KE-NRB-2018-02546,2018,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,41.6,moderate_burden
KE-NRB-2014-02547,2014,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.8,moderate_burden
KE-NRB-2014-02548,2014,53,45-54,Female,Thyroid,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.8,moderate_burden
KE-NRB-2010-02549,2010,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-02550,2018,39,35-44,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-02551,2011,55,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,55.3,moderate_burden
KE-NRB-2018-02552,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Dead,43.9,moderate_burden
KE-NRB-2017-02553,2017,33,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,12.5,moderate_burden
KE-NRB-2016-02554,2016,41,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,6.7,moderate_burden
KE-NRB-2015-02555,2015,66,65-74,Male,Prostate,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,22.7,moderate_burden
KE-NRB-2017-02556,2017,30,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,25.2,moderate_burden
KE-NRB-2012-02557,2012,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02558,2014,56,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,21.0,moderate_burden
KE-NRB-2015-02559,2015,55,55-64,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,56.2,moderate_burden
KE-NRB-2015-02560,2015,55,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-02561,2017,49,45-54,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02562,2012,67,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Peri-urban,N/A,Alive,44.9,moderate_burden
KE-NRB-2016-02563,2016,49,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.0,moderate_burden
KE-NRB-2014-02564,2014,65,65-74,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.5,moderate_burden
KE-NRB-2014-02565,2014,28,25-34,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Dead,35.5,moderate_burden
KE-NRB-2013-02566,2013,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,moderate_burden
KE-NRB-2017-02567,2017,39,35-44,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.7,moderate_burden
KE-NRB-2017-02568,2017,39,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,57.0,moderate_burden
KE-NRB-2013-02569,2013,43,35-44,Female,Cervix uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-02570,2010,38,35-44,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,0.3,moderate_burden
KE-NRB-2012-02571,2012,38,35-44,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery only,Dead,11.9,moderate_burden
KE-NRB-2010-02572,2010,59,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.2,moderate_burden
KE-NRB-2015-02573,2015,69,65-74,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,13.0,moderate_burden
KE-NRB-2010-02574,2010,62,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.7,moderate_burden
KE-NRB-2010-02575,2010,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.4,moderate_burden
KE-NRB-2009-02576,2009,47,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,40.2,moderate_burden
KE-NRB-2012-02577,2012,45,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,33.2,moderate_burden
KE-NRB-2011-02578,2011,47,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-02579,2013,72,65-74,Female,Corpus uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,16.8,moderate_burden
KE-NRB-2016-02580,2016,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,7.8,moderate_burden
KE-NRB-2018-02581,2018,47,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,9.9,moderate_burden
KE-NRB-2015-02582,2015,70,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,44.8,moderate_burden
KE-NRB-2015-02583,2015,71,65-74,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.3,moderate_burden
KE-NRB-2017-02584,2017,38,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.7,moderate_burden
KE-NRB-2017-02585,2017,73,65-74,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-02586,2017,73,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,6.4,moderate_burden
KE-NRB-2015-02587,2015,53,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,52.7,moderate_burden
KE-NRB-2018-02588,2018,62,55-64,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,46.8,moderate_burden
KE-NRB-2009-02589,2009,50,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,18.6,moderate_burden
KE-NRB-2013-02590,2013,73,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Imaging + clinical,Benign/uncertain,Rural,N/A,Dead,0.5,moderate_burden
KE-NRB-2016-02591,2016,44,35-44,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Other,Malignant,Urban,Palliative care only,Alive,13.8,moderate_burden
KE-NRB-2018-02592,2018,48,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,moderate_burden
KE-NRB-2012-02593,2012,50,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02594,2014,54,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.7,moderate_burden
KE-NRB-2013-02595,2013,43,35-44,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.7,moderate_burden
KE-NRB-2014-02596,2014,52,45-54,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,13.4,moderate_burden
KE-NRB-2017-02597,2017,71,65-74,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02598,2018,47,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,37.7,moderate_burden
KE-NRB-2018-02599,2018,31,25-34,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.1,moderate_burden
KE-NRB-2012-02600,2012,65,65-74,Male,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-02601,2009,2,0-14,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.7,moderate_burden
KE-NRB-2011-02602,2011,83,75+,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.0,moderate_burden
KE-NRB-2014-02603,2014,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,25.2,moderate_burden
KE-NRB-2016-02604,2016,35,35-44,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02605,2014,58,55-64,Female,Corpus uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.9,moderate_burden
KE-NRB-2013-02606,2013,36,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2009-02607,2009,57,55-64,Male,Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,33.8,moderate_burden
KE-NRB-2014-02608,2014,79,75+,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,56.0,moderate_burden
KE-NRB-2011-02609,2011,31,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,11.3,moderate_burden
KE-NRB-2011-02610,2011,61,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.2,moderate_burden
KE-NRB-2012-02611,2012,53,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Chemotherapy only,Dead,6.7,moderate_burden
KE-NRB-2013-02612,2013,73,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.1,moderate_burden
KE-NRB-2012-02613,2012,54,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,30.7,moderate_burden
KE-NRB-2016-02614,2016,48,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,29.0,moderate_burden
KE-NRB-2018-02615,2018,70,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.4,moderate_burden
KE-NRB-2015-02616,2015,36,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-02617,2011,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,17.1,moderate_burden
KE-NRB-2016-02618,2016,48,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,4.0,moderate_burden
KE-NRB-2017-02619,2017,67,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,7.4,moderate_burden
KE-NRB-2017-02620,2017,66,65-74,Male,Pancreas,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,31.4,moderate_burden
KE-NRB-2013-02621,2013,30,25-34,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,17.3,moderate_burden
KE-NRB-2017-02622,2017,36,35-44,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Lost to follow-up,12.9,moderate_burden
KE-NRB-2018-02623,2018,54,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,2.5,moderate_burden
KE-NRB-2016-02624,2016,59,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,40.1,moderate_burden
KE-NRB-2009-02625,2009,37,35-44,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,40.1,moderate_burden
KE-NRB-2010-02626,2010,36,35-44,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,27.2,moderate_burden
KE-NRB-2017-02627,2017,39,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,12.8,moderate_burden
KE-NRB-2012-02628,2012,52,45-54,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,6.9,moderate_burden
KE-NRB-2017-02629,2017,78,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,44.9,moderate_burden
KE-NRB-2017-02630,2017,94,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,9.9,moderate_burden
KE-NRB-2016-02631,2016,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-02632,2011,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,47.9,moderate_burden
KE-NRB-2016-02633,2016,35,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,8.9,moderate_burden
KE-NRB-2018-02634,2018,52,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,No treatment,Alive,6.8,moderate_burden
KE-NRB-2015-02635,2015,59,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.1,moderate_burden
KE-NRB-2010-02636,2010,16,15-24,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,23.2,moderate_burden
KE-NRB-2015-02637,2015,44,35-44,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,51.6,moderate_burden
KE-NRB-2017-02638,2017,35,35-44,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,5.7,moderate_burden
KE-NRB-2011-02639,2011,61,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.5,moderate_burden
KE-NRB-2016-02640,2016,47,45-54,Male,Oesophagus,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,14.7,moderate_burden
KE-NRB-2016-02641,2016,67,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.0,moderate_burden
KE-NRB-2013-02642,2013,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02643,2018,79,75+,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-02644,2016,34,25-34,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-02645,2014,26,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2015-02646,2015,86,75+,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,6.2,moderate_burden
KE-NRB-2014-02647,2014,43,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-02648,2016,61,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,0.9,moderate_burden
KE-NRB-2016-02649,2016,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,26.9,moderate_burden
KE-NRB-2016-02650,2016,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,36.8,moderate_burden
KE-NRB-2010-02651,2010,54,45-54,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02652,2015,42,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,23.3,moderate_burden
KE-NRB-2010-02653,2010,65,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,3.2,moderate_burden
KE-NRB-2018-02654,2018,56,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,16.8,moderate_burden
KE-NRB-2015-02655,2015,83,75+,Male,Bladder,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,8.7,moderate_burden
KE-NRB-2016-02656,2016,74,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.0,moderate_burden
KE-NRB-2017-02657,2017,71,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,29.3,moderate_burden
KE-NRB-2015-02658,2015,43,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,24.2,moderate_burden
KE-NRB-2017-02659,2017,41,35-44,Female,Breast,Unspecified,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Palliative care only,Dead,8.0,moderate_burden
KE-NRB-2010-02660,2010,55,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,7.1,moderate_burden
KE-NRB-2010-02661,2010,59,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,8.8,moderate_burden
KE-NRB-2014-02662,2014,23,15-24,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,10.2,moderate_burden
KE-NRB-2013-02663,2013,41,35-44,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,24.7,moderate_burden
KE-NRB-2013-02664,2013,37,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,10.7,moderate_burden
KE-NRB-2010-02665,2010,64,55-64,Male,Liver,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,59.5,moderate_burden
KE-NRB-2017-02666,2017,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.1,moderate_burden
KE-NRB-2013-02667,2013,95,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,52.8,moderate_burden
KE-NRB-2010-02668,2010,70,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2014-02669,2014,72,65-74,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,41.7,moderate_burden
KE-NRB-2014-02670,2014,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.2,moderate_burden
KE-NRB-2014-02671,2014,49,45-54,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-02672,2015,95,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,37.3,moderate_burden
KE-NRB-2017-02673,2017,55,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,57.7,moderate_burden
KE-NRB-2013-02674,2013,34,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,14.5,moderate_burden
KE-NRB-2017-02675,2017,33,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.2,moderate_burden
KE-NRB-2018-02676,2018,81,75+,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.9,moderate_burden
KE-NRB-2018-02677,2018,57,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.9,moderate_burden
KE-NRB-2010-02678,2010,71,65-74,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,12.7,moderate_burden
KE-NRB-2011-02679,2011,45,45-54,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.1,moderate_burden
KE-NRB-2015-02680,2015,35,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.7,moderate_burden
KE-NRB-2012-02681,2012,55,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,21.0,moderate_burden
KE-NRB-2012-02682,2012,53,45-54,Male,Lung,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,34.1,moderate_burden
KE-NRB-2018-02683,2018,68,65-74,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,47.2,moderate_burden
KE-NRB-2016-02684,2016,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,48.0,moderate_burden
KE-NRB-2017-02685,2017,29,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,47.5,moderate_burden
KE-NRB-2012-02686,2012,44,35-44,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,45.8,moderate_burden
KE-NRB-2011-02687,2011,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.3,moderate_burden
KE-NRB-2013-02688,2013,55,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,9.4,moderate_burden
KE-NRB-2018-02689,2018,74,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-02690,2015,89,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,moderate_burden
KE-NRB-2011-02691,2011,35,35-44,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.9,moderate_burden
KE-NRB-2009-02692,2009,33,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-02693,2011,27,25-34,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,1.3,moderate_burden
KE-NRB-2012-02694,2012,51,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.5,moderate_burden
KE-NRB-2017-02695,2017,55,55-64,Male,Bladder,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.0,moderate_burden
KE-NRB-2015-02696,2015,64,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-02697,2018,73,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,47.8,moderate_burden
KE-NRB-2016-02698,2016,28,25-34,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,17.8,moderate_burden
KE-NRB-2016-02699,2016,83,75+,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,2.4,moderate_burden
KE-NRB-2011-02700,2011,70,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,44.4,moderate_burden
KE-NRB-2018-02701,2018,45,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,49.1,moderate_burden
KE-NRB-2013-02702,2013,74,65-74,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,34.9,moderate_burden
KE-NRB-2013-02703,2013,51,45-54,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,17.7,moderate_burden
KE-NRB-2013-02704,2013,33,25-34,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02705,2015,41,35-44,Female,Corpus uteri,Other specified,Unknown,Imaging + clinical,In situ,Urban,N/A,Alive,9.4,moderate_burden
KE-NRB-2010-02706,2010,47,45-54,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,49.5,moderate_burden
KE-NRB-2010-02707,2010,36,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,9.4,moderate_burden
KE-NRB-2009-02708,2009,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02709,2012,30,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.8,moderate_burden
KE-NRB-2017-02710,2017,70,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02711,2015,47,45-54,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2018-02712,2018,62,55-64,Female,Ovary,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,4.0,moderate_burden
KE-NRB-2011-02713,2011,74,65-74,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,12.5,moderate_burden
KE-NRB-2015-02714,2015,63,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,22.5,moderate_burden
KE-NRB-2012-02715,2012,29,25-34,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,11.5,moderate_burden
KE-NRB-2018-02716,2018,53,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.3,moderate_burden
KE-NRB-2017-02717,2017,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.1,moderate_burden
KE-NRB-2015-02718,2015,46,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.9,moderate_burden
KE-NRB-2012-02719,2012,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-02720,2017,60,55-64,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2012-02721,2012,50,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,12.0,moderate_burden
KE-NRB-2015-02722,2015,64,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.8,moderate_burden
KE-NRB-2018-02723,2018,73,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-02724,2013,63,55-64,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.0,moderate_burden
KE-NRB-2017-02725,2017,55,55-64,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,9.2,moderate_burden
KE-NRB-2013-02726,2013,43,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02727,2017,67,65-74,Male,Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Surgery only,Alive,10.1,moderate_burden
KE-NRB-2015-02728,2015,95,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,59.9,moderate_burden
KE-NRB-2015-02729,2015,40,35-44,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.3,moderate_burden
KE-NRB-2013-02730,2013,67,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2018-02731,2018,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,44.1,moderate_burden
KE-NRB-2016-02732,2016,54,45-54,Male,Oesophagus,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.8,moderate_burden
KE-NRB-2011-02733,2011,47,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-02734,2013,48,45-54,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.4,moderate_burden
KE-NRB-2016-02735,2016,32,25-34,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,26.8,moderate_burden
KE-NRB-2012-02736,2012,66,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,25.3,moderate_burden
KE-NRB-2012-02737,2012,44,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02738,2014,67,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,24.2,moderate_burden
KE-NRB-2010-02739,2010,41,35-44,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,49.2,moderate_burden
KE-NRB-2017-02740,2017,57,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2015-02741,2015,41,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-02742,2017,59,55-64,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,6.1,moderate_burden
KE-NRB-2011-02743,2011,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,9.2,moderate_burden
KE-NRB-2014-02744,2014,61,55-64,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.8,moderate_burden
KE-NRB-2015-02745,2015,64,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.3,moderate_burden
KE-NRB-2017-02746,2017,64,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Alive,11.2,moderate_burden
KE-NRB-2017-02747,2017,51,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,52.7,moderate_burden
KE-NRB-2017-02748,2017,67,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,18.8,moderate_burden
KE-NRB-2016-02749,2016,61,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,50.5,moderate_burden
KE-NRB-2014-02750,2014,43,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,23.7,moderate_burden
KE-NRB-2015-02751,2015,58,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,22.4,moderate_burden
KE-NRB-2017-02752,2017,71,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.0,moderate_burden
KE-NRB-2011-02753,2011,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02754,2017,42,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,14.7,moderate_burden
KE-NRB-2013-02755,2013,57,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2016-02756,2016,55,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,11.8,moderate_burden
KE-NRB-2017-02757,2017,50,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.0,moderate_burden
KE-NRB-2017-02758,2017,49,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-02759,2011,85,75+,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-02760,2011,50,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,60.0,moderate_burden
KE-NRB-2009-02761,2009,32,25-34,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,45.3,moderate_burden
KE-NRB-2015-02762,2015,88,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,3.7,moderate_burden
KE-NRB-2013-02763,2013,45,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.7,moderate_burden
KE-NRB-2011-02764,2011,54,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-02765,2015,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,49.0,moderate_burden
KE-NRB-2017-02766,2017,56,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.5,moderate_burden
KE-NRB-2015-02767,2015,34,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2011-02768,2011,65,65-74,Male,Liver,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,16.3,moderate_burden
KE-NRB-2012-02769,2012,73,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,4.0,moderate_burden
KE-NRB-2015-02770,2015,53,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.0,moderate_burden
KE-NRB-2011-02771,2011,71,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.3,moderate_burden
KE-NRB-2016-02772,2016,32,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-02773,2018,53,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2017-02774,2017,42,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,10.1,moderate_burden
KE-NRB-2016-02775,2016,29,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,20.5,moderate_burden
KE-NRB-2012-02776,2012,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,52.8,moderate_burden
KE-NRB-2016-02777,2016,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.2,moderate_burden
KE-NRB-2015-02778,2015,38,35-44,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,30.7,moderate_burden
KE-NRB-2016-02779,2016,41,35-44,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.6,moderate_burden
KE-NRB-2016-02780,2016,25,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,14.1,moderate_burden
KE-NRB-2014-02781,2014,37,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.4,moderate_burden
KE-NRB-2014-02782,2014,45,45-54,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.9,moderate_burden
KE-NRB-2014-02783,2014,54,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,7.7,moderate_burden
KE-NRB-2011-02784,2011,31,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,0.9,moderate_burden
KE-NRB-2018-02785,2018,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,11.8,moderate_burden
KE-NRB-2011-02786,2011,56,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,48.1,moderate_burden
KE-NRB-2015-02787,2015,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,53.2,moderate_burden
KE-NRB-2009-02788,2009,28,25-34,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Dead,7.8,moderate_burden
KE-NRB-2015-02789,2015,59,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,11.5,moderate_burden
KE-NRB-2011-02790,2011,37,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,50.5,moderate_burden
KE-NRB-2014-02791,2014,64,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.8,moderate_burden
KE-NRB-2009-02792,2009,12,0-14,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,37.2,moderate_burden
KE-NRB-2017-02793,2017,57,55-64,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,11.8,moderate_burden
KE-NRB-2017-02794,2017,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.7,moderate_burden
KE-NRB-2016-02795,2016,57,55-64,Male,Liver,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.4,moderate_burden
KE-NRB-2015-02796,2015,72,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,8.9,moderate_burden
KE-NRB-2016-02797,2016,52,45-54,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-02798,2009,36,35-44,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,12.6,moderate_burden
KE-NRB-2018-02799,2018,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.8,moderate_burden
KE-NRB-2011-02800,2011,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,7.0,moderate_burden
KE-NRB-2012-02801,2012,95,75+,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,15.1,moderate_burden
KE-NRB-2012-02802,2012,51,45-54,Male,Colorectum,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-02803,2015,28,25-34,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.5,moderate_burden
KE-NRB-2012-02804,2012,73,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.9,moderate_burden
KE-NRB-2014-02805,2014,64,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,40.5,moderate_burden
KE-NRB-2013-02806,2013,59,55-64,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,25.8,moderate_burden
KE-NRB-2013-02807,2013,76,75+,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-02808,2018,51,45-54,Male,Multiple myeloma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-02809,2012,63,55-64,Male,Other,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,33.3,moderate_burden
KE-NRB-2013-02810,2013,51,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,28.8,moderate_burden
KE-NRB-2015-02811,2015,28,25-34,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-02812,2017,56,55-64,Female,Other,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,9.7,moderate_burden
KE-NRB-2017-02813,2017,46,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.0,moderate_burden
KE-NRB-2013-02814,2013,79,75+,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.5,moderate_burden
KE-NRB-2015-02815,2015,68,65-74,Female,Thyroid,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02816,2014,41,35-44,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-02817,2016,64,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2014-02818,2014,45,45-54,Female,Other,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,9.7,moderate_burden
KE-NRB-2017-02819,2017,58,55-64,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,7.3,moderate_burden
KE-NRB-2011-02820,2011,46,45-54,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.3,moderate_burden
KE-NRB-2012-02821,2012,57,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,33.5,moderate_burden
KE-NRB-2016-02822,2016,39,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,42.8,moderate_burden
KE-NRB-2016-02823,2016,57,55-64,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,moderate_burden
KE-NRB-2015-02824,2015,70,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,22.0,moderate_burden
KE-NRB-2014-02825,2014,78,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Dead,24.4,moderate_burden
KE-NRB-2012-02826,2012,65,65-74,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-02827,2010,55,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,21.9,moderate_burden
KE-NRB-2017-02828,2017,49,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,58.1,moderate_burden
KE-NRB-2016-02829,2016,46,45-54,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,45.3,moderate_burden
KE-NRB-2011-02830,2011,68,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.0,moderate_burden
KE-NRB-2018-02831,2018,48,45-54,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,9.2,moderate_burden
KE-NRB-2012-02832,2012,72,65-74,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,14.9,moderate_burden
KE-NRB-2017-02833,2017,8,0-14,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,6.6,moderate_burden
KE-NRB-2018-02834,2018,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,6.6,moderate_burden
KE-NRB-2017-02835,2017,66,65-74,Female,Ovary,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.7,moderate_burden
KE-NRB-2012-02836,2012,28,25-34,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.6,moderate_burden
KE-NRB-2011-02837,2011,59,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2013-02838,2013,41,35-44,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-02839,2018,29,25-34,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-02840,2015,57,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.9,moderate_burden
KE-NRB-2017-02841,2017,49,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.8,moderate_burden
KE-NRB-2015-02842,2015,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Lost to follow-up,22.3,moderate_burden
KE-NRB-2014-02843,2014,25,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.2,moderate_burden
KE-NRB-2014-02844,2014,63,55-64,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.9,moderate_burden
KE-NRB-2010-02845,2010,46,45-54,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.8,moderate_burden
KE-NRB-2015-02846,2015,43,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Lost to follow-up,45.2,moderate_burden
KE-NRB-2012-02847,2012,29,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.4,moderate_burden
KE-NRB-2012-02848,2012,85,75+,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-02849,2015,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.8,moderate_burden
KE-NRB-2016-02850,2016,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,31.8,moderate_burden
KE-NRB-2014-02851,2014,37,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-02852,2017,36,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,15.6,moderate_burden
KE-NRB-2011-02853,2011,40,35-44,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,18.2,moderate_burden
KE-NRB-2015-02854,2015,59,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-02855,2010,58,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02856,2014,65,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,25.4,moderate_burden
KE-NRB-2016-02857,2016,71,65-74,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,20.7,moderate_burden
KE-NRB-2014-02858,2014,31,25-34,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,13.4,moderate_burden
KE-NRB-2017-02859,2017,65,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.7,moderate_burden
KE-NRB-2011-02860,2011,58,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.9,moderate_burden
KE-NRB-2009-02861,2009,60,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Lost to follow-up,1.0,moderate_burden
KE-NRB-2013-02862,2013,46,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.0,moderate_burden
KE-NRB-2011-02863,2011,64,55-64,Female,Other,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,7.8,moderate_burden
KE-NRB-2013-02864,2013,61,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-02865,2009,42,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-02866,2016,29,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.3,moderate_burden
KE-NRB-2011-02867,2011,71,65-74,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,21.2,moderate_burden
KE-NRB-2015-02868,2015,44,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,52.3,moderate_burden
KE-NRB-2017-02869,2017,53,45-54,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.4,moderate_burden
KE-NRB-2012-02870,2012,69,65-74,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,55.6,moderate_burden
KE-NRB-2011-02871,2011,88,75+,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.2,moderate_burden
KE-NRB-2014-02872,2014,74,65-74,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,17.1,moderate_burden
KE-NRB-2015-02873,2015,41,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,31.2,moderate_burden
KE-NRB-2010-02874,2010,57,55-64,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,37.2,moderate_burden
KE-NRB-2014-02875,2014,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-02876,2016,49,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,28.2,moderate_burden
KE-NRB-2018-02877,2018,51,45-54,Male,Lung,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Dead,9.8,moderate_burden
KE-NRB-2016-02878,2016,72,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,20.7,moderate_burden
KE-NRB-2017-02879,2017,23,15-24,Female,Breast,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-02880,2013,25,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,40.4,moderate_burden
KE-NRB-2016-02881,2016,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,1.5,moderate_burden
KE-NRB-2018-02882,2018,79,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,14.8,moderate_burden
KE-NRB-2010-02883,2010,53,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-02884,2011,50,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.2,moderate_burden
KE-NRB-2017-02885,2017,25,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-02886,2009,42,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,7.6,moderate_burden
KE-NRB-2018-02887,2018,69,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,37.3,moderate_burden
KE-NRB-2017-02888,2017,52,45-54,Male,Prostate,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,23.6,moderate_burden
KE-NRB-2012-02889,2012,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,12.2,moderate_burden
KE-NRB-2009-02890,2009,83,75+,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.9,moderate_burden
KE-NRB-2009-02891,2009,92,75+,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,1.7,moderate_burden
KE-NRB-2016-02892,2016,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,13.1,moderate_burden
KE-NRB-2014-02893,2014,23,15-24,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemo + Radiotherapy,Dead,18.1,moderate_burden
KE-NRB-2015-02894,2015,50,45-54,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.8,moderate_burden
KE-NRB-2016-02895,2016,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Alive,51.4,moderate_burden
KE-NRB-2017-02896,2017,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,17.7,moderate_burden
KE-NRB-2014-02897,2014,56,55-64,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02898,2017,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,20.8,moderate_burden
KE-NRB-2009-02899,2009,71,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,3.0,moderate_burden
KE-NRB-2012-02900,2012,59,55-64,Male,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,39.8,moderate_burden
KE-NRB-2015-02901,2015,59,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,20.3,moderate_burden
KE-NRB-2018-02902,2018,28,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,20.1,moderate_burden
KE-NRB-2013-02903,2013,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,2.0,moderate_burden
KE-NRB-2011-02904,2011,50,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,2.8,moderate_burden
KE-NRB-2018-02905,2018,58,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,1.0,moderate_burden
KE-NRB-2014-02906,2014,3,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,13.7,moderate_burden
KE-NRB-2018-02907,2018,51,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,16.6,moderate_burden
KE-NRB-2014-02908,2014,48,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,3.4,moderate_burden
KE-NRB-2010-02909,2010,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,4.6,moderate_burden
KE-NRB-2018-02910,2018,48,45-54,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,7.7,moderate_burden
KE-NRB-2013-02911,2013,51,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.1,moderate_burden
KE-NRB-2011-02912,2011,36,35-44,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.0,moderate_burden
KE-NRB-2014-02913,2014,49,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,30.6,moderate_burden
KE-NRB-2011-02914,2011,37,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-02915,2018,61,55-64,Female,Other,Unspecified,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-02916,2014,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,8.5,moderate_burden
KE-NRB-2013-02917,2013,28,25-34,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-02918,2009,15,15-24,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.5,moderate_burden
KE-NRB-2011-02919,2011,67,65-74,Male,Skin (melanoma),Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,3.4,moderate_burden
KE-NRB-2009-02920,2009,26,25-34,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,36.5,moderate_burden
KE-NRB-2013-02921,2013,61,55-64,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Rural,Surgery only,Alive,46.1,moderate_burden
KE-NRB-2017-02922,2017,11,0-14,Female,Breast,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-02923,2012,46,45-54,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,2.8,moderate_burden
KE-NRB-2015-02924,2015,56,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,40.3,moderate_burden
KE-NRB-2011-02925,2011,56,55-64,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,9.2,moderate_burden
KE-NRB-2014-02926,2014,63,55-64,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,51.3,moderate_burden
KE-NRB-2018-02927,2018,68,65-74,Female,Thyroid,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,12.8,moderate_burden
KE-NRB-2017-02928,2017,34,25-34,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.2,moderate_burden
KE-NRB-2011-02929,2011,90,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,26.3,moderate_burden
KE-NRB-2016-02930,2016,41,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,7.4,moderate_burden
KE-NRB-2016-02931,2016,39,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,5.7,moderate_burden
KE-NRB-2015-02932,2015,40,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.5,moderate_burden
KE-NRB-2010-02933,2010,11,0-14,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,32.1,moderate_burden
KE-NRB-2013-02934,2013,65,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,9.9,moderate_burden
KE-NRB-2016-02935,2016,27,25-34,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.3,moderate_burden
KE-NRB-2009-02936,2009,62,55-64,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.1,moderate_burden
KE-NRB-2018-02937,2018,74,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,40.9,moderate_burden
KE-NRB-2010-02938,2010,55,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.0,moderate_burden
KE-NRB-2018-02939,2018,55,55-64,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,8.5,moderate_burden
KE-NRB-2011-02940,2011,44,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-02941,2017,24,15-24,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.1,moderate_burden
KE-NRB-2011-02942,2011,59,55-64,Male,Colorectum,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.4,moderate_burden
KE-NRB-2018-02943,2018,55,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,11.3,moderate_burden
KE-NRB-2016-02944,2016,27,25-34,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.6,moderate_burden
KE-NRB-2012-02945,2012,29,25-34,Male,Pancreas,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,3.0,moderate_burden
KE-NRB-2016-02946,2016,54,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,18.3,moderate_burden
KE-NRB-2015-02947,2015,74,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,22.7,moderate_burden
KE-NRB-2013-02948,2013,63,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.0,moderate_burden
KE-NRB-2015-02949,2015,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,25.5,moderate_burden
KE-NRB-2016-02950,2016,78,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,7.5,moderate_burden
KE-NRB-2014-02951,2014,44,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,27.4,moderate_burden
KE-NRB-2015-02952,2015,45,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,12.0,moderate_burden
KE-NRB-2011-02953,2011,57,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.6,moderate_burden
KE-NRB-2014-02954,2014,76,75+,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,14.6,moderate_burden
KE-NRB-2012-02955,2012,58,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.2,moderate_burden
KE-NRB-2012-02956,2012,27,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,8.6,moderate_burden
KE-NRB-2014-02957,2014,47,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,17.5,moderate_burden
KE-NRB-2010-02958,2010,21,15-24,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,7.6,moderate_burden
KE-NRB-2014-02959,2014,38,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.3,moderate_burden
KE-NRB-2009-02960,2009,43,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.3,moderate_burden
KE-NRB-2018-02961,2018,44,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,16.0,moderate_burden
KE-NRB-2018-02962,2018,33,25-34,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,2.1,moderate_burden
KE-NRB-2013-02963,2013,21,15-24,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,40.5,moderate_burden
KE-NRB-2016-02964,2016,73,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,15.0,moderate_burden
KE-NRB-2010-02965,2010,42,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,33.9,moderate_burden
KE-NRB-2013-02966,2013,66,65-74,Male,Liver,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.9,moderate_burden
KE-NRB-2013-02967,2013,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-02968,2012,17,15-24,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-02969,2014,50,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,6.7,moderate_burden
KE-NRB-2018-02970,2018,53,45-54,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,8.5,moderate_burden
KE-NRB-2017-02971,2017,54,45-54,Male,Liver,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,12.0,moderate_burden
KE-NRB-2011-02972,2011,30,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2016-02973,2016,50,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.7,moderate_burden
KE-NRB-2013-02974,2013,63,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,42.8,moderate_burden
KE-NRB-2011-02975,2011,69,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.2,moderate_burden
KE-NRB-2013-02976,2013,69,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,11.0,moderate_burden
KE-NRB-2010-02977,2010,62,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,37.0,moderate_burden
KE-NRB-2013-02978,2013,77,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-02979,2012,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,4.4,moderate_burden
KE-NRB-2013-02980,2013,71,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,11.6,moderate_burden
KE-NRB-2014-02981,2014,82,75+,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-02982,2017,37,35-44,Male,Kidney,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.7,moderate_burden
KE-NRB-2018-02983,2018,35,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery only,Dead,32.2,moderate_burden
KE-NRB-2018-02984,2018,63,55-64,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,24.4,moderate_burden
KE-NRB-2009-02985,2009,57,55-64,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-02986,2010,62,55-64,Male,Stomach,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.1,moderate_burden
KE-NRB-2018-02987,2018,41,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,26.8,moderate_burden
KE-NRB-2015-02988,2015,28,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.4,moderate_burden
KE-NRB-2017-02989,2017,40,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-02990,2013,45,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,53.2,moderate_burden
KE-NRB-2011-02991,2011,42,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-02992,2016,69,65-74,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,3.0,moderate_burden
KE-NRB-2012-02993,2012,48,45-54,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.8,moderate_burden
KE-NRB-2018-02994,2018,48,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,12.5,moderate_burden
KE-NRB-2012-02995,2012,90,75+,Male,Skin (melanoma),Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,8.6,moderate_burden
KE-NRB-2015-02996,2015,55,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,23.3,moderate_burden
KE-NRB-2013-02997,2013,67,65-74,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,8.6,moderate_burden
KE-NRB-2017-02998,2017,49,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,11.6,moderate_burden
KE-NRB-2014-02999,2014,28,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,2.9,moderate_burden
KE-NRB-2014-03000,2014,31,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,41.8,moderate_burden
KE-NRB-2016-03001,2016,59,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,3.3,moderate_burden
KE-NRB-2010-03002,2010,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,7.6,moderate_burden
KE-NRB-2018-03003,2018,40,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,2.3,moderate_burden
KE-NRB-2014-03004,2014,27,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,24.2,moderate_burden
KE-NRB-2018-03005,2018,32,25-34,Male,Bladder,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Alive,0.0,moderate_burden
KE-NRB-2018-03006,2018,41,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,7.7,moderate_burden
KE-NRB-2012-03007,2012,47,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.4,moderate_burden
KE-NRB-2018-03008,2018,51,45-54,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,4.5,moderate_burden
KE-NRB-2012-03009,2012,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Alive,21.3,moderate_burden
KE-NRB-2014-03010,2014,56,55-64,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2015-03011,2015,25,25-34,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,23.2,moderate_burden
KE-NRB-2016-03012,2016,55,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2018-03013,2018,49,45-54,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Dead,9.5,moderate_burden
KE-NRB-2011-03014,2011,76,75+,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.3,moderate_burden
KE-NRB-2017-03015,2017,42,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-03016,2015,61,55-64,Female,Other,Unspecified,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemotherapy only,Dead,6.4,moderate_burden
KE-NRB-2011-03017,2011,73,65-74,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,34.9,moderate_burden
KE-NRB-2017-03018,2017,70,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,20.2,moderate_burden
KE-NRB-2011-03019,2011,54,45-54,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,12.5,moderate_burden
KE-NRB-2015-03020,2015,66,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-03021,2018,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.8,moderate_burden
KE-NRB-2014-03022,2014,51,45-54,Male,Stomach,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,21.2,moderate_burden
KE-NRB-2013-03023,2013,41,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,20.8,moderate_burden
KE-NRB-2017-03024,2017,56,55-64,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,0.2,moderate_burden
KE-NRB-2016-03025,2016,13,0-14,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,13.2,moderate_burden
KE-NRB-2012-03026,2012,41,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,19.9,moderate_burden
KE-NRB-2012-03027,2012,61,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,3.4,moderate_burden
KE-NRB-2016-03028,2016,27,25-34,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,5.0,moderate_burden
KE-NRB-2015-03029,2015,37,35-44,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.1,moderate_burden
KE-NRB-2015-03030,2015,36,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,1.4,moderate_burden
KE-NRB-2014-03031,2014,54,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03032,2011,59,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,35.1,moderate_burden
KE-NRB-2017-03033,2017,36,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-03034,2017,17,15-24,Male,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,18.1,moderate_burden
KE-NRB-2013-03035,2013,17,15-24,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2016-03036,2016,82,75+,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,16.3,moderate_burden
KE-NRB-2018-03037,2018,63,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,42.0,moderate_burden
KE-NRB-2018-03038,2018,43,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Alive,3.1,moderate_burden
KE-NRB-2013-03039,2013,70,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,3.6,moderate_burden
KE-NRB-2017-03040,2017,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,17.6,moderate_burden
KE-NRB-2018-03041,2018,68,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.1,moderate_burden
KE-NRB-2015-03042,2015,50,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,20.9,moderate_burden
KE-NRB-2011-03043,2011,65,65-74,Male,Leukemia,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,10.7,moderate_burden
KE-NRB-2018-03044,2018,27,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-03045,2018,61,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03046,2013,87,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.4,moderate_burden
KE-NRB-2016-03047,2016,49,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03048,2016,68,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,15.6,moderate_burden
KE-NRB-2017-03049,2017,30,25-34,Female,Thyroid,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,12.6,moderate_burden
KE-NRB-2012-03050,2012,71,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,25.2,moderate_burden
KE-NRB-2018-03051,2018,64,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2017-03052,2017,65,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,59.9,moderate_burden
KE-NRB-2017-03053,2017,45,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.2,moderate_burden
KE-NRB-2018-03054,2018,62,55-64,Male,Colorectum,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,13.9,moderate_burden
KE-NRB-2016-03055,2016,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.2,moderate_burden
KE-NRB-2016-03056,2016,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Alive,10.9,moderate_burden
KE-NRB-2016-03057,2016,54,45-54,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-03058,2010,74,65-74,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-03059,2011,19,15-24,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,0.0,moderate_burden
KE-NRB-2012-03060,2012,40,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,1.5,moderate_burden
KE-NRB-2017-03061,2017,66,65-74,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,6.9,moderate_burden
KE-NRB-2010-03062,2010,72,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,52.8,moderate_burden
KE-NRB-2017-03063,2017,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,54.1,moderate_burden
KE-NRB-2015-03064,2015,56,55-64,Female,Breast,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.8,moderate_burden
KE-NRB-2011-03065,2011,56,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.4,moderate_burden
KE-NRB-2016-03066,2016,39,35-44,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.8,moderate_burden
KE-NRB-2016-03067,2016,66,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.1,moderate_burden
KE-NRB-2010-03068,2010,68,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,44.2,moderate_burden
KE-NRB-2015-03069,2015,59,55-64,Male,Kaposi sarcoma,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,50.7,moderate_burden
KE-NRB-2017-03070,2017,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,32.0,moderate_burden
KE-NRB-2015-03071,2015,41,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,5.9,moderate_burden
KE-NRB-2009-03072,2009,65,65-74,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,17.3,moderate_burden
KE-NRB-2016-03073,2016,56,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,40.8,moderate_burden
KE-NRB-2017-03074,2017,44,35-44,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03075,2017,64,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,18.5,moderate_burden
KE-NRB-2016-03076,2016,60,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,moderate_burden
KE-NRB-2012-03077,2012,73,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.1,moderate_burden
KE-NRB-2009-03078,2009,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,47.6,moderate_burden
KE-NRB-2014-03079,2014,55,55-64,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2018-03080,2018,63,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,20.2,moderate_burden
KE-NRB-2014-03081,2014,50,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.6,moderate_burden
KE-NRB-2017-03082,2017,62,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,20.0,moderate_burden
KE-NRB-2014-03083,2014,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,10.6,moderate_burden
KE-NRB-2011-03084,2011,93,75+,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-03085,2012,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.8,moderate_burden
KE-NRB-2009-03086,2009,69,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,28.9,moderate_burden
KE-NRB-2014-03087,2014,25,25-34,Female,Breast,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,5.9,moderate_burden
KE-NRB-2016-03088,2016,30,25-34,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.3,moderate_burden
KE-NRB-2015-03089,2015,39,35-44,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-03090,2011,57,55-64,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,48.9,moderate_burden
KE-NRB-2013-03091,2013,35,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,34.4,moderate_burden
KE-NRB-2009-03092,2009,61,55-64,Male,Kidney,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-03093,2013,58,55-64,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,10.1,moderate_burden
KE-NRB-2011-03094,2011,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.3,moderate_burden
KE-NRB-2017-03095,2017,51,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.2,moderate_burden
KE-NRB-2014-03096,2014,73,65-74,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.0,moderate_burden
KE-NRB-2016-03097,2016,69,65-74,Male,Stomach,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.9,moderate_burden
KE-NRB-2017-03098,2017,74,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,4.9,moderate_burden
KE-NRB-2017-03099,2017,47,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-03100,2014,43,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,2.6,moderate_burden
KE-NRB-2011-03101,2011,54,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.7,moderate_burden
KE-NRB-2016-03102,2016,40,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.7,moderate_burden
KE-NRB-2012-03103,2012,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,4.6,moderate_burden
KE-NRB-2018-03104,2018,4,0-14,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-03105,2012,35,35-44,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03106,2015,61,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.1,moderate_burden
KE-NRB-2015-03107,2015,54,45-54,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03108,2013,1,0-14,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.5,moderate_burden
KE-NRB-2015-03109,2015,53,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Radiotherapy only,Alive,3.1,moderate_burden
KE-NRB-2014-03110,2014,67,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Lost to follow-up,13.7,moderate_burden
KE-NRB-2018-03111,2018,59,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.5,moderate_burden
KE-NRB-2016-03112,2016,42,35-44,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.9,moderate_burden
KE-NRB-2013-03113,2013,64,55-64,Female,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03114,2017,50,45-54,Female,Ovary,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,9.6,moderate_burden
KE-NRB-2018-03115,2018,70,65-74,Male,Prostate,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,49.0,moderate_burden
KE-NRB-2015-03116,2015,73,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,31.7,moderate_burden
KE-NRB-2018-03117,2018,28,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03118,2015,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,17.4,moderate_burden
KE-NRB-2015-03119,2015,46,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,5.1,moderate_burden
KE-NRB-2015-03120,2015,57,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,57.9,moderate_burden
KE-NRB-2012-03121,2012,62,55-64,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.7,moderate_burden
KE-NRB-2013-03122,2013,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,23.9,moderate_burden
KE-NRB-2018-03123,2018,53,45-54,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,23.7,moderate_burden
KE-NRB-2012-03124,2012,31,25-34,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,55.9,moderate_burden
KE-NRB-2016-03125,2016,54,45-54,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Other,Malignant,Urban,Chemotherapy only,Dead,28.9,moderate_burden
KE-NRB-2016-03126,2016,38,35-44,Male,Other,Leukemia,Unknown,Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,30.5,moderate_burden
KE-NRB-2017-03127,2017,67,65-74,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03128,2013,52,45-54,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,36.8,moderate_burden
KE-NRB-2015-03129,2015,68,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Alive,55.8,moderate_burden
KE-NRB-2010-03130,2010,50,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,26.6,moderate_burden
KE-NRB-2011-03131,2011,80,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,44.8,moderate_burden
KE-NRB-2009-03132,2009,55,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.1,moderate_burden
KE-NRB-2010-03133,2010,49,45-54,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,5.0,moderate_burden
KE-NRB-2014-03134,2014,92,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03135,2016,66,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,13.2,moderate_burden
KE-NRB-2016-03136,2016,46,45-54,Male,Liver,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,29.1,moderate_burden
KE-NRB-2018-03137,2018,18,15-24,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.5,moderate_burden
KE-NRB-2014-03138,2014,55,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.9,moderate_burden
KE-NRB-2018-03139,2018,29,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.2,moderate_burden
KE-NRB-2018-03140,2018,35,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.2,moderate_burden
KE-NRB-2014-03141,2014,66,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.6,moderate_burden
KE-NRB-2017-03142,2017,69,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03143,2015,91,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.6,moderate_burden
KE-NRB-2015-03144,2015,39,35-44,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,11.1,moderate_burden
KE-NRB-2017-03145,2017,55,55-64,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,21.5,moderate_burden
KE-NRB-2016-03146,2016,15,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03147,2016,50,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,37.6,moderate_burden
KE-NRB-2014-03148,2014,56,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,0.2,moderate_burden
KE-NRB-2013-03149,2013,35,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.9,moderate_burden
KE-NRB-2018-03150,2018,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,8.0,moderate_burden
KE-NRB-2015-03151,2015,42,35-44,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,12.1,moderate_burden
KE-NRB-2010-03152,2010,42,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.6,moderate_burden
KE-NRB-2017-03153,2017,47,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-03154,2009,41,35-44,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,42.4,moderate_burden
KE-NRB-2014-03155,2014,72,65-74,Male,Liver,Other specified,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03156,2013,58,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,23.4,moderate_burden
KE-NRB-2012-03157,2012,54,45-54,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-03158,2013,49,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.8,moderate_burden
KE-NRB-2014-03159,2014,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,18.5,moderate_burden
KE-NRB-2018-03160,2018,47,45-54,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.6,moderate_burden
KE-NRB-2009-03161,2009,47,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,55.2,moderate_burden
KE-NRB-2013-03162,2013,57,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,56.9,moderate_burden
KE-NRB-2017-03163,2017,64,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,44.4,moderate_burden
KE-NRB-2010-03164,2010,45,45-54,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,6.6,moderate_burden
KE-NRB-2010-03165,2010,39,35-44,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.8,moderate_burden
KE-NRB-2016-03166,2016,71,65-74,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,11.4,moderate_burden
KE-NRB-2016-03167,2016,66,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,36.6,moderate_burden
KE-NRB-2018-03168,2018,62,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.4,moderate_burden
KE-NRB-2014-03169,2014,47,45-54,Male,Pancreas,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery only,Alive,14.8,moderate_burden
KE-NRB-2017-03170,2017,60,55-64,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,0.6,moderate_burden
KE-NRB-2011-03171,2011,64,55-64,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-03172,2018,67,65-74,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,26.7,moderate_burden
KE-NRB-2014-03173,2014,54,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,20.0,moderate_burden
KE-NRB-2016-03174,2016,53,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,46.5,moderate_burden
KE-NRB-2013-03175,2013,70,65-74,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.7,moderate_burden
KE-NRB-2016-03176,2016,57,55-64,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Dead,0.1,moderate_burden
KE-NRB-2013-03177,2013,32,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,0.9,moderate_burden
KE-NRB-2017-03178,2017,67,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,8.5,moderate_burden
KE-NRB-2016-03179,2016,47,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,6.1,moderate_burden
KE-NRB-2010-03180,2010,41,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,1.6,moderate_burden
KE-NRB-2018-03181,2018,50,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-03182,2013,53,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.4,moderate_burden
KE-NRB-2009-03183,2009,66,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,14.1,moderate_burden
KE-NRB-2017-03184,2017,73,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-03185,2011,93,75+,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-03186,2018,41,35-44,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,42.1,moderate_burden
KE-NRB-2011-03187,2011,49,45-54,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,2.0,moderate_burden
KE-NRB-2013-03188,2013,46,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,9.0,moderate_burden
KE-NRB-2017-03189,2017,17,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,5.9,moderate_burden
KE-NRB-2014-03190,2014,39,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.8,moderate_burden
KE-NRB-2016-03191,2016,50,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.9,moderate_burden
KE-NRB-2015-03192,2015,64,55-64,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.8,moderate_burden
KE-NRB-2011-03193,2011,52,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.0,moderate_burden
KE-NRB-2012-03194,2012,28,25-34,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-03195,2016,70,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,41.4,moderate_burden
KE-NRB-2013-03196,2013,55,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2014-03197,2014,44,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,15.0,moderate_burden
KE-NRB-2016-03198,2016,64,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.5,moderate_burden
KE-NRB-2016-03199,2016,59,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,21.3,moderate_burden
KE-NRB-2009-03200,2009,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.8,moderate_burden
KE-NRB-2018-03201,2018,6,0-14,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,8.7,moderate_burden
KE-NRB-2010-03202,2010,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-03203,2014,69,65-74,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-03204,2013,78,75+,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,2.6,moderate_burden
KE-NRB-2013-03205,2013,47,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,14.2,moderate_burden
KE-NRB-2010-03206,2010,35,35-44,Male,Skin (melanoma),Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,54.8,moderate_burden
KE-NRB-2015-03207,2015,60,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,0.7,moderate_burden
KE-NRB-2018-03208,2018,71,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,51.8,moderate_burden
KE-NRB-2016-03209,2016,71,65-74,Male,Leukemia,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03210,2015,37,35-44,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.8,moderate_burden
KE-NRB-2015-03211,2015,58,55-64,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Alive,47.5,moderate_burden
KE-NRB-2010-03212,2010,39,35-44,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.6,moderate_burden
KE-NRB-2010-03213,2010,64,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,2.9,moderate_burden
KE-NRB-2010-03214,2010,38,35-44,Male,Liver,Other specified,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03215,2013,65,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,26.2,moderate_burden
KE-NRB-2011-03216,2011,42,35-44,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,3.4,moderate_burden
KE-NRB-2017-03217,2017,45,45-54,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.7,moderate_burden
KE-NRB-2012-03218,2012,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.3,moderate_burden
KE-NRB-2018-03219,2018,43,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,1.4,moderate_burden
KE-NRB-2011-03220,2011,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,3.6,moderate_burden
KE-NRB-2011-03221,2011,42,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,35.8,moderate_burden
KE-NRB-2010-03222,2010,46,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,46.1,moderate_burden
KE-NRB-2015-03223,2015,35,35-44,Female,Corpus uteri,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,34.0,moderate_burden
KE-NRB-2018-03224,2018,56,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Other,Malignant,Urban,Surgery only,Dead,27.4,moderate_burden
KE-NRB-2016-03225,2016,42,35-44,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,34.1,moderate_burden
KE-NRB-2017-03226,2017,32,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,0.1,moderate_burden
KE-NRB-2011-03227,2011,70,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2016-03228,2016,62,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,18.0,moderate_burden
KE-NRB-2012-03229,2012,35,35-44,Male,Oesophagus,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.1,moderate_burden
KE-NRB-2014-03230,2014,62,55-64,Male,Bladder,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,7.4,moderate_burden
KE-NRB-2016-03231,2016,32,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,9.5,moderate_burden
KE-NRB-2015-03232,2015,62,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,25.6,moderate_burden
KE-NRB-2017-03233,2017,52,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,36.7,moderate_burden
KE-NRB-2013-03234,2013,38,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-03235,2012,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.9,moderate_burden
KE-NRB-2018-03236,2018,20,15-24,Female,Breast,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,20.5,moderate_burden
KE-NRB-2016-03237,2016,63,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-03238,2018,35,35-44,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-03239,2014,43,35-44,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.9,moderate_burden
KE-NRB-2016-03240,2016,70,65-74,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-03241,2012,37,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Death certificate only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-03242,2014,46,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,31.5,moderate_burden
KE-NRB-2014-03243,2014,45,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-03244,2011,55,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-03245,2010,48,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,31.9,moderate_burden
KE-NRB-2011-03246,2011,61,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,1.8,moderate_burden
KE-NRB-2015-03247,2015,38,35-44,Female,Other,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03248,2015,45,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,52.0,moderate_burden
KE-NRB-2010-03249,2010,66,65-74,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,56.4,moderate_burden
KE-NRB-2012-03250,2012,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.3,moderate_burden
KE-NRB-2012-03251,2012,65,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.2,moderate_burden
KE-NRB-2017-03252,2017,63,55-64,Female,Corpus uteri,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,26.8,moderate_burden
KE-NRB-2016-03253,2016,57,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,34.1,moderate_burden
KE-NRB-2012-03254,2012,52,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.1,moderate_burden
KE-NRB-2013-03255,2013,39,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,6.4,moderate_burden
KE-NRB-2011-03256,2011,54,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,19.7,moderate_burden
KE-NRB-2016-03257,2016,52,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-03258,2015,57,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Dead,27.1,moderate_burden
KE-NRB-2011-03259,2011,63,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.7,moderate_burden
KE-NRB-2017-03260,2017,52,45-54,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,22.8,moderate_burden
KE-NRB-2015-03261,2015,53,45-54,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-03262,2018,65,65-74,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,14.8,moderate_burden
KE-NRB-2016-03263,2016,71,65-74,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,50.7,moderate_burden
KE-NRB-2018-03264,2018,52,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,30.5,moderate_burden
KE-NRB-2017-03265,2017,57,55-64,Male,Stomach,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.1,moderate_burden
KE-NRB-2015-03266,2015,56,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.9,moderate_burden
KE-NRB-2014-03267,2014,70,65-74,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.6,moderate_burden
KE-NRB-2017-03268,2017,42,35-44,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,29.8,moderate_burden
KE-NRB-2010-03269,2010,45,45-54,Male,Bladder,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.4,moderate_burden
KE-NRB-2015-03270,2015,65,65-74,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,11.5,moderate_burden
KE-NRB-2014-03271,2014,88,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,21.7,moderate_burden
KE-NRB-2014-03272,2014,34,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-03273,2009,43,35-44,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.5,moderate_burden
KE-NRB-2016-03274,2016,39,35-44,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,1.4,moderate_burden
KE-NRB-2018-03275,2018,66,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.5,moderate_burden
KE-NRB-2014-03276,2014,38,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.1,moderate_burden
KE-NRB-2015-03277,2015,38,35-44,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-03278,2017,28,25-34,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,11.0,moderate_burden
KE-NRB-2014-03279,2014,74,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-03280,2011,41,35-44,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Clinical only,In situ,Peri-urban,N/A,Lost to follow-up,6.0,moderate_burden
KE-NRB-2013-03281,2013,42,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03282,2015,75,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.6,moderate_burden
KE-NRB-2014-03283,2014,86,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,6.4,moderate_burden
KE-NRB-2017-03284,2017,69,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,10.9,moderate_burden
KE-NRB-2017-03285,2017,43,35-44,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,21.9,moderate_burden
KE-NRB-2017-03286,2017,72,65-74,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.3,moderate_burden
KE-NRB-2011-03287,2011,38,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Alive,14.4,moderate_burden
KE-NRB-2015-03288,2015,45,45-54,Male,Stomach,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,27.5,moderate_burden
KE-NRB-2014-03289,2014,56,55-64,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.7,moderate_burden
KE-NRB-2014-03290,2014,53,45-54,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,18.7,moderate_burden
KE-NRB-2015-03291,2015,58,55-64,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.4,moderate_burden
KE-NRB-2011-03292,2011,59,55-64,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.2,moderate_burden
KE-NRB-2015-03293,2015,17,15-24,Male,Prostate,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,3.3,moderate_burden
KE-NRB-2010-03294,2010,35,35-44,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,28.5,moderate_burden
KE-NRB-2010-03295,2010,55,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03296,2016,29,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03297,2015,50,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.5,moderate_burden
KE-NRB-2010-03298,2010,31,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,18.8,moderate_burden
KE-NRB-2011-03299,2011,65,65-74,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,9.2,moderate_burden
KE-NRB-2018-03300,2018,39,35-44,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.8,moderate_burden
KE-NRB-2016-03301,2016,38,35-44,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,36.9,moderate_burden
KE-NRB-2018-03302,2018,36,35-44,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,6.6,moderate_burden
KE-NRB-2013-03303,2013,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,22.5,moderate_burden
KE-NRB-2010-03304,2010,44,35-44,Male,Prostate,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-03305,2014,63,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,11.3,moderate_burden
KE-NRB-2018-03306,2018,44,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-03307,2015,67,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,49.4,moderate_burden
KE-NRB-2010-03308,2010,69,65-74,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,36.7,moderate_burden
KE-NRB-2014-03309,2014,62,55-64,Male,Lung,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,1.1,moderate_burden
KE-NRB-2018-03310,2018,35,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.1,moderate_burden
KE-NRB-2014-03311,2014,49,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-03312,2015,38,35-44,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.3,moderate_burden
KE-NRB-2010-03313,2010,49,45-54,Female,Other,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,13.1,moderate_burden
KE-NRB-2016-03314,2016,58,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,40.7,moderate_burden
KE-NRB-2018-03315,2018,35,35-44,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,8.1,moderate_burden
KE-NRB-2018-03316,2018,59,55-64,Male,Prostate,Lymphoma,Unknown,Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,2.9,moderate_burden
KE-NRB-2014-03317,2014,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,51.6,moderate_burden
KE-NRB-2017-03318,2017,43,35-44,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,5.9,moderate_burden
KE-NRB-2017-03319,2017,46,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.1,moderate_burden
KE-NRB-2016-03320,2016,47,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,23.3,moderate_burden
KE-NRB-2016-03321,2016,57,55-64,Male,Pancreas,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,52.1,moderate_burden
KE-NRB-2013-03322,2013,35,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,59.1,moderate_burden
KE-NRB-2018-03323,2018,24,15-24,Male,Multiple myeloma,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,8.7,moderate_burden
KE-NRB-2010-03324,2010,73,65-74,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,32.7,moderate_burden
KE-NRB-2015-03325,2015,41,35-44,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03326,2009,63,55-64,Male,Kaposi sarcoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.9,moderate_burden
KE-NRB-2015-03327,2015,16,15-24,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Palliative care only,Dead,11.8,moderate_burden
KE-NRB-2014-03328,2014,63,55-64,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,59.4,moderate_burden
KE-NRB-2010-03329,2010,45,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,24.6,moderate_burden
KE-NRB-2017-03330,2017,61,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,7.3,moderate_burden
KE-NRB-2014-03331,2014,45,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-03332,2017,70,65-74,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.5,moderate_burden
KE-NRB-2018-03333,2018,55,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,37.8,moderate_burden
KE-NRB-2011-03334,2011,90,75+,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.0,moderate_burden
KE-NRB-2018-03335,2018,66,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,18.4,moderate_burden
KE-NRB-2010-03336,2010,71,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Clinical only,In situ,Peri-urban,N/A,Alive,11.6,moderate_burden
KE-NRB-2009-03337,2009,79,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03338,2016,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,1.0,moderate_burden
KE-NRB-2012-03339,2012,70,65-74,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,45.0,moderate_burden
KE-NRB-2017-03340,2017,45,45-54,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,10.3,moderate_burden
KE-NRB-2010-03341,2010,57,55-64,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,49.2,moderate_burden
KE-NRB-2018-03342,2018,59,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Alive,4.7,moderate_burden
KE-NRB-2009-03343,2009,50,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,3.2,moderate_burden
KE-NRB-2017-03344,2017,29,25-34,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-03345,2015,65,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.7,moderate_burden
KE-NRB-2014-03346,2014,69,65-74,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,15.0,moderate_burden
KE-NRB-2014-03347,2014,68,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,31.8,moderate_burden
KE-NRB-2012-03348,2012,60,55-64,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,1.2,moderate_burden
KE-NRB-2014-03349,2014,45,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.3,moderate_burden
KE-NRB-2013-03350,2013,53,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2018-03351,2018,27,25-34,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,7.6,moderate_burden
KE-NRB-2009-03352,2009,85,75+,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2018-03353,2018,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2016-03354,2016,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.1,moderate_burden
KE-NRB-2012-03355,2012,63,55-64,Male,Leukemia,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03356,2017,34,25-34,Male,Other,Leukemia,Unknown,Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,26.0,moderate_burden
KE-NRB-2009-03357,2009,18,15-24,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Radiotherapy only,Dead,50.8,moderate_burden
KE-NRB-2014-03358,2014,49,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,37.0,moderate_burden
KE-NRB-2012-03359,2012,30,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,14.5,moderate_burden
KE-NRB-2016-03360,2016,55,55-64,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,15.5,moderate_burden
KE-NRB-2018-03361,2018,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03362,2011,40,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Benign/uncertain,Peri-urban,N/A,Alive,26.9,moderate_burden
KE-NRB-2011-03363,2011,54,45-54,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,2.3,moderate_burden
KE-NRB-2009-03364,2009,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-03365,2015,71,65-74,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03366,2015,72,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.2,moderate_burden
KE-NRB-2014-03367,2014,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-03368,2012,38,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,43.6,moderate_burden
KE-NRB-2016-03369,2016,46,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.8,moderate_burden
KE-NRB-2014-03370,2014,47,45-54,Male,Oesophagus,Unspecified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.5,moderate_burden
KE-NRB-2015-03371,2015,68,65-74,Male,Colorectum,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,6.7,moderate_burden
KE-NRB-2018-03372,2018,58,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-03373,2016,45,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Other,In situ,Urban,N/A,Dead,34.1,moderate_burden
KE-NRB-2013-03374,2013,72,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,55.9,moderate_burden
KE-NRB-2013-03375,2013,56,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,5.7,moderate_burden
KE-NRB-2011-03376,2011,69,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,6.6,moderate_burden
KE-NRB-2011-03377,2011,70,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.0,moderate_burden
KE-NRB-2011-03378,2011,47,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,45.8,moderate_burden
KE-NRB-2010-03379,2010,50,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,33.6,moderate_burden
KE-NRB-2012-03380,2012,88,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,29.6,moderate_burden
KE-NRB-2015-03381,2015,74,65-74,Female,Corpus uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,56.6,moderate_burden
KE-NRB-2016-03382,2016,53,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.1,moderate_burden
KE-NRB-2015-03383,2015,37,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03384,2014,71,65-74,Male,Kidney,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,46.3,moderate_burden
KE-NRB-2018-03385,2018,44,35-44,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,21.6,moderate_burden
KE-NRB-2011-03386,2011,48,45-54,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,50.6,moderate_burden
KE-NRB-2015-03387,2015,61,55-64,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-03388,2014,38,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Lost to follow-up,16.7,moderate_burden
KE-NRB-2017-03389,2017,35,35-44,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,57.9,moderate_burden
KE-NRB-2011-03390,2011,55,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.9,moderate_burden
KE-NRB-2017-03391,2017,53,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,11.3,moderate_burden
KE-NRB-2018-03392,2018,53,45-54,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,1.7,moderate_burden
KE-NRB-2013-03393,2013,13,0-14,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,6.7,moderate_burden
KE-NRB-2017-03394,2017,47,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-03395,2018,28,25-34,Male,Bladder,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,36.3,moderate_burden
KE-NRB-2018-03396,2018,68,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,23.0,moderate_burden
KE-NRB-2016-03397,2016,57,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,2.2,moderate_burden
KE-NRB-2017-03398,2017,50,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,21.6,moderate_burden
KE-NRB-2013-03399,2013,44,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.3,moderate_burden
KE-NRB-2018-03400,2018,36,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,20.8,moderate_burden
KE-NRB-2018-03401,2018,48,45-54,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,1.2,moderate_burden
KE-NRB-2016-03402,2016,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,34.6,moderate_burden
KE-NRB-2013-03403,2013,26,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,0.2,moderate_burden
KE-NRB-2016-03404,2016,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,1.0,moderate_burden
KE-NRB-2013-03405,2013,33,25-34,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.5,moderate_burden
KE-NRB-2012-03406,2012,58,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,32.4,moderate_burden
KE-NRB-2016-03407,2016,36,35-44,Female,Ovary,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.6,moderate_burden
KE-NRB-2012-03408,2012,37,35-44,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,6.4,moderate_burden
KE-NRB-2011-03409,2011,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2017-03410,2017,50,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,32.7,moderate_burden
KE-NRB-2009-03411,2009,47,45-54,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,35.8,moderate_burden
KE-NRB-2010-03412,2010,47,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,12.2,moderate_burden
KE-NRB-2013-03413,2013,54,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,48.2,moderate_burden
KE-NRB-2014-03414,2014,39,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,52.5,moderate_burden
KE-NRB-2012-03415,2012,68,65-74,Male,Non-Hodgkin lymphoma,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-03416,2013,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,1.6,moderate_burden
KE-NRB-2011-03417,2011,31,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Dead,3.8,moderate_burden
KE-NRB-2016-03418,2016,17,15-24,Male,Liver,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.2,moderate_burden
KE-NRB-2012-03419,2012,57,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.7,moderate_burden
KE-NRB-2010-03420,2010,62,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03421,2009,51,45-54,Male,Liver,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,59.3,moderate_burden
KE-NRB-2012-03422,2012,38,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.3,moderate_burden
KE-NRB-2010-03423,2010,61,55-64,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,41.9,moderate_burden
KE-NRB-2016-03424,2016,58,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,4.0,moderate_burden
KE-NRB-2011-03425,2011,57,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.2,moderate_burden
KE-NRB-2015-03426,2015,44,35-44,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,56.4,moderate_burden
KE-NRB-2014-03427,2014,57,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,60.0,moderate_burden
KE-NRB-2009-03428,2009,53,45-54,Male,Pancreas,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,15.0,moderate_burden
KE-NRB-2018-03429,2018,37,35-44,Male,Skin (melanoma),Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-03430,2017,21,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,34.7,moderate_burden
KE-NRB-2013-03431,2013,48,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.3,moderate_burden
KE-NRB-2017-03432,2017,85,75+,Female,Breast,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.6,moderate_burden
KE-NRB-2015-03433,2015,43,35-44,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,13.0,moderate_burden
KE-NRB-2009-03434,2009,34,25-34,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,14.5,moderate_burden
KE-NRB-2013-03435,2013,61,55-64,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,7.5,moderate_burden
KE-NRB-2014-03436,2014,60,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.9,moderate_burden
KE-NRB-2016-03437,2016,16,15-24,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,11.4,moderate_burden
KE-NRB-2018-03438,2018,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.1,moderate_burden
KE-NRB-2018-03439,2018,54,45-54,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Alive,5.8,moderate_burden
KE-NRB-2013-03440,2013,55,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,7.7,moderate_burden
KE-NRB-2009-03441,2009,49,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.9,moderate_burden
KE-NRB-2013-03442,2013,33,25-34,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Alive,42.8,moderate_burden
KE-NRB-2009-03443,2009,61,55-64,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03444,2016,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,moderate_burden
KE-NRB-2014-03445,2014,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,42.6,moderate_burden
KE-NRB-2010-03446,2010,55,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03447,2011,68,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,10.8,moderate_burden
KE-NRB-2016-03448,2016,25,25-34,Male,Liver,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,43.8,moderate_burden
KE-NRB-2012-03449,2012,56,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery only,Dead,5.2,moderate_burden
KE-NRB-2013-03450,2013,44,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.5,moderate_burden
KE-NRB-2014-03451,2014,29,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,14.5,moderate_burden
KE-NRB-2017-03452,2017,35,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.0,moderate_burden
KE-NRB-2011-03453,2011,34,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,2.5,moderate_burden
KE-NRB-2016-03454,2016,69,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,55.4,moderate_burden
KE-NRB-2015-03455,2015,82,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,60.0,moderate_burden
KE-NRB-2016-03456,2016,25,25-34,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,6.5,moderate_burden
KE-NRB-2014-03457,2014,69,65-74,Female,Breast,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,6.1,moderate_burden
KE-NRB-2014-03458,2014,72,65-74,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.7,moderate_burden
KE-NRB-2013-03459,2013,58,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,38.1,moderate_burden
KE-NRB-2015-03460,2015,54,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,55.7,moderate_burden
KE-NRB-2016-03461,2016,46,45-54,Male,Bladder,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,53.8,moderate_burden
KE-NRB-2018-03462,2018,34,25-34,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-03463,2016,53,45-54,Female,Thyroid,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,9.7,moderate_burden
KE-NRB-2017-03464,2017,50,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,38.4,moderate_burden
KE-NRB-2010-03465,2010,43,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Alive,35.5,moderate_burden
KE-NRB-2012-03466,2012,37,35-44,Female,Ovary,Other specified,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,6.8,moderate_burden
KE-NRB-2009-03467,2009,34,25-34,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,32.4,moderate_burden
KE-NRB-2016-03468,2016,61,55-64,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.4,moderate_burden
KE-NRB-2014-03469,2014,45,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,8.7,moderate_burden
KE-NRB-2018-03470,2018,49,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03471,2011,58,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,6.9,moderate_burden
KE-NRB-2018-03472,2018,61,55-64,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,16.2,moderate_burden
KE-NRB-2017-03473,2017,31,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.4,moderate_burden
KE-NRB-2017-03474,2017,48,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,19.4,moderate_burden
KE-NRB-2018-03475,2018,59,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,17.0,moderate_burden
KE-NRB-2013-03476,2013,93,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03477,2014,50,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,3.3,moderate_burden
KE-NRB-2011-03478,2011,61,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,3.1,moderate_burden
KE-NRB-2015-03479,2015,35,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-03480,2018,58,55-64,Male,Kidney,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.3,moderate_burden
KE-NRB-2017-03481,2017,46,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-03482,2018,48,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,48.4,moderate_burden
KE-NRB-2017-03483,2017,27,25-34,Female,Breast,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Surgery only,Dead,8.0,moderate_burden
KE-NRB-2016-03484,2016,25,25-34,Male,Liver,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.6,moderate_burden
KE-NRB-2011-03485,2011,57,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-03486,2014,42,35-44,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,37.3,moderate_burden
KE-NRB-2011-03487,2011,63,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,54.9,moderate_burden
KE-NRB-2010-03488,2010,63,55-64,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,46.9,moderate_burden
KE-NRB-2014-03489,2014,39,35-44,Female,Breast,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2018-03490,2018,55,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.3,moderate_burden
KE-NRB-2017-03491,2017,33,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Rural,Surgery + Chemotherapy,Dead,25.3,moderate_burden
KE-NRB-2011-03492,2011,57,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.4,moderate_burden
KE-NRB-2009-03493,2009,88,75+,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.8,moderate_burden
KE-NRB-2012-03494,2012,74,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,26.1,moderate_burden
KE-NRB-2014-03495,2014,37,35-44,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-03496,2018,67,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.5,moderate_burden
KE-NRB-2016-03497,2016,57,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,47.4,moderate_burden
KE-NRB-2015-03498,2015,47,45-54,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,10.1,moderate_burden
KE-NRB-2017-03499,2017,52,45-54,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.6,moderate_burden
KE-NRB-2018-03500,2018,30,25-34,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.8,moderate_burden
KE-NRB-2016-03501,2016,51,45-54,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Radiotherapy only,Lost to follow-up,42.3,moderate_burden
KE-NRB-2010-03502,2010,78,75+,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,3.7,moderate_burden
KE-NRB-2017-03503,2017,28,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,35.0,moderate_burden
KE-NRB-2009-03504,2009,71,65-74,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,19.5,moderate_burden
KE-NRB-2011-03505,2011,28,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,42.0,moderate_burden
KE-NRB-2014-03506,2014,74,65-74,Female,Thyroid,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.8,moderate_burden
KE-NRB-2015-03507,2015,65,65-74,Male,Stomach,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,8.7,moderate_burden
KE-NRB-2015-03508,2015,66,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-03509,2014,81,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.1,moderate_burden
KE-NRB-2013-03510,2013,74,65-74,Male,Leukemia,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03511,2015,27,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.0,moderate_burden
KE-NRB-2017-03512,2017,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2013-03513,2013,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,4.3,moderate_burden
KE-NRB-2017-03514,2017,63,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.6,moderate_burden
KE-NRB-2015-03515,2015,72,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,6.2,moderate_burden
KE-NRB-2013-03516,2013,39,35-44,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,35.0,moderate_burden
KE-NRB-2017-03517,2017,48,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,45.4,moderate_burden
KE-NRB-2015-03518,2015,30,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,44.0,moderate_burden
KE-NRB-2016-03519,2016,40,35-44,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Radiotherapy only,Alive,12.5,moderate_burden
KE-NRB-2010-03520,2010,36,35-44,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,48.1,moderate_burden
KE-NRB-2015-03521,2015,62,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,4.3,moderate_burden
KE-NRB-2015-03522,2015,71,65-74,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,15.9,moderate_burden
KE-NRB-2011-03523,2011,64,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,32.1,moderate_burden
KE-NRB-2017-03524,2017,61,55-64,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.7,moderate_burden
KE-NRB-2010-03525,2010,40,35-44,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-03526,2012,41,35-44,Female,Thyroid,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,24.6,moderate_burden
KE-NRB-2017-03527,2017,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2017-03528,2017,51,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,32.3,moderate_burden
KE-NRB-2013-03529,2013,38,35-44,Male,Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.2,moderate_burden
KE-NRB-2011-03530,2011,28,25-34,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,33.1,moderate_burden
KE-NRB-2010-03531,2010,54,45-54,Male,Other,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,25.3,moderate_burden
KE-NRB-2011-03532,2011,85,75+,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,15.5,moderate_burden
KE-NRB-2016-03533,2016,95,75+,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2015-03534,2015,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.8,moderate_burden
KE-NRB-2016-03535,2016,39,35-44,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Chemotherapy only,Dead,3.2,moderate_burden
KE-NRB-2017-03536,2017,50,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,7.6,moderate_burden
KE-NRB-2012-03537,2012,70,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,3.1,moderate_burden
KE-NRB-2017-03538,2017,63,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,60.0,moderate_burden
KE-NRB-2018-03539,2018,91,75+,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,10.5,moderate_burden
KE-NRB-2017-03540,2017,55,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,40.8,moderate_burden
KE-NRB-2018-03541,2018,42,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,50.8,moderate_burden
KE-NRB-2014-03542,2014,45,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,0.6,moderate_burden
KE-NRB-2011-03543,2011,44,35-44,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.4,moderate_burden
KE-NRB-2012-03544,2012,48,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,30.5,moderate_burden
KE-NRB-2013-03545,2013,67,65-74,Male,Stomach,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,0.9,moderate_burden
KE-NRB-2013-03546,2013,60,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,47.8,moderate_burden
KE-NRB-2018-03547,2018,45,45-54,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.2,moderate_burden
KE-NRB-2018-03548,2018,63,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,3.5,moderate_burden
KE-NRB-2012-03549,2012,71,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.4,moderate_burden
KE-NRB-2017-03550,2017,64,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03551,2016,76,75+,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,7.4,moderate_burden
KE-NRB-2013-03552,2013,8,0-14,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Alive,33.1,moderate_burden
KE-NRB-2016-03553,2016,61,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,15.8,moderate_burden
KE-NRB-2010-03554,2010,34,25-34,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,1.8,moderate_burden
KE-NRB-2017-03555,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2016-03556,2016,77,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Lost to follow-up,45.3,moderate_burden
KE-NRB-2015-03557,2015,36,35-44,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.9,moderate_burden
KE-NRB-2012-03558,2012,65,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,7.0,moderate_burden
KE-NRB-2012-03559,2012,39,35-44,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-03560,2009,58,55-64,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-03561,2012,57,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.9,moderate_burden
KE-NRB-2013-03562,2013,47,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,4.4,moderate_burden
KE-NRB-2017-03563,2017,66,65-74,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-03564,2016,65,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,59.7,moderate_burden
KE-NRB-2014-03565,2014,52,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.0,moderate_burden
KE-NRB-2016-03566,2016,77,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,20.0,moderate_burden
KE-NRB-2018-03567,2018,60,55-64,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,3.7,moderate_burden
KE-NRB-2016-03568,2016,30,25-34,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,57.3,moderate_burden
KE-NRB-2014-03569,2014,57,55-64,Male,Stomach,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,21.3,moderate_burden
KE-NRB-2015-03570,2015,18,15-24,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,1.6,moderate_burden
KE-NRB-2013-03571,2013,45,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2010-03572,2010,59,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,52.7,moderate_burden
KE-NRB-2012-03573,2012,29,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,14.4,moderate_burden
KE-NRB-2014-03574,2014,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,3.5,moderate_burden
KE-NRB-2013-03575,2013,64,55-64,Male,Colorectum,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,55.4,moderate_burden
KE-NRB-2011-03576,2011,56,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,27.2,moderate_burden
KE-NRB-2017-03577,2017,38,35-44,Female,Thyroid,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,28.3,moderate_burden
KE-NRB-2009-03578,2009,36,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,12.5,moderate_burden
KE-NRB-2016-03579,2016,32,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,13.2,moderate_burden
KE-NRB-2017-03580,2017,61,55-64,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,11.9,moderate_burden
KE-NRB-2017-03581,2017,60,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,15.5,moderate_burden
KE-NRB-2010-03582,2010,74,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,9.0,moderate_burden
KE-NRB-2014-03583,2014,54,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.4,moderate_burden
KE-NRB-2010-03584,2010,40,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,21.4,moderate_burden
KE-NRB-2012-03585,2012,78,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,14.3,moderate_burden
KE-NRB-2018-03586,2018,46,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.7,moderate_burden
KE-NRB-2012-03587,2012,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.7,moderate_burden
KE-NRB-2011-03588,2011,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.9,moderate_burden
KE-NRB-2016-03589,2016,51,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,13.9,moderate_burden
KE-NRB-2014-03590,2014,64,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,2.8,moderate_burden
KE-NRB-2009-03591,2009,43,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.4,moderate_burden
KE-NRB-2014-03592,2014,37,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,6.4,moderate_burden
KE-NRB-2017-03593,2017,49,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,25.0,moderate_burden
KE-NRB-2018-03594,2018,62,55-64,Female,Ovary,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,52.7,moderate_burden
KE-NRB-2017-03595,2017,42,35-44,Female,Other,Unspecified,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,9.7,moderate_burden
KE-NRB-2018-03596,2018,58,55-64,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Benign/uncertain,Peri-urban,N/A,Dead,12.8,moderate_burden
KE-NRB-2011-03597,2011,44,35-44,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Alive,11.6,moderate_burden
KE-NRB-2016-03598,2016,67,65-74,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,23.9,moderate_burden
KE-NRB-2018-03599,2018,37,35-44,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,25.2,moderate_burden
KE-NRB-2018-03600,2018,43,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.8,moderate_burden
KE-NRB-2014-03601,2014,46,45-54,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,4.3,moderate_burden
KE-NRB-2011-03602,2011,40,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,No treatment,Dead,1.1,moderate_burden
KE-NRB-2017-03603,2017,70,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,20.4,moderate_burden
KE-NRB-2017-03604,2017,32,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-03605,2016,93,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.9,moderate_burden
KE-NRB-2012-03606,2012,53,45-54,Female,Ovary,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,7.0,moderate_burden
KE-NRB-2011-03607,2011,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,49.1,moderate_burden
KE-NRB-2013-03608,2013,54,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.9,moderate_burden
KE-NRB-2017-03609,2017,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.5,moderate_burden
KE-NRB-2017-03610,2017,50,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,7.0,moderate_burden
KE-NRB-2016-03611,2016,58,55-64,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-03612,2014,60,55-64,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-03613,2016,58,55-64,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.4,moderate_burden
KE-NRB-2017-03614,2017,38,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,5.7,moderate_burden
KE-NRB-2014-03615,2014,52,45-54,Male,Multiple myeloma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,2.8,moderate_burden
KE-NRB-2011-03616,2011,46,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,2.1,moderate_burden
KE-NRB-2015-03617,2015,48,45-54,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,7.6,moderate_burden
KE-NRB-2009-03618,2009,48,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,40.9,moderate_burden
KE-NRB-2016-03619,2016,10,0-14,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,36.2,moderate_burden
KE-NRB-2016-03620,2016,76,75+,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2011-03621,2011,68,65-74,Male,Other,Adenocarcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery only,Dead,16.1,moderate_burden
KE-NRB-2016-03622,2016,63,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-03623,2012,57,55-64,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-03624,2018,34,25-34,Male,Prostate,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,0.7,moderate_burden
KE-NRB-2015-03625,2015,37,35-44,Male,Lung,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,26.9,moderate_burden
KE-NRB-2011-03626,2011,44,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,8.4,moderate_burden
KE-NRB-2015-03627,2015,66,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.0,moderate_burden
KE-NRB-2017-03628,2017,43,35-44,Female,Cervix uteri,Leukemia,Unknown,Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2018-03629,2018,19,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,53.3,moderate_burden
KE-NRB-2016-03630,2016,56,55-64,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.8,moderate_burden
KE-NRB-2009-03631,2009,30,25-34,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,34.6,moderate_burden
KE-NRB-2016-03632,2016,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,20.8,moderate_burden
KE-NRB-2016-03633,2016,37,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,20.9,moderate_burden
KE-NRB-2013-03634,2013,56,55-64,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.6,moderate_burden
KE-NRB-2017-03635,2017,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,6.2,moderate_burden
KE-NRB-2012-03636,2012,62,55-64,Male,Bladder,Other specified,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,13.8,moderate_burden
KE-NRB-2016-03637,2016,50,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-03638,2010,70,65-74,Male,Liver,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Lost to follow-up,1.7,moderate_burden
KE-NRB-2012-03639,2012,86,75+,Male,Oesophagus,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,7.6,moderate_burden
KE-NRB-2018-03640,2018,69,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,4.6,moderate_burden
KE-NRB-2012-03641,2012,29,25-34,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,10.4,moderate_burden
KE-NRB-2017-03642,2017,60,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,5.2,moderate_burden
KE-NRB-2012-03643,2012,49,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,14.7,moderate_burden
KE-NRB-2017-03644,2017,51,45-54,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.1,moderate_burden
KE-NRB-2011-03645,2011,47,45-54,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,12.8,moderate_burden
KE-NRB-2010-03646,2010,69,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,0.3,moderate_burden
KE-NRB-2017-03647,2017,31,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.5,moderate_burden
KE-NRB-2018-03648,2018,36,35-44,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,3.3,moderate_burden
KE-NRB-2014-03649,2014,44,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.6,moderate_burden
KE-NRB-2015-03650,2015,24,15-24,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,17.6,moderate_burden
KE-NRB-2015-03651,2015,56,55-64,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Alive,43.8,moderate_burden
KE-NRB-2010-03652,2010,83,75+,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03653,2013,32,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,0.6,moderate_burden
KE-NRB-2010-03654,2010,49,45-54,Male,Bladder,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-03655,2014,44,35-44,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,22.0,moderate_burden
KE-NRB-2017-03656,2017,65,65-74,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-03657,2018,45,45-54,Female,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2015-03658,2015,65,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,33.7,moderate_burden
KE-NRB-2018-03659,2018,59,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,9.5,moderate_burden
KE-NRB-2016-03660,2016,41,35-44,Male,Pancreas,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,23.9,moderate_burden
KE-NRB-2018-03661,2018,66,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,16.6,moderate_burden
KE-NRB-2015-03662,2015,45,45-54,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-03663,2013,43,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,2.1,moderate_burden
KE-NRB-2015-03664,2015,63,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.3,moderate_burden
KE-NRB-2015-03665,2015,25,25-34,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,25.3,moderate_burden
KE-NRB-2014-03666,2014,68,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,1.9,moderate_burden
KE-NRB-2014-03667,2014,46,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.5,moderate_burden
KE-NRB-2012-03668,2012,85,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-03669,2009,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,25.8,moderate_burden
KE-NRB-2013-03670,2013,26,25-34,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,27.3,moderate_burden
KE-NRB-2018-03671,2018,37,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,10.0,moderate_burden
KE-NRB-2016-03672,2016,56,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-03673,2014,53,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,17.4,moderate_burden
KE-NRB-2009-03674,2009,30,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,14.7,moderate_burden
KE-NRB-2016-03675,2016,46,45-54,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,16.1,moderate_burden
KE-NRB-2015-03676,2015,46,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,7.7,moderate_burden
KE-NRB-2016-03677,2016,20,15-24,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,No treatment,Alive,15.8,moderate_burden
KE-NRB-2009-03678,2009,39,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,13.5,moderate_burden
KE-NRB-2014-03679,2014,31,25-34,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,43.4,moderate_burden
KE-NRB-2017-03680,2017,65,65-74,Male,Hodgkin lymphoma,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,29.8,moderate_burden
KE-NRB-2014-03681,2014,65,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,29.1,moderate_burden
KE-NRB-2016-03682,2016,23,15-24,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-03683,2014,60,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-03684,2014,72,65-74,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03685,2015,45,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-03686,2016,12,0-14,Male,Oesophagus,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,27.4,moderate_burden
KE-NRB-2018-03687,2018,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,5.9,moderate_burden
KE-NRB-2012-03688,2012,66,65-74,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.1,moderate_burden
KE-NRB-2010-03689,2010,53,45-54,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,25.2,moderate_burden
KE-NRB-2016-03690,2016,34,25-34,Female,Breast,Adenocarcinoma,Unknown,Other,Malignant,Urban,Chemotherapy only,Dead,20.1,moderate_burden
KE-NRB-2015-03691,2015,49,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,12.8,moderate_burden
KE-NRB-2010-03692,2010,64,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,In situ,Rural,N/A,Dead,5.2,moderate_burden
KE-NRB-2011-03693,2011,72,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Alive,20.8,moderate_burden
KE-NRB-2009-03694,2009,52,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,1.1,moderate_burden
KE-NRB-2010-03695,2010,71,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,25.3,moderate_burden
KE-NRB-2012-03696,2012,62,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,18.7,moderate_burden
KE-NRB-2011-03697,2011,36,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,12.2,moderate_burden
KE-NRB-2012-03698,2012,42,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-03699,2018,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,13.2,moderate_burden
KE-NRB-2015-03700,2015,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.0,moderate_burden
KE-NRB-2016-03701,2016,88,75+,Male,Prostate,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,45.9,moderate_burden
KE-NRB-2014-03702,2014,44,35-44,Male,Skin (melanoma),Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2012-03703,2012,72,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,12.5,moderate_burden
KE-NRB-2011-03704,2011,43,35-44,Female,Other,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,9.6,moderate_burden
KE-NRB-2016-03705,2016,4,0-14,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,3.4,moderate_burden
KE-NRB-2015-03706,2015,64,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-03707,2012,46,45-54,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,No treatment,Alive,28.9,moderate_burden
KE-NRB-2017-03708,2017,26,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,8.3,moderate_burden
KE-NRB-2018-03709,2018,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.2,moderate_burden
KE-NRB-2015-03710,2015,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,33.1,moderate_burden
KE-NRB-2012-03711,2012,67,65-74,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,18.4,moderate_burden
KE-NRB-2012-03712,2012,70,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,52.2,moderate_burden
KE-NRB-2013-03713,2013,48,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,11.6,moderate_burden
KE-NRB-2010-03714,2010,72,65-74,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,44.7,moderate_burden
KE-NRB-2017-03715,2017,55,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,36.9,moderate_burden
KE-NRB-2014-03716,2014,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,26.4,moderate_burden
KE-NRB-2012-03717,2012,74,65-74,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-03718,2018,27,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-03719,2013,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,21.6,moderate_burden
KE-NRB-2012-03720,2012,82,75+,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-03721,2009,52,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Dead,2.8,moderate_burden
KE-NRB-2017-03722,2017,29,25-34,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.2,moderate_burden
KE-NRB-2017-03723,2017,31,25-34,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,17.9,moderate_burden
KE-NRB-2011-03724,2011,45,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.2,moderate_burden
KE-NRB-2013-03725,2013,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.9,moderate_burden
KE-NRB-2015-03726,2015,52,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,16.6,moderate_burden
KE-NRB-2015-03727,2015,69,65-74,Male,Leukemia,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.9,moderate_burden
KE-NRB-2011-03728,2011,31,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,25.1,moderate_burden
KE-NRB-2014-03729,2014,70,65-74,Male,Colorectum,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-03730,2016,35,35-44,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,26.9,moderate_burden
KE-NRB-2014-03731,2014,67,65-74,Female,Other,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-03732,2012,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.0,moderate_burden
KE-NRB-2015-03733,2015,62,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,10.3,moderate_burden
KE-NRB-2018-03734,2018,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,45.7,moderate_burden
KE-NRB-2018-03735,2018,51,45-54,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,52.2,moderate_burden
KE-NRB-2009-03736,2009,45,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03737,2009,30,25-34,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.0,moderate_burden
KE-NRB-2015-03738,2015,72,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-03739,2018,7,0-14,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,24.8,moderate_burden
KE-NRB-2011-03740,2011,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,6.2,moderate_burden
KE-NRB-2018-03741,2018,64,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,37.9,moderate_burden
KE-NRB-2015-03742,2015,46,45-54,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,5.6,moderate_burden
KE-NRB-2017-03743,2017,35,35-44,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,51.7,moderate_burden
KE-NRB-2017-03744,2017,83,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,26.0,moderate_burden
KE-NRB-2012-03745,2012,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,42.3,moderate_burden
KE-NRB-2016-03746,2016,55,55-64,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2009-03747,2009,68,65-74,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,9.3,moderate_burden
KE-NRB-2013-03748,2013,46,45-54,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-03749,2018,37,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.5,moderate_burden
KE-NRB-2014-03750,2014,46,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-03751,2015,10,0-14,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-03752,2016,62,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,27.8,moderate_burden
KE-NRB-2015-03753,2015,58,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03754,2014,54,45-54,Male,Lung,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-03755,2011,61,55-64,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03756,2009,27,25-34,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,35.0,moderate_burden
KE-NRB-2016-03757,2016,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,55.5,moderate_burden
KE-NRB-2014-03758,2014,29,25-34,Female,Corpus uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,5.7,moderate_burden
KE-NRB-2013-03759,2013,37,35-44,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,moderate_burden
KE-NRB-2011-03760,2011,48,45-54,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,24.1,moderate_burden
KE-NRB-2012-03761,2012,39,35-44,Female,Other,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,26.6,moderate_burden
KE-NRB-2014-03762,2014,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2016-03763,2016,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.1,moderate_burden
KE-NRB-2016-03764,2016,41,35-44,Male,Liver,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,13.6,moderate_burden
KE-NRB-2016-03765,2016,67,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,44.4,moderate_burden
KE-NRB-2012-03766,2012,59,55-64,Male,Bladder,Lymphoma,Unknown,Death certificate only,Malignant,Urban,Palliative care only,Dead,23.7,moderate_burden
KE-NRB-2011-03767,2011,48,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,13.9,moderate_burden
KE-NRB-2018-03768,2018,63,55-64,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Peri-urban,N/A,Dead,28.4,moderate_burden
KE-NRB-2014-03769,2014,2,0-14,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,7.0,moderate_burden
KE-NRB-2017-03770,2017,49,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-03771,2010,42,35-44,Female,Breast,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,44.1,moderate_burden
KE-NRB-2014-03772,2014,59,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,24.4,moderate_burden
KE-NRB-2016-03773,2016,51,45-54,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,12.4,moderate_burden
KE-NRB-2018-03774,2018,61,55-64,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,25.8,moderate_burden
KE-NRB-2010-03775,2010,22,15-24,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-03776,2015,42,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03777,2009,45,45-54,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.1,moderate_burden
KE-NRB-2014-03778,2014,55,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2010-03779,2010,39,35-44,Female,Other,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.7,moderate_burden
KE-NRB-2018-03780,2018,34,25-34,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03781,2009,57,55-64,Male,Oesophagus,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03782,2017,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,27.4,moderate_burden
KE-NRB-2017-03783,2017,46,45-54,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,19.2,moderate_burden
KE-NRB-2014-03784,2014,67,65-74,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.2,moderate_burden
KE-NRB-2014-03785,2014,70,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,52.8,moderate_burden
KE-NRB-2009-03786,2009,55,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,57.5,moderate_burden
KE-NRB-2012-03787,2012,58,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.7,moderate_burden
KE-NRB-2016-03788,2016,70,65-74,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-03789,2018,38,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,56.9,moderate_burden
KE-NRB-2018-03790,2018,35,35-44,Female,Thyroid,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.4,moderate_burden
KE-NRB-2018-03791,2018,49,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2011-03792,2011,58,55-64,Male,Prostate,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-03793,2016,57,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,9.4,moderate_burden
KE-NRB-2012-03794,2012,36,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,20.0,moderate_burden
KE-NRB-2013-03795,2013,63,55-64,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,23.8,moderate_burden
KE-NRB-2009-03796,2009,14,0-14,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Radiotherapy only,Dead,1.7,moderate_burden
KE-NRB-2018-03797,2018,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,18.3,moderate_burden
KE-NRB-2014-03798,2014,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,23.8,moderate_burden
KE-NRB-2012-03799,2012,84,75+,Male,Kaposi sarcoma,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Peri-urban,Palliative care only,Dead,12.6,moderate_burden
KE-NRB-2014-03800,2014,75,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,9.1,moderate_burden
KE-NRB-2011-03801,2011,41,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,26.4,moderate_burden
KE-NRB-2010-03802,2010,63,55-64,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-03803,2009,73,65-74,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Alive,13.7,moderate_burden
KE-NRB-2013-03804,2013,55,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,9.0,moderate_burden
KE-NRB-2015-03805,2015,54,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03806,2014,69,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,48.1,moderate_burden
KE-NRB-2010-03807,2010,87,75+,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,5.3,moderate_burden
KE-NRB-2013-03808,2013,24,15-24,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Dead,39.1,moderate_burden
KE-NRB-2017-03809,2017,58,55-64,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,4.0,moderate_burden
KE-NRB-2018-03810,2018,56,55-64,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,40.2,moderate_burden
KE-NRB-2018-03811,2018,47,45-54,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.9,moderate_burden
KE-NRB-2017-03812,2017,74,65-74,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Radiotherapy,Alive,12.5,moderate_burden
KE-NRB-2010-03813,2010,61,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,48.5,moderate_burden
KE-NRB-2010-03814,2010,16,15-24,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,28.2,moderate_burden
KE-NRB-2011-03815,2011,16,15-24,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.4,moderate_burden
KE-NRB-2015-03816,2015,50,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.4,moderate_burden
KE-NRB-2017-03817,2017,46,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,38.8,moderate_burden
KE-NRB-2018-03818,2018,32,25-34,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Palliative care only,Alive,19.4,moderate_burden
KE-NRB-2010-03819,2010,74,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-03820,2013,52,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2016-03821,2016,47,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03822,2014,69,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-03823,2017,70,65-74,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.0,moderate_burden
KE-NRB-2012-03824,2012,63,55-64,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,24.1,moderate_burden
KE-NRB-2014-03825,2014,61,55-64,Female,Breast,Unspecified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,0.3,moderate_burden
KE-NRB-2013-03826,2013,56,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,32.5,moderate_burden
KE-NRB-2018-03827,2018,48,45-54,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Radiotherapy only,Dead,11.3,moderate_burden
KE-NRB-2013-03828,2013,60,55-64,Female,Ovary,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,10.1,moderate_burden
KE-NRB-2018-03829,2018,54,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Peri-urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-03830,2016,80,75+,Male,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,In situ,Urban,N/A,Alive,15.4,moderate_burden
KE-NRB-2011-03831,2011,48,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-03832,2017,69,65-74,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03833,2014,48,45-54,Male,Prostate,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,5.7,moderate_burden
KE-NRB-2010-03834,2010,58,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.4,moderate_burden
KE-NRB-2015-03835,2015,69,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,1.4,moderate_burden
KE-NRB-2009-03836,2009,71,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,19.1,moderate_burden
KE-NRB-2018-03837,2018,43,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.8,moderate_burden
KE-NRB-2014-03838,2014,67,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,15.0,moderate_burden
KE-NRB-2015-03839,2015,41,35-44,Male,Stomach,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Lost to follow-up,23.3,moderate_burden
KE-NRB-2013-03840,2013,62,55-64,Female,Other,Sarcoma,Unknown,Clinical only,In situ,Peri-urban,N/A,Dead,30.8,moderate_burden
KE-NRB-2018-03841,2018,65,65-74,Female,Thyroid,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,6.5,moderate_burden
KE-NRB-2016-03842,2016,26,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,0.5,moderate_burden
KE-NRB-2016-03843,2016,81,75+,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.7,moderate_burden
KE-NRB-2014-03844,2014,42,35-44,Male,Prostate,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-03845,2015,72,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,13.8,moderate_burden
KE-NRB-2018-03846,2018,38,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,38.3,moderate_burden
KE-NRB-2010-03847,2010,44,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03848,2014,44,35-44,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Rural,N/A,Alive,50.4,moderate_burden
KE-NRB-2013-03849,2013,45,45-54,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2018-03850,2018,24,15-24,Male,Colorectum,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Surgery only,Alive,13.4,moderate_burden
KE-NRB-2015-03851,2015,47,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Lost to follow-up,42.7,moderate_burden
KE-NRB-2014-03852,2014,51,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Dead,8.7,moderate_burden
KE-NRB-2017-03853,2017,65,65-74,Female,Corpus uteri,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-03854,2012,46,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,23.5,moderate_burden
KE-NRB-2015-03855,2015,48,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,4.3,moderate_burden
KE-NRB-2014-03856,2014,67,65-74,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,38.7,moderate_burden
KE-NRB-2015-03857,2015,63,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-03858,2014,51,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,18.6,moderate_burden
KE-NRB-2010-03859,2010,44,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.7,moderate_burden
KE-NRB-2014-03860,2014,47,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,34.3,moderate_burden
KE-NRB-2018-03861,2018,62,55-64,Female,Cervix uteri,Other specified,Unknown,Death certificate only,Malignant,Peri-urban,Chemotherapy only,Dead,18.8,moderate_burden
KE-NRB-2017-03862,2017,64,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,55.9,moderate_burden
KE-NRB-2011-03863,2011,48,45-54,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,19.9,moderate_burden
KE-NRB-2018-03864,2018,49,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03865,2011,61,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-03866,2011,34,25-34,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Dead,5.8,moderate_burden
KE-NRB-2011-03867,2011,32,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,17.4,moderate_burden
KE-NRB-2016-03868,2016,60,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,moderate_burden
KE-NRB-2018-03869,2018,45,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,0.7,moderate_burden
KE-NRB-2018-03870,2018,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,2.3,moderate_burden
KE-NRB-2013-03871,2013,39,35-44,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,39.9,moderate_burden
KE-NRB-2011-03872,2011,64,55-64,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,21.2,moderate_burden
KE-NRB-2010-03873,2010,45,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,17.5,moderate_burden
KE-NRB-2011-03874,2011,64,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2018-03875,2018,36,35-44,Female,Thyroid,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,5.0,moderate_burden
KE-NRB-2017-03876,2017,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,22.7,moderate_burden
KE-NRB-2018-03877,2018,51,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-03878,2015,37,35-44,Male,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery + Radiotherapy,Dead,9.0,moderate_burden
KE-NRB-2016-03879,2016,27,25-34,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-03880,2012,52,45-54,Male,Prostate,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,9.2,moderate_burden
KE-NRB-2011-03881,2011,54,45-54,Female,Ovary,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,44.3,moderate_burden
KE-NRB-2011-03882,2011,33,25-34,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,15.0,moderate_burden
KE-NRB-2011-03883,2011,80,75+,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-03884,2012,72,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,12.4,moderate_burden
KE-NRB-2013-03885,2013,59,55-64,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,35.4,moderate_burden
KE-NRB-2010-03886,2010,62,55-64,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,46.0,moderate_burden
KE-NRB-2014-03887,2014,31,25-34,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,6.5,moderate_burden
KE-NRB-2016-03888,2016,61,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,1.6,moderate_burden
KE-NRB-2014-03889,2014,37,35-44,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03890,2014,44,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,moderate_burden
KE-NRB-2016-03891,2016,43,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,22.7,moderate_burden
KE-NRB-2011-03892,2011,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.1,moderate_burden
KE-NRB-2012-03893,2012,69,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,0.6,moderate_burden
KE-NRB-2014-03894,2014,77,75+,Male,Multiple myeloma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,16.2,moderate_burden
KE-NRB-2013-03895,2013,94,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-03896,2012,5,0-14,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,No treatment,Dead,21.0,moderate_burden
KE-NRB-2010-03897,2010,64,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.5,moderate_burden
KE-NRB-2013-03898,2013,50,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Alive,47.5,moderate_burden
KE-NRB-2009-03899,2009,22,15-24,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.0,moderate_burden
KE-NRB-2011-03900,2011,73,65-74,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,41.6,moderate_burden
KE-NRB-2014-03901,2014,30,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2017-03902,2017,61,55-64,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.8,moderate_burden
KE-NRB-2009-03903,2009,49,45-54,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,41.9,moderate_burden
KE-NRB-2012-03904,2012,44,35-44,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,9.8,moderate_burden
KE-NRB-2017-03905,2017,58,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Chemotherapy only,Alive,5.3,moderate_burden
KE-NRB-2015-03906,2015,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,11.6,moderate_burden
KE-NRB-2017-03907,2017,48,45-54,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,38.8,moderate_burden
KE-NRB-2012-03908,2012,42,35-44,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,6.5,moderate_burden
KE-NRB-2013-03909,2013,50,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2009-03910,2009,49,45-54,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,45.5,moderate_burden
KE-NRB-2018-03911,2018,45,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.2,moderate_burden
KE-NRB-2016-03912,2016,43,35-44,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,5.1,moderate_burden
KE-NRB-2017-03913,2017,90,75+,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,16.7,moderate_burden
KE-NRB-2016-03914,2016,43,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.6,moderate_burden
KE-NRB-2010-03915,2010,49,45-54,Male,Stomach,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,9.9,moderate_burden
KE-NRB-2018-03916,2018,62,55-64,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2018-03917,2018,37,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,20.3,moderate_burden
KE-NRB-2011-03918,2011,63,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,19.7,moderate_burden
KE-NRB-2013-03919,2013,68,65-74,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,1.3,moderate_burden
KE-NRB-2017-03920,2017,47,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.3,moderate_burden
KE-NRB-2013-03921,2013,50,45-54,Male,Pancreas,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,25.5,moderate_burden
KE-NRB-2017-03922,2017,73,65-74,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,2.4,moderate_burden
KE-NRB-2015-03923,2015,59,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,54.2,moderate_burden
KE-NRB-2011-03924,2011,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,43.3,moderate_burden
KE-NRB-2017-03925,2017,53,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,No treatment,Alive,55.9,moderate_burden
KE-NRB-2013-03926,2013,20,15-24,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.8,moderate_burden
KE-NRB-2014-03927,2014,51,45-54,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,24.4,moderate_burden
KE-NRB-2017-03928,2017,60,55-64,Male,Liver,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,No treatment,Dead,5.3,moderate_burden
KE-NRB-2016-03929,2016,88,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2016-03930,2016,39,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.1,moderate_burden
KE-NRB-2011-03931,2011,26,25-34,Male,Colorectum,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Dead,5.6,moderate_burden
KE-NRB-2010-03932,2010,33,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,0.7,moderate_burden
KE-NRB-2011-03933,2011,33,25-34,Male,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Dead,29.3,moderate_burden
KE-NRB-2013-03934,2013,69,65-74,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-03935,2013,58,55-64,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,22.8,moderate_burden
KE-NRB-2011-03936,2011,73,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,52.8,moderate_burden
KE-NRB-2014-03937,2014,40,35-44,Male,Stomach,Adenocarcinoma,Unknown,Other,Malignant,Rural,Chemo + Radiotherapy,Alive,12.7,moderate_burden
KE-NRB-2015-03938,2015,67,65-74,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Radiotherapy only,Alive,51.3,moderate_burden
KE-NRB-2014-03939,2014,48,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.7,moderate_burden
KE-NRB-2016-03940,2016,70,65-74,Female,Breast,Unspecified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,16.4,moderate_burden
KE-NRB-2015-03941,2015,71,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,46.5,moderate_burden
KE-NRB-2015-03942,2015,72,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,41.7,moderate_burden
KE-NRB-2015-03943,2015,94,75+,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,7.8,moderate_burden
KE-NRB-2009-03944,2009,66,65-74,Male,Lung,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,17.2,moderate_burden
KE-NRB-2016-03945,2016,58,55-64,Male,Stomach,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.9,moderate_burden
KE-NRB-2012-03946,2012,71,65-74,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,27.7,moderate_burden
KE-NRB-2018-03947,2018,58,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemotherapy only,Alive,6.6,moderate_burden
KE-NRB-2018-03948,2018,86,75+,Female,Ovary,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,28.0,moderate_burden
KE-NRB-2013-03949,2013,48,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,30.3,moderate_burden
KE-NRB-2014-03950,2014,35,35-44,Male,Bladder,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03951,2014,67,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Peri-urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2015-03952,2015,63,55-64,Male,Pancreas,Other specified,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,12.8,moderate_burden
KE-NRB-2018-03953,2018,67,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2013-03954,2013,58,55-64,Male,Colorectum,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,8.6,moderate_burden
KE-NRB-2013-03955,2013,49,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2016-03956,2016,35,35-44,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,16.8,moderate_burden
KE-NRB-2014-03957,2014,50,45-54,Male,Leukemia,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,29.3,moderate_burden
KE-NRB-2016-03958,2016,47,45-54,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-03959,2011,44,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.1,moderate_burden
KE-NRB-2011-03960,2011,55,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2014-03961,2014,41,35-44,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.3,moderate_burden
KE-NRB-2014-03962,2014,94,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03963,2017,19,15-24,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,18.6,moderate_burden
KE-NRB-2010-03964,2010,61,55-64,Male,Bladder,Lymphoma,Unknown,Other,Malignant,Urban,Palliative care only,Alive,31.4,moderate_burden
KE-NRB-2009-03965,2009,66,65-74,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,52.8,moderate_burden
KE-NRB-2016-03966,2016,29,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,37.3,moderate_burden
KE-NRB-2013-03967,2013,31,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.1,moderate_burden
KE-NRB-2010-03968,2010,74,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.1,moderate_burden
KE-NRB-2016-03969,2016,50,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,7.3,moderate_burden
KE-NRB-2013-03970,2013,47,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,25.2,moderate_burden
KE-NRB-2010-03971,2010,46,45-54,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,42.3,moderate_burden
KE-NRB-2016-03972,2016,91,75+,Male,Prostate,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Dead,21.7,moderate_burden
KE-NRB-2014-03973,2014,51,45-54,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,37.0,moderate_burden
KE-NRB-2017-03974,2017,50,45-54,Female,Other,Sarcoma,Undifferentiated (Grade IV),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,3.1,moderate_burden
KE-NRB-2013-03975,2013,29,25-34,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,6.8,moderate_burden
KE-NRB-2012-03976,2012,77,75+,Male,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,9.6,moderate_burden
KE-NRB-2015-03977,2015,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-03978,2013,71,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Surgery only,Alive,3.6,moderate_burden
KE-NRB-2017-03979,2017,56,55-64,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-03980,2017,69,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.5,moderate_burden
KE-NRB-2014-03981,2014,71,65-74,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-03982,2017,47,45-54,Male,Lung,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-03983,2018,48,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,12.4,moderate_burden
KE-NRB-2018-03984,2018,65,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,45.6,moderate_burden
KE-NRB-2012-03985,2012,58,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.2,moderate_burden
KE-NRB-2017-03986,2017,53,45-54,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-03987,2009,38,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.7,moderate_burden
KE-NRB-2012-03988,2012,66,65-74,Male,Kidney,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,5.2,moderate_burden
KE-NRB-2011-03989,2011,49,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.5,moderate_burden
KE-NRB-2012-03990,2012,57,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,53.6,moderate_burden
KE-NRB-2016-03991,2016,61,55-64,Female,Breast,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,7.1,moderate_burden
KE-NRB-2017-03992,2017,84,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,6.5,moderate_burden
KE-NRB-2013-03993,2013,3,0-14,Male,Lung,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,38.6,moderate_burden
KE-NRB-2009-03994,2009,72,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,39.6,moderate_burden
KE-NRB-2012-03995,2012,62,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2017-03996,2017,42,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-03997,2014,72,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,29.9,moderate_burden
KE-NRB-2011-03998,2011,22,15-24,Male,Oesophagus,Adenocarcinoma,Undifferentiated (Grade IV),Other,Malignant,Urban,Surgery + Chemotherapy,Alive,11.1,moderate_burden
KE-NRB-2010-03999,2010,39,35-44,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04000,2016,28,25-34,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,56.1,moderate_burden
KE-NRB-2014-04001,2014,41,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,20.4,moderate_burden
KE-NRB-2010-04002,2010,34,25-34,Male,Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,1.2,moderate_burden
KE-NRB-2010-04003,2010,37,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,17.1,moderate_burden
KE-NRB-2011-04004,2011,92,75+,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,16.3,moderate_burden
KE-NRB-2017-04005,2017,62,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-04006,2013,73,65-74,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,41.3,moderate_burden
KE-NRB-2014-04007,2014,27,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery + Radiotherapy,Lost to follow-up,31.2,moderate_burden
KE-NRB-2018-04008,2018,53,45-54,Male,Oesophagus,Lymphoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-04009,2013,41,35-44,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,48.4,moderate_burden
KE-NRB-2018-04010,2018,48,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,41.1,moderate_burden
KE-NRB-2016-04011,2016,59,55-64,Male,Kaposi sarcoma,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,51.9,moderate_burden
KE-NRB-2009-04012,2009,59,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.1,moderate_burden
KE-NRB-2015-04013,2015,69,65-74,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,2.2,moderate_burden
KE-NRB-2017-04014,2017,68,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,48.8,moderate_burden
KE-NRB-2018-04015,2018,47,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-04016,2014,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04017,2017,46,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04018,2016,63,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,33.7,moderate_burden
KE-NRB-2013-04019,2013,9,0-14,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,moderate_burden
KE-NRB-2017-04020,2017,25,25-34,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,7.9,moderate_burden
KE-NRB-2014-04021,2014,57,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,46.5,moderate_burden
KE-NRB-2010-04022,2010,84,75+,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2009-04023,2009,42,35-44,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,8.9,moderate_burden
KE-NRB-2015-04024,2015,45,45-54,Female,Breast,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Palliative care only,Alive,22.9,moderate_burden
KE-NRB-2018-04025,2018,50,45-54,Male,Oesophagus,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,43.6,moderate_burden
KE-NRB-2016-04026,2016,51,45-54,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,33.8,moderate_burden
KE-NRB-2013-04027,2013,40,35-44,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-04028,2018,63,55-64,Female,Breast,Adenocarcinoma,Unknown,Death certificate only,Malignant,Peri-urban,Surgery only,Dead,14.2,moderate_burden
KE-NRB-2011-04029,2011,60,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,0.4,moderate_burden
KE-NRB-2018-04030,2018,56,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,49.4,moderate_burden
KE-NRB-2012-04031,2012,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,28.7,moderate_burden
KE-NRB-2015-04032,2015,76,75+,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-04033,2013,56,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04034,2018,15,15-24,Male,Pancreas,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,12.8,moderate_burden
KE-NRB-2014-04035,2014,46,45-54,Female,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.0,moderate_burden
KE-NRB-2012-04036,2012,89,75+,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-04037,2011,64,55-64,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2018-04038,2018,53,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,16.0,moderate_burden
KE-NRB-2017-04039,2017,23,15-24,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,40.7,moderate_burden
KE-NRB-2018-04040,2018,42,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2017-04041,2017,19,15-24,Male,Liver,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,27.0,moderate_burden
KE-NRB-2013-04042,2013,84,75+,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,4.4,moderate_burden
KE-NRB-2012-04043,2012,43,35-44,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.0,moderate_burden
KE-NRB-2015-04044,2015,51,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,37.6,moderate_burden
KE-NRB-2018-04045,2018,52,45-54,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery + Chemotherapy,Alive,18.6,moderate_burden
KE-NRB-2013-04046,2013,65,65-74,Male,Kaposi sarcoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,1.9,moderate_burden
KE-NRB-2017-04047,2017,4,0-14,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.0,moderate_burden
KE-NRB-2013-04048,2013,30,25-34,Female,Thyroid,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,19.1,moderate_burden
KE-NRB-2012-04049,2012,60,55-64,Male,Leukemia,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-04050,2010,55,55-64,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.6,moderate_burden
KE-NRB-2012-04051,2012,28,25-34,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,25.5,moderate_burden
KE-NRB-2015-04052,2015,44,35-44,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,10.0,moderate_burden
KE-NRB-2009-04053,2009,47,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Rural,Chemotherapy only,Alive,46.7,moderate_burden
KE-NRB-2009-04054,2009,34,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,33.6,moderate_burden
KE-NRB-2018-04055,2018,38,35-44,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-04056,2012,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,7.0,moderate_burden
KE-NRB-2009-04057,2009,94,75+,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.0,moderate_burden
KE-NRB-2015-04058,2015,38,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,3.6,moderate_burden
KE-NRB-2017-04059,2017,29,25-34,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-04060,2017,45,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,0.1,moderate_burden
KE-NRB-2016-04061,2016,61,55-64,Male,Oesophagus,Lymphoma,Unknown,Clinical only,Malignant,Rural,Surgery + Chemotherapy,Dead,1.9,moderate_burden
KE-NRB-2012-04062,2012,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.6,moderate_burden
KE-NRB-2018-04063,2018,61,55-64,Male,Oesophagus,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.4,moderate_burden
KE-NRB-2014-04064,2014,38,35-44,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2016-04065,2016,56,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.0,moderate_burden
KE-NRB-2009-04066,2009,50,45-54,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-04067,2012,44,35-44,Female,Thyroid,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,18.3,moderate_burden
KE-NRB-2016-04068,2016,46,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-04069,2010,68,65-74,Female,Thyroid,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-04070,2018,54,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,17.4,moderate_burden
KE-NRB-2017-04071,2017,25,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,42.3,moderate_burden
KE-NRB-2013-04072,2013,57,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04073,2016,53,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,37.9,moderate_burden
KE-NRB-2015-04074,2015,28,25-34,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2015-04075,2015,60,55-64,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.2,moderate_burden
KE-NRB-2013-04076,2013,50,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,33.3,moderate_burden
KE-NRB-2016-04077,2016,54,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,13.4,moderate_burden
KE-NRB-2016-04078,2016,72,65-74,Male,Brain and CNS,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Lost to follow-up,16.2,moderate_burden
KE-NRB-2015-04079,2015,47,45-54,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,16.9,moderate_burden
KE-NRB-2017-04080,2017,42,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,51.7,moderate_burden
KE-NRB-2018-04081,2018,31,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,50.6,moderate_burden
KE-NRB-2018-04082,2018,61,55-64,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,16.3,moderate_burden
KE-NRB-2016-04083,2016,61,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,39.2,moderate_burden
KE-NRB-2011-04084,2011,21,15-24,Male,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,2.3,moderate_burden
KE-NRB-2010-04085,2010,71,65-74,Female,Other,Sarcoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,21.9,moderate_burden
KE-NRB-2009-04086,2009,52,45-54,Male,Leukemia,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,58.2,moderate_burden
KE-NRB-2014-04087,2014,42,35-44,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,1.8,moderate_burden
KE-NRB-2017-04088,2017,48,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Alive,42.9,moderate_burden
KE-NRB-2018-04089,2018,7,0-14,Male,Stomach,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04090,2015,65,65-74,Male,Kaposi sarcoma,Lymphoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,3.3,moderate_burden
KE-NRB-2012-04091,2012,66,65-74,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2016-04092,2016,70,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,33.4,moderate_burden
KE-NRB-2016-04093,2016,81,75+,Female,Breast,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,2.2,moderate_burden
KE-NRB-2015-04094,2015,51,45-54,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-04095,2009,14,0-14,Male,Non-Hodgkin lymphoma,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,4.9,moderate_burden
KE-NRB-2013-04096,2013,39,35-44,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Dead,4.0,moderate_burden
KE-NRB-2010-04097,2010,59,55-64,Male,Lung,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.4,moderate_burden
KE-NRB-2013-04098,2013,49,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,20.1,moderate_burden
KE-NRB-2009-04099,2009,73,65-74,Female,Breast,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.5,moderate_burden
KE-NRB-2010-04100,2010,53,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.1,moderate_burden
KE-NRB-2012-04101,2012,62,55-64,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,6.0,moderate_burden
KE-NRB-2010-04102,2010,46,45-54,Female,Thyroid,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,2.1,moderate_burden
KE-NRB-2018-04103,2018,64,55-64,Male,Liver,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2016-04104,2016,60,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,47.8,moderate_burden
KE-NRB-2010-04105,2010,39,35-44,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-04106,2014,85,75+,Male,Pancreas,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemo + Radiotherapy,Dead,13.6,moderate_burden
KE-NRB-2009-04107,2009,58,55-64,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,8.4,moderate_burden
KE-NRB-2013-04108,2013,29,25-34,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,40.4,moderate_burden
KE-NRB-2010-04109,2010,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,19.0,moderate_burden
KE-NRB-2017-04110,2017,36,35-44,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,8.7,moderate_burden
KE-NRB-2014-04111,2014,29,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,24.5,moderate_burden
KE-NRB-2018-04112,2018,21,15-24,Female,Other,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,40.0,moderate_burden
KE-NRB-2009-04113,2009,53,45-54,Male,Pancreas,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-04114,2017,36,35-44,Female,Cervix uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-04115,2012,58,55-64,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,55.1,moderate_burden
KE-NRB-2017-04116,2017,56,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.1,moderate_burden
KE-NRB-2011-04117,2011,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-04118,2016,66,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,27.9,moderate_burden
KE-NRB-2012-04119,2012,65,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,9.5,moderate_burden
KE-NRB-2009-04120,2009,57,55-64,Female,Breast,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Palliative care only,Dead,14.4,moderate_burden
KE-NRB-2011-04121,2011,39,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.9,moderate_burden
KE-NRB-2011-04122,2011,31,25-34,Female,Other,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,21.2,moderate_burden
KE-NRB-2015-04123,2015,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Dead,7.8,moderate_burden
KE-NRB-2018-04124,2018,48,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-04125,2012,49,45-54,Male,Kidney,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,55.5,moderate_burden
KE-NRB-2017-04126,2017,40,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04127,2017,37,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,11.2,moderate_burden
KE-NRB-2011-04128,2011,25,25-34,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,2.9,moderate_burden
KE-NRB-2010-04129,2010,58,55-64,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.7,moderate_burden
KE-NRB-2010-04130,2010,53,45-54,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,22.1,moderate_burden
KE-NRB-2011-04131,2011,26,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,27.9,moderate_burden
KE-NRB-2015-04132,2015,71,65-74,Male,Other,Non-keratinizing carcinoma,Unknown,Clinical only,Benign/uncertain,Urban,N/A,Dead,14.0,moderate_burden
KE-NRB-2015-04133,2015,52,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,8.5,moderate_burden
KE-NRB-2016-04134,2016,62,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.5,moderate_burden
KE-NRB-2013-04135,2013,42,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,7.9,moderate_burden
KE-NRB-2017-04136,2017,61,55-64,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Other,Malignant,Peri-urban,Chemotherapy only,Dead,15.7,moderate_burden
KE-NRB-2016-04137,2016,53,45-54,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.0,moderate_burden
KE-NRB-2014-04138,2014,85,75+,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.6,moderate_burden
KE-NRB-2018-04139,2018,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,3.2,moderate_burden
KE-NRB-2011-04140,2011,54,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,8.8,moderate_burden
KE-NRB-2014-04141,2014,25,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Dead,3.0,moderate_burden
KE-NRB-2016-04142,2016,58,55-64,Male,Pancreas,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04143,2016,38,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,13.1,moderate_burden
KE-NRB-2014-04144,2014,60,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,44.2,moderate_burden
KE-NRB-2011-04145,2011,88,75+,Male,Liver,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,14.1,moderate_burden
KE-NRB-2011-04146,2011,65,65-74,Female,Ovary,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,23.8,moderate_burden
KE-NRB-2014-04147,2014,35,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.7,moderate_burden
KE-NRB-2010-04148,2010,51,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,29.2,moderate_burden
KE-NRB-2018-04149,2018,53,45-54,Female,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,32.4,moderate_burden
KE-NRB-2018-04150,2018,37,35-44,Male,Colorectum,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.0,moderate_burden
KE-NRB-2010-04151,2010,46,45-54,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.7,moderate_burden
KE-NRB-2012-04152,2012,94,75+,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,2.9,moderate_burden
KE-NRB-2014-04153,2014,65,65-74,Female,Ovary,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,31.8,moderate_burden
KE-NRB-2011-04154,2011,66,65-74,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,29.7,moderate_burden
KE-NRB-2010-04155,2010,58,55-64,Female,Corpus uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,8.0,moderate_burden
KE-NRB-2016-04156,2016,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,59.3,moderate_burden
KE-NRB-2013-04157,2013,69,65-74,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,4.3,moderate_burden
KE-NRB-2009-04158,2009,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Peri-urban,Palliative care only,Alive,23.7,moderate_burden
KE-NRB-2017-04159,2017,35,35-44,Male,Stomach,Squamous cell carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery only,Dead,5.1,moderate_burden
KE-NRB-2014-04160,2014,44,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,15.3,moderate_burden
KE-NRB-2018-04161,2018,57,55-64,Male,Liver,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2011-04162,2011,74,65-74,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,17.9,moderate_burden
KE-NRB-2010-04163,2010,29,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.2,moderate_burden
KE-NRB-2011-04164,2011,59,55-64,Male,Lung,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,41.6,moderate_burden
KE-NRB-2009-04165,2009,73,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Dead,48.4,moderate_burden
KE-NRB-2015-04166,2015,49,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Chemotherapy only,Dead,3.3,moderate_burden
KE-NRB-2016-04167,2016,64,55-64,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,29.3,moderate_burden
KE-NRB-2014-04168,2014,56,55-64,Male,Kidney,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-04169,2010,64,55-64,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,34.9,moderate_burden
KE-NRB-2009-04170,2009,44,35-44,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,7.2,moderate_burden
KE-NRB-2013-04171,2013,74,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04172,2018,47,45-54,Female,Ovary,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,33.8,moderate_burden
KE-NRB-2014-04173,2014,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04174,2018,65,65-74,Male,Other,Unspecified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,32.2,moderate_burden
KE-NRB-2012-04175,2012,16,15-24,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,14.4,moderate_burden
KE-NRB-2011-04176,2011,73,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-04177,2018,45,45-54,Male,Prostate,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,19.1,moderate_burden
KE-NRB-2011-04178,2011,52,45-54,Male,Prostate,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,10.1,moderate_burden
KE-NRB-2015-04179,2015,64,55-64,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,55.9,moderate_burden
KE-NRB-2014-04180,2014,67,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Lost to follow-up,23.8,moderate_burden
KE-NRB-2015-04181,2015,74,65-74,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-04182,2011,65,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,8.2,moderate_burden
KE-NRB-2016-04183,2016,46,45-54,Male,Skin (melanoma),Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,3.8,moderate_burden
KE-NRB-2014-04184,2014,37,35-44,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Clinical only,In situ,Urban,N/A,Lost to follow-up,25.5,moderate_burden
KE-NRB-2018-04185,2018,69,65-74,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,41.2,moderate_burden
KE-NRB-2013-04186,2013,74,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,19.8,moderate_burden
KE-NRB-2017-04187,2017,68,65-74,Female,Ovary,Squamous cell carcinoma,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,34.1,moderate_burden
KE-NRB-2018-04188,2018,25,25-34,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Dead,2.1,moderate_burden
KE-NRB-2012-04189,2012,6,0-14,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Dead,41.5,moderate_burden
KE-NRB-2017-04190,2017,87,75+,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2017-04191,2017,53,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,36.6,moderate_burden
KE-NRB-2009-04192,2009,72,65-74,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2014-04193,2014,14,0-14,Female,Other,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,No treatment,Dead,14.1,moderate_burden
KE-NRB-2018-04194,2018,27,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,28.7,moderate_burden
KE-NRB-2018-04195,2018,45,45-54,Male,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,5.7,moderate_burden
KE-NRB-2018-04196,2018,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.0,moderate_burden
KE-NRB-2011-04197,2011,64,55-64,Male,Other,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,34.9,moderate_burden
KE-NRB-2016-04198,2016,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,In situ,Urban,N/A,Dead,3.0,moderate_burden
KE-NRB-2016-04199,2016,92,75+,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04200,2017,30,25-34,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,26.8,moderate_burden
KE-NRB-2016-04201,2016,52,45-54,Female,Breast,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,11.8,moderate_burden
KE-NRB-2013-04202,2013,43,35-44,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,3.9,moderate_burden
KE-NRB-2018-04203,2018,71,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,18.7,moderate_burden
KE-NRB-2017-04204,2017,36,35-44,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.5,moderate_burden
KE-NRB-2014-04205,2014,37,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,41.1,moderate_burden
KE-NRB-2010-04206,2010,86,75+,Male,Stomach,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,38.3,moderate_burden
KE-NRB-2013-04207,2013,82,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,18.0,moderate_burden
KE-NRB-2012-04208,2012,67,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.7,moderate_burden
KE-NRB-2017-04209,2017,70,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,2.5,moderate_burden
KE-NRB-2009-04210,2009,64,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Alive,31.5,moderate_burden
KE-NRB-2015-04211,2015,60,55-64,Male,Liver,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,20.2,moderate_burden
KE-NRB-2009-04212,2009,48,45-54,Male,Oesophagus,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,35.8,moderate_burden
KE-NRB-2016-04213,2016,63,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,46.8,moderate_burden
KE-NRB-2011-04214,2011,45,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,15.5,moderate_burden
KE-NRB-2015-04215,2015,43,35-44,Female,Other,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2017-04216,2017,30,25-34,Male,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-04217,2015,27,25-34,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-04218,2017,58,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,28.8,moderate_burden
KE-NRB-2010-04219,2010,56,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Alive,33.5,moderate_burden
KE-NRB-2014-04220,2014,73,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.6,moderate_burden
KE-NRB-2015-04221,2015,74,65-74,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04222,2018,37,35-44,Male,Bladder,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,34.0,moderate_burden
KE-NRB-2016-04223,2016,40,35-44,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.1,moderate_burden
KE-NRB-2015-04224,2015,68,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,48.3,moderate_burden
KE-NRB-2015-04225,2015,44,35-44,Male,Prostate,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,18.7,moderate_burden
KE-NRB-2015-04226,2015,48,45-54,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,17.8,moderate_burden
KE-NRB-2015-04227,2015,1,0-14,Male,Kidney,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.2,moderate_burden
KE-NRB-2014-04228,2014,74,65-74,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.1,moderate_burden
KE-NRB-2016-04229,2016,79,75+,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,40.5,moderate_burden
KE-NRB-2018-04230,2018,55,55-64,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,49.0,moderate_burden
KE-NRB-2013-04231,2013,55,55-64,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Dead,0.0,moderate_burden
KE-NRB-2014-04232,2014,54,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,44.0,moderate_burden
KE-NRB-2016-04233,2016,52,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,30.1,moderate_burden
KE-NRB-2018-04234,2018,35,35-44,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04235,2016,64,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2010-04236,2010,62,55-64,Male,Kaposi sarcoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,13.2,moderate_burden
KE-NRB-2017-04237,2017,74,65-74,Male,Skin (melanoma),Adenocarcinoma,Well differentiated (Grade I),Death certificate only,In situ,Peri-urban,N/A,Alive,23.1,moderate_burden
KE-NRB-2010-04238,2010,72,65-74,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,19.8,moderate_burden
KE-NRB-2010-04239,2010,68,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,9.8,moderate_burden
KE-NRB-2018-04240,2018,37,35-44,Male,Kidney,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,No treatment,Dead,48.2,moderate_burden
KE-NRB-2017-04241,2017,46,45-54,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Dead,4.3,moderate_burden
KE-NRB-2013-04242,2013,52,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.2,moderate_burden
KE-NRB-2017-04243,2017,53,45-54,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,No treatment,Dead,48.1,moderate_burden
KE-NRB-2009-04244,2009,83,75+,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,43.4,moderate_burden
KE-NRB-2012-04245,2012,37,35-44,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,25.5,moderate_burden
KE-NRB-2017-04246,2017,51,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.5,moderate_burden
KE-NRB-2014-04247,2014,57,55-64,Male,Prostate,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-04248,2011,71,65-74,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.8,moderate_burden
KE-NRB-2018-04249,2018,32,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Alive,19.3,moderate_burden
KE-NRB-2016-04250,2016,37,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,41.5,moderate_burden
KE-NRB-2014-04251,2014,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04252,2015,29,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.1,moderate_burden
KE-NRB-2012-04253,2012,62,55-64,Male,Bladder,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,21.8,moderate_burden
KE-NRB-2012-04254,2012,95,75+,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Alive,10.2,moderate_burden
KE-NRB-2018-04255,2018,81,75+,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-04256,2014,68,65-74,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.9,moderate_burden
KE-NRB-2018-04257,2018,25,25-34,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,13.9,moderate_burden
KE-NRB-2018-04258,2018,40,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,13.3,moderate_burden
KE-NRB-2018-04259,2018,49,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,13.6,moderate_burden
KE-NRB-2017-04260,2017,93,75+,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,55.2,moderate_burden
KE-NRB-2014-04261,2014,17,15-24,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04262,2015,19,15-24,Male,Non-Hodgkin lymphoma,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,6.2,moderate_burden
KE-NRB-2017-04263,2017,40,35-44,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,43.8,moderate_burden
KE-NRB-2010-04264,2010,86,75+,Male,Bladder,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Radiotherapy only,Dead,2.9,moderate_burden
KE-NRB-2015-04265,2015,46,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-04266,2010,37,35-44,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,14.9,moderate_burden
KE-NRB-2018-04267,2018,81,75+,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-04268,2014,66,65-74,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,0.4,moderate_burden
KE-NRB-2016-04269,2016,41,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,45.0,moderate_burden
KE-NRB-2014-04270,2014,90,75+,Male,Other,Lymphoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Dead,4.4,moderate_burden
KE-NRB-2012-04271,2012,45,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,36.0,moderate_burden
KE-NRB-2017-04272,2017,81,75+,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,5.0,moderate_burden
KE-NRB-2018-04273,2018,40,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.5,moderate_burden
KE-NRB-2016-04274,2016,35,35-44,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,32.2,moderate_burden
KE-NRB-2010-04275,2010,34,25-34,Female,Cervix uteri,Other specified,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,No treatment,Dead,23.3,moderate_burden
KE-NRB-2010-04276,2010,74,65-74,Female,Breast,Sarcoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,57.1,moderate_burden
KE-NRB-2018-04277,2018,48,45-54,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,8.2,moderate_burden
KE-NRB-2010-04278,2010,50,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,42.4,moderate_burden
KE-NRB-2012-04279,2012,76,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,19.6,moderate_burden
KE-NRB-2013-04280,2013,69,65-74,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.1,moderate_burden
KE-NRB-2014-04281,2014,19,15-24,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,47.5,moderate_burden
KE-NRB-2016-04282,2016,57,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.7,moderate_burden
KE-NRB-2016-04283,2016,95,75+,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,43.7,moderate_burden
KE-NRB-2012-04284,2012,59,55-64,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Rural,Surgery only,Alive,27.6,moderate_burden
KE-NRB-2016-04285,2016,48,45-54,Male,Pancreas,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,27.4,moderate_burden
KE-NRB-2017-04286,2017,44,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,15.7,moderate_burden
KE-NRB-2018-04287,2018,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,26.8,moderate_burden
KE-NRB-2018-04288,2018,51,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.1,moderate_burden
KE-NRB-2010-04289,2010,27,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.6,moderate_burden
KE-NRB-2016-04290,2016,37,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,14.7,moderate_burden
KE-NRB-2011-04291,2011,95,75+,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,29.5,moderate_burden
KE-NRB-2011-04292,2011,66,65-74,Male,Lung,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,49.0,moderate_burden
KE-NRB-2015-04293,2015,59,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,37.5,moderate_burden
KE-NRB-2014-04294,2014,54,45-54,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,No treatment,Dead,17.9,moderate_burden
KE-NRB-2018-04295,2018,41,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,5.4,moderate_burden
KE-NRB-2012-04296,2012,28,25-34,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2011-04297,2011,28,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,49.7,moderate_burden
KE-NRB-2014-04298,2014,92,75+,Female,Other,Sarcoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,38.2,moderate_burden
KE-NRB-2016-04299,2016,56,55-64,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Dead,13.9,moderate_burden
KE-NRB-2013-04300,2013,31,25-34,Male,Stomach,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,11.0,moderate_burden
KE-NRB-2011-04301,2011,55,55-64,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,2.9,moderate_burden
KE-NRB-2018-04302,2018,28,25-34,Female,Corpus uteri,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,22.2,moderate_burden
KE-NRB-2014-04303,2014,64,55-64,Female,Other,Other specified,Moderately differentiated (Grade II),Imaging + clinical,In situ,Peri-urban,N/A,Alive,8.0,moderate_burden
KE-NRB-2015-04304,2015,42,35-44,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,16.7,moderate_burden
KE-NRB-2009-04305,2009,44,35-44,Male,Other,Lymphoma,Unknown,Death certificate only,In situ,Peri-urban,N/A,Dead,6.3,moderate_burden
KE-NRB-2014-04306,2014,23,15-24,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Dead,29.2,moderate_burden
KE-NRB-2010-04307,2010,60,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,24.2,moderate_burden
KE-NRB-2018-04308,2018,41,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04309,2016,33,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.6,moderate_burden
KE-NRB-2018-04310,2018,70,65-74,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,43.7,moderate_burden
KE-NRB-2016-04311,2016,65,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,36.8,moderate_burden
KE-NRB-2016-04312,2016,71,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,23.4,moderate_burden
KE-NRB-2017-04313,2017,43,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,9.1,moderate_burden
KE-NRB-2011-04314,2011,51,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,4.0,moderate_burden
KE-NRB-2011-04315,2011,81,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.1,moderate_burden
KE-NRB-2010-04316,2010,53,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,8.1,moderate_burden
KE-NRB-2014-04317,2014,64,55-64,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.9,moderate_burden
KE-NRB-2018-04318,2018,63,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Alive,41.8,moderate_burden
KE-NRB-2018-04319,2018,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04320,2016,69,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.7,moderate_burden
KE-NRB-2014-04321,2014,56,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.0,moderate_burden
KE-NRB-2014-04322,2014,61,55-64,Female,Ovary,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,37.8,moderate_burden
KE-NRB-2016-04323,2016,85,75+,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,34.8,moderate_burden
KE-NRB-2016-04324,2016,57,55-64,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Death certificate only,Malignant,Urban,Surgery only,Alive,42.4,moderate_burden
KE-NRB-2014-04325,2014,23,15-24,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Surgery only,Dead,1.9,moderate_burden
KE-NRB-2015-04326,2015,53,45-54,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,30.7,moderate_burden
KE-NRB-2013-04327,2013,51,45-54,Male,Prostate,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,3.8,moderate_burden
KE-NRB-2017-04328,2017,62,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-04329,2015,41,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,17.8,moderate_burden
KE-NRB-2010-04330,2010,73,65-74,Male,Bladder,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.5,moderate_burden
KE-NRB-2010-04331,2010,29,25-34,Male,Non-Hodgkin lymphoma,Unspecified,Poorly differentiated (Grade III),Clinical only,Malignant,Peri-urban,Radiotherapy only,Dead,23.0,moderate_burden
KE-NRB-2018-04332,2018,51,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Rural,N/A,Lost to follow-up,42.8,moderate_burden
KE-NRB-2017-04333,2017,49,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,35.1,moderate_burden
KE-NRB-2010-04334,2010,69,65-74,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.8,moderate_burden
KE-NRB-2018-04335,2018,87,75+,Female,Breast,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,33.7,moderate_burden
KE-NRB-2015-04336,2015,66,65-74,Female,Breast,Leukemia,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,10.7,moderate_burden
KE-NRB-2014-04337,2014,30,25-34,Female,Cervix uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,51.0,moderate_burden
KE-NRB-2017-04338,2017,42,35-44,Female,Other,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2017-04339,2017,68,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,32.0,moderate_burden
KE-NRB-2013-04340,2013,28,25-34,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Imaging + clinical,In situ,Urban,N/A,Dead,6.5,moderate_burden
KE-NRB-2015-04341,2015,56,55-64,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,14.1,moderate_burden
KE-NRB-2013-04342,2013,24,15-24,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.9,moderate_burden
KE-NRB-2009-04343,2009,38,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,15.2,moderate_burden
KE-NRB-2014-04344,2014,49,45-54,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,12.3,moderate_burden
KE-NRB-2016-04345,2016,41,35-44,Male,Colorectum,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,27.4,moderate_burden
KE-NRB-2013-04346,2013,36,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,25.7,moderate_burden
KE-NRB-2011-04347,2011,74,65-74,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04348,2018,67,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04349,2015,61,55-64,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-04350,2014,61,55-64,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2012-04351,2012,49,45-54,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,4.9,moderate_burden
KE-NRB-2013-04352,2013,64,55-64,Male,Lung,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,56.9,moderate_burden
KE-NRB-2015-04353,2015,69,65-74,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,13.0,moderate_burden
KE-NRB-2015-04354,2015,6,0-14,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,22.4,moderate_burden
KE-NRB-2018-04355,2018,31,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-04356,2013,15,15-24,Female,Thyroid,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,40.8,moderate_burden
KE-NRB-2013-04357,2013,41,35-44,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,28.3,moderate_burden
KE-NRB-2018-04358,2018,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,16.5,moderate_burden
KE-NRB-2017-04359,2017,58,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.1,moderate_burden
KE-NRB-2011-04360,2011,46,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,8.7,moderate_burden
KE-NRB-2018-04361,2018,89,75+,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,47.1,moderate_burden
KE-NRB-2013-04362,2013,70,65-74,Male,Lung,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,20.1,moderate_burden
KE-NRB-2009-04363,2009,49,45-54,Male,Other,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,6.1,moderate_burden
KE-NRB-2016-04364,2016,53,45-54,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,17.4,moderate_burden
KE-NRB-2018-04365,2018,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,31.1,moderate_burden
KE-NRB-2016-04366,2016,31,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-04367,2015,56,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Surgery only,Alive,20.0,moderate_burden
KE-NRB-2016-04368,2016,59,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2009-04369,2009,51,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-04370,2015,65,65-74,Female,Thyroid,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.7,moderate_burden
KE-NRB-2017-04371,2017,48,45-54,Female,Corpus uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery + Radiotherapy,Alive,50.5,moderate_burden
KE-NRB-2014-04372,2014,60,55-64,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,33.4,moderate_burden
KE-NRB-2013-04373,2013,61,55-64,Female,Breast,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,21.3,moderate_burden
KE-NRB-2012-04374,2012,66,65-74,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,5.8,moderate_burden
KE-NRB-2014-04375,2014,71,65-74,Female,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.9,moderate_burden
KE-NRB-2011-04376,2011,48,45-54,Female,Breast,Unspecified,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,9.2,moderate_burden
KE-NRB-2009-04377,2009,63,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Chemotherapy only,Alive,59.7,moderate_burden
KE-NRB-2013-04378,2013,27,25-34,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Alive,54.0,moderate_burden
KE-NRB-2016-04379,2016,61,55-64,Female,Thyroid,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery + Radiotherapy,Alive,4.2,moderate_burden
KE-NRB-2012-04380,2012,86,75+,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2010-04381,2010,38,35-44,Male,Leukemia,Sarcoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,0.4,moderate_burden
KE-NRB-2009-04382,2009,83,75+,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-04383,2017,62,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,36.0,moderate_burden
KE-NRB-2009-04384,2009,39,35-44,Male,Leukemia,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,13.4,moderate_burden
KE-NRB-2017-04385,2017,53,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,0.6,moderate_burden
KE-NRB-2009-04386,2009,60,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.4,moderate_burden
KE-NRB-2015-04387,2015,74,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Other,Malignant,Urban,Surgery + Radiotherapy,Alive,29.1,moderate_burden
KE-NRB-2014-04388,2014,71,65-74,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,1.5,moderate_burden
KE-NRB-2016-04389,2016,26,25-34,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,24.4,moderate_burden
KE-NRB-2018-04390,2018,51,45-54,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,43.4,moderate_burden
KE-NRB-2017-04391,2017,51,45-54,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,7.5,moderate_burden
KE-NRB-2017-04392,2017,44,35-44,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,28.8,moderate_burden
KE-NRB-2013-04393,2013,50,45-54,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-04394,2012,56,55-64,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Dead,9.3,moderate_burden
KE-NRB-2016-04395,2016,34,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-04396,2018,65,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Radiotherapy only,Dead,0.0,moderate_burden
KE-NRB-2013-04397,2013,25,25-34,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,4.0,moderate_burden
KE-NRB-2013-04398,2013,57,55-64,Male,Non-Hodgkin lymphoma,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,In situ,Urban,N/A,Dead,13.4,moderate_burden
KE-NRB-2011-04399,2011,48,45-54,Female,Other,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,17.7,moderate_burden
KE-NRB-2009-04400,2009,45,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-04401,2015,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2018-04402,2018,34,25-34,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,3.9,moderate_burden
KE-NRB-2014-04403,2014,72,65-74,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,20.7,moderate_burden
KE-NRB-2015-04404,2015,59,55-64,Male,Other,Sarcoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Chemo + Radiotherapy,Alive,49.6,moderate_burden
KE-NRB-2014-04405,2014,69,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,11.5,moderate_burden
KE-NRB-2018-04406,2018,45,45-54,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-04407,2009,64,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,3.0,moderate_burden
KE-NRB-2018-04408,2018,59,55-64,Male,Prostate,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,10.1,moderate_burden
KE-NRB-2014-04409,2014,61,55-64,Female,Corpus uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,33.1,moderate_burden
KE-NRB-2010-04410,2010,51,45-54,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,31.6,moderate_burden
KE-NRB-2013-04411,2013,42,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Rural,N/A,Dead,60.0,moderate_burden
KE-NRB-2015-04412,2015,70,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2015-04413,2015,40,35-44,Female,Breast,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,34.4,moderate_burden
KE-NRB-2018-04414,2018,52,45-54,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,19.6,moderate_burden
KE-NRB-2012-04415,2012,54,45-54,Male,Lung,Leukemia,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,7.5,moderate_burden
KE-NRB-2014-04416,2014,58,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,15.7,moderate_burden
KE-NRB-2015-04417,2015,70,65-74,Male,Multiple myeloma,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2017-04418,2017,30,25-34,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,5.1,moderate_burden
KE-NRB-2014-04419,2014,51,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,32.1,moderate_burden
KE-NRB-2011-04420,2011,44,35-44,Male,Prostate,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,47.8,moderate_burden
KE-NRB-2013-04421,2013,80,75+,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,6.2,moderate_burden
KE-NRB-2010-04422,2010,51,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-04423,2012,58,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,60.0,moderate_burden
KE-NRB-2014-04424,2014,72,65-74,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-04425,2017,65,65-74,Male,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-04426,2014,53,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-04427,2012,54,45-54,Male,Oesophagus,Unspecified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,4.6,moderate_burden
KE-NRB-2010-04428,2010,48,45-54,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,8.1,moderate_burden
KE-NRB-2018-04429,2018,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,22.3,moderate_burden
KE-NRB-2016-04430,2016,58,55-64,Male,Leukemia,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,1.6,moderate_burden
KE-NRB-2016-04431,2016,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,3.3,moderate_burden
KE-NRB-2018-04432,2018,25,25-34,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,22.8,moderate_burden
KE-NRB-2017-04433,2017,59,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,1.8,moderate_burden
KE-NRB-2013-04434,2013,51,45-54,Female,Cervix uteri,Unspecified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,2.8,moderate_burden
KE-NRB-2017-04435,2017,49,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-04436,2012,43,35-44,Female,Breast,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,12.4,moderate_burden
KE-NRB-2011-04437,2011,26,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,32.1,moderate_burden
KE-NRB-2018-04438,2018,64,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,3.4,moderate_burden
KE-NRB-2011-04439,2011,63,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2015-04440,2015,14,0-14,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,13.4,moderate_burden
KE-NRB-2012-04441,2012,67,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,13.3,moderate_burden
KE-NRB-2014-04442,2014,60,55-64,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,26.7,moderate_burden
KE-NRB-2011-04443,2011,17,15-24,Male,Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.8,moderate_burden
KE-NRB-2011-04444,2011,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,35.0,moderate_burden
KE-NRB-2017-04445,2017,41,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,48.5,moderate_burden
KE-NRB-2017-04446,2017,51,45-54,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.4,moderate_burden
KE-NRB-2013-04447,2013,23,15-24,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,53.8,moderate_burden
KE-NRB-2015-04448,2015,25,25-34,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,25.2,moderate_burden
KE-NRB-2017-04449,2017,65,65-74,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,44.6,moderate_burden
KE-NRB-2016-04450,2016,46,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.2,moderate_burden
KE-NRB-2015-04451,2015,30,25-34,Female,Other,Sarcoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Alive,16.3,moderate_burden
KE-NRB-2017-04452,2017,67,65-74,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,49.3,moderate_burden
KE-NRB-2017-04453,2017,36,35-44,Female,Cervix uteri,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,42.0,moderate_burden
KE-NRB-2012-04454,2012,51,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-04455,2016,66,65-74,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,3.5,moderate_burden
KE-NRB-2018-04456,2018,38,35-44,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,1.9,moderate_burden
KE-NRB-2011-04457,2011,70,65-74,Male,Colorectum,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2011-04458,2011,81,75+,Female,Cervix uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-04459,2011,71,65-74,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2018-04460,2018,58,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.5,moderate_burden
KE-NRB-2015-04461,2015,32,25-34,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04462,2018,65,65-74,Male,Non-Hodgkin lymphoma,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,60.0,moderate_burden
KE-NRB-2010-04463,2010,67,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-04464,2016,74,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,12.7,moderate_burden
KE-NRB-2014-04465,2014,50,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,40.8,moderate_burden
KE-NRB-2017-04466,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Lost to follow-up,15.6,moderate_burden
KE-NRB-2018-04467,2018,40,35-44,Female,Other,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-04468,2012,39,35-44,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.7,moderate_burden
KE-NRB-2016-04469,2016,53,45-54,Female,Other,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,8.8,moderate_burden
KE-NRB-2017-04470,2017,42,35-44,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,10.3,moderate_burden
KE-NRB-2017-04471,2017,35,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,2.5,moderate_burden
KE-NRB-2013-04472,2013,52,45-54,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04473,2016,83,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2010-04474,2010,46,45-54,Male,Colorectum,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,19.9,moderate_burden
KE-NRB-2013-04475,2013,55,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,7.4,moderate_burden
KE-NRB-2013-04476,2013,61,55-64,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.5,moderate_burden
KE-NRB-2015-04477,2015,73,65-74,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,21.0,moderate_burden
KE-NRB-2013-04478,2013,39,35-44,Male,Other,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,2.5,moderate_burden
KE-NRB-2009-04479,2009,61,55-64,Female,Cervix uteri,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,16.0,moderate_burden
KE-NRB-2013-04480,2013,28,25-34,Female,Cervix uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,8.0,moderate_burden
KE-NRB-2011-04481,2011,73,65-74,Female,Other,Lymphoma,Well differentiated (Grade I),Other,Malignant,Urban,Radiotherapy only,Alive,2.2,moderate_burden
KE-NRB-2016-04482,2016,67,65-74,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04483,2017,5,0-14,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Dead,11.6,moderate_burden
KE-NRB-2012-04484,2012,48,45-54,Male,Liver,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.8,moderate_burden
KE-NRB-2014-04485,2014,59,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,14.4,moderate_burden
KE-NRB-2014-04486,2014,45,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,3.6,moderate_burden
KE-NRB-2017-04487,2017,65,65-74,Female,Corpus uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,9.5,moderate_burden
KE-NRB-2018-04488,2018,33,25-34,Male,Liver,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,6.2,moderate_burden
KE-NRB-2010-04489,2010,74,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04490,2018,77,75+,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,7.5,moderate_burden
KE-NRB-2012-04491,2012,67,65-74,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,31.4,moderate_burden
KE-NRB-2009-04492,2009,55,55-64,Female,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04493,2015,60,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,29.5,moderate_burden
KE-NRB-2018-04494,2018,61,55-64,Female,Breast,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,23.7,moderate_burden
KE-NRB-2016-04495,2016,64,55-64,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,49.3,moderate_burden
KE-NRB-2015-04496,2015,55,55-64,Female,Cervix uteri,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,7.2,moderate_burden
KE-NRB-2015-04497,2015,56,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,40.9,moderate_burden
KE-NRB-2013-04498,2013,28,25-34,Male,Liver,Adenocarcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery only,Alive,38.1,moderate_burden
KE-NRB-2018-04499,2018,53,45-54,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.9,moderate_burden
KE-NRB-2014-04500,2014,31,25-34,Male,Kaposi sarcoma,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,35.8,moderate_burden
KE-NRB-2018-04501,2018,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,16.2,moderate_burden
KE-NRB-2018-04502,2018,40,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-04503,2012,46,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,25.9,moderate_burden
KE-NRB-2010-04504,2010,53,45-54,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.6,moderate_burden
KE-NRB-2015-04505,2015,72,65-74,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,32.4,moderate_burden
KE-NRB-2013-04506,2013,81,75+,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-04507,2016,46,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,1.2,moderate_burden
KE-NRB-2017-04508,2017,53,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,4.2,moderate_burden
KE-NRB-2015-04509,2015,67,65-74,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,10.6,moderate_burden
KE-NRB-2016-04510,2016,34,25-34,Male,Other,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,16.6,moderate_burden
KE-NRB-2009-04511,2009,73,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,23.2,moderate_burden
KE-NRB-2012-04512,2012,64,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Rural,N/A,Alive,16.6,moderate_burden
KE-NRB-2013-04513,2013,39,35-44,Female,Cervix uteri,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,18.3,moderate_burden
KE-NRB-2010-04514,2010,79,75+,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-04515,2014,74,65-74,Male,Bladder,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,36.1,moderate_burden
KE-NRB-2015-04516,2015,34,25-34,Female,Breast,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.9,moderate_burden
KE-NRB-2018-04517,2018,36,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.8,moderate_burden
KE-NRB-2014-04518,2014,49,45-54,Female,Other,Sarcoma,Unknown,Clinical only,Malignant,Peri-urban,Chemotherapy only,Alive,13.4,moderate_burden
KE-NRB-2011-04519,2011,94,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,30.5,moderate_burden
KE-NRB-2014-04520,2014,70,65-74,Female,Ovary,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,3.9,moderate_burden
KE-NRB-2016-04521,2016,51,45-54,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,moderate_burden
KE-NRB-2014-04522,2014,44,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04523,2016,40,35-44,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,6.3,moderate_burden
KE-NRB-2011-04524,2011,54,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.3,moderate_burden
KE-NRB-2010-04525,2010,85,75+,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-04526,2014,41,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,28.7,moderate_burden
KE-NRB-2015-04527,2015,53,45-54,Female,Breast,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2014-04528,2014,57,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.1,moderate_burden
KE-NRB-2018-04529,2018,50,45-54,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,0.2,moderate_burden
KE-NRB-2009-04530,2009,58,55-64,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,37.1,moderate_burden
KE-NRB-2010-04531,2010,40,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-04532,2012,65,65-74,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,12.4,moderate_burden
KE-NRB-2011-04533,2011,25,25-34,Male,Prostate,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,28.9,moderate_burden
KE-NRB-2010-04534,2010,40,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-04535,2009,59,55-64,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,50.9,moderate_burden
KE-NRB-2013-04536,2013,29,25-34,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Peri-urban,N/A,Dead,29.3,moderate_burden
KE-NRB-2016-04537,2016,52,45-54,Male,Oesophagus,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,32.6,moderate_burden
KE-NRB-2018-04538,2018,88,75+,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,22.9,moderate_burden
KE-NRB-2009-04539,2009,89,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,15.1,moderate_burden
KE-NRB-2015-04540,2015,18,15-24,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,20.9,moderate_burden
KE-NRB-2018-04541,2018,49,45-54,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,11.5,moderate_burden
KE-NRB-2012-04542,2012,72,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Malignant,Rural,Chemotherapy only,Dead,17.6,moderate_burden
KE-NRB-2011-04543,2011,65,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Dead,6.9,moderate_burden
KE-NRB-2015-04544,2015,47,45-54,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,No treatment,Lost to follow-up,1.3,moderate_burden
KE-NRB-2011-04545,2011,46,45-54,Male,Non-Hodgkin lymphoma,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Dead,55.7,moderate_burden
KE-NRB-2015-04546,2015,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,3.5,moderate_burden
KE-NRB-2018-04547,2018,56,55-64,Female,Other,Unspecified,Undifferentiated (Grade IV),Clinical only,Malignant,Rural,Chemotherapy only,Dead,21.2,moderate_burden
KE-NRB-2014-04548,2014,46,45-54,Male,Leukemia,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Dead,3.6,moderate_burden
KE-NRB-2009-04549,2009,21,15-24,Female,Breast,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,6.6,moderate_burden
KE-NRB-2009-04550,2009,37,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Rural,N/A,Dead,1.3,moderate_burden
KE-NRB-2017-04551,2017,35,35-44,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.2,moderate_burden
KE-NRB-2018-04552,2018,48,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,4.6,moderate_burden
KE-NRB-2009-04553,2009,38,35-44,Female,Ovary,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,5.2,moderate_burden
KE-NRB-2018-04554,2018,67,65-74,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-04555,2014,33,25-34,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2017-04556,2017,49,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,43.7,moderate_burden
KE-NRB-2012-04557,2012,64,55-64,Male,Lung,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,36.8,moderate_burden
KE-NRB-2011-04558,2011,62,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,30.1,moderate_burden
KE-NRB-2016-04559,2016,46,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,53.6,moderate_burden
KE-NRB-2015-04560,2015,46,45-54,Male,Colorectum,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,54.9,moderate_burden
KE-NRB-2010-04561,2010,55,55-64,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.1,moderate_burden
KE-NRB-2014-04562,2014,41,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Urban,Surgery only,Dead,19.7,moderate_burden
KE-NRB-2014-04563,2014,68,65-74,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,6.0,moderate_burden
KE-NRB-2018-04564,2018,80,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.0,moderate_burden
KE-NRB-2014-04565,2014,49,45-54,Male,Colorectum,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,22.9,moderate_burden
KE-NRB-2009-04566,2009,59,55-64,Male,Liver,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,2.3,moderate_burden
KE-NRB-2017-04567,2017,36,35-44,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,16.3,moderate_burden
KE-NRB-2016-04568,2016,46,45-54,Male,Kaposi sarcoma,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Lost to follow-up,4.3,moderate_burden
KE-NRB-2014-04569,2014,51,45-54,Female,Corpus uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-04570,2013,28,25-34,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,5.0,moderate_burden
KE-NRB-2012-04571,2012,51,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,1.3,moderate_burden
KE-NRB-2018-04572,2018,42,35-44,Female,Ovary,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-04573,2013,65,65-74,Female,Cervix uteri,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,38.2,moderate_burden
KE-NRB-2011-04574,2011,57,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Alive,8.0,moderate_burden
KE-NRB-2011-04575,2011,86,75+,Female,Corpus uteri,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,6.7,moderate_burden
KE-NRB-2014-04576,2014,92,75+,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,34.0,moderate_burden
KE-NRB-2010-04577,2010,93,75+,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,14.2,moderate_burden
KE-NRB-2016-04578,2016,63,55-64,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04579,2015,42,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04580,2018,73,65-74,Male,Oesophagus,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Lost to follow-up,56.9,moderate_burden
KE-NRB-2014-04581,2014,68,65-74,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.4,moderate_burden
KE-NRB-2011-04582,2011,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-04583,2014,63,55-64,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,30.7,moderate_burden
KE-NRB-2014-04584,2014,95,75+,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04585,2018,61,55-64,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,20.6,moderate_burden
KE-NRB-2016-04586,2016,58,55-64,Female,Thyroid,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,12.7,moderate_burden
KE-NRB-2017-04587,2017,19,15-24,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,28.1,moderate_burden
KE-NRB-2011-04588,2011,95,75+,Male,Stomach,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,54.8,moderate_burden
KE-NRB-2018-04589,2018,76,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,15.3,moderate_burden
KE-NRB-2014-04590,2014,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,10.0,moderate_burden
KE-NRB-2015-04591,2015,58,55-64,Male,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,7.3,moderate_burden
KE-NRB-2013-04592,2013,47,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,14.9,moderate_burden
KE-NRB-2016-04593,2016,55,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,43.6,moderate_burden
KE-NRB-2018-04594,2018,52,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,24.2,moderate_burden
KE-NRB-2010-04595,2010,70,65-74,Female,Cervix uteri,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,20.7,moderate_burden
KE-NRB-2012-04596,2012,56,55-64,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.8,moderate_burden
KE-NRB-2014-04597,2014,66,65-74,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Other,Malignant,Peri-urban,Surgery only,Dead,34.7,moderate_burden
KE-NRB-2011-04598,2011,35,35-44,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,10.5,moderate_burden
KE-NRB-2009-04599,2009,68,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,26.3,moderate_burden
KE-NRB-2017-04600,2017,30,25-34,Female,Thyroid,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,42.0,moderate_burden
KE-NRB-2013-04601,2013,39,35-44,Male,Oesophagus,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-04602,2012,49,45-54,Female,Ovary,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04603,2016,36,35-44,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,57.8,moderate_burden
KE-NRB-2010-04604,2010,43,35-44,Female,Other,Non-keratinizing carcinoma,Well differentiated (Grade I),Other,Malignant,Urban,Surgery + Chemotherapy,Dead,2.6,moderate_burden
KE-NRB-2014-04605,2014,54,45-54,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,23.4,moderate_burden
KE-NRB-2014-04606,2014,82,75+,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,34.5,moderate_burden
KE-NRB-2011-04607,2011,47,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,39.9,moderate_burden
KE-NRB-2012-04608,2012,54,45-54,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.3,moderate_burden
KE-NRB-2017-04609,2017,74,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,4.7,moderate_burden
KE-NRB-2018-04610,2018,54,45-54,Female,Corpus uteri,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,6.9,moderate_burden
KE-NRB-2011-04611,2011,64,55-64,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,4.4,moderate_burden
KE-NRB-2018-04612,2018,55,55-64,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2016-04613,2016,25,25-34,Female,Cervix uteri,Leukemia,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Surgery only,Alive,15.0,moderate_burden
KE-NRB-2014-04614,2014,40,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,42.3,moderate_burden
KE-NRB-2011-04615,2011,34,25-34,Female,Other,Leukemia,Well differentiated (Grade I),Other,Malignant,Peri-urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2009-04616,2009,61,55-64,Male,Prostate,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,19.3,moderate_burden
KE-NRB-2012-04617,2012,38,35-44,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,17.3,moderate_burden
KE-NRB-2011-04618,2011,72,65-74,Male,Prostate,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,0.9,moderate_burden
KE-NRB-2009-04619,2009,74,65-74,Male,Brain and CNS,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,4.1,moderate_burden
KE-NRB-2012-04620,2012,41,35-44,Male,Kaposi sarcoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,51.6,moderate_burden
KE-NRB-2018-04621,2018,72,65-74,Female,Cervix uteri,Other specified,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.4,moderate_burden
KE-NRB-2015-04622,2015,52,45-54,Female,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,17.1,moderate_burden
KE-NRB-2011-04623,2011,48,45-54,Male,Prostate,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,45.5,moderate_burden
KE-NRB-2013-04624,2013,58,55-64,Male,Hodgkin lymphoma,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,38.4,moderate_burden
KE-NRB-2017-04625,2017,57,55-64,Male,Leukemia,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-04626,2013,62,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Palliative care only,Alive,32.6,moderate_burden
KE-NRB-2015-04627,2015,48,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04628,2015,53,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,16.2,moderate_burden
KE-NRB-2018-04629,2018,25,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.9,moderate_burden
KE-NRB-2011-04630,2011,46,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Dead,9.2,moderate_burden
KE-NRB-2013-04631,2013,18,15-24,Male,Leukemia,Other specified,Well differentiated (Grade I),Clinical only,Benign/uncertain,Urban,N/A,Alive,18.4,moderate_burden
KE-NRB-2016-04632,2016,61,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,22.1,moderate_burden
KE-NRB-2018-04633,2018,48,45-54,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Alive,36.0,moderate_burden
KE-NRB-2016-04634,2016,70,65-74,Male,Colorectum,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,12.5,moderate_burden
KE-NRB-2016-04635,2016,64,55-64,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,18.2,moderate_burden
KE-NRB-2018-04636,2018,57,55-64,Male,Multiple myeloma,Unspecified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,19.4,moderate_burden
KE-NRB-2015-04637,2015,36,35-44,Female,Breast,Other specified,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,27.0,moderate_burden
KE-NRB-2013-04638,2013,39,35-44,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Urban,N/A,Dead,51.2,moderate_burden
KE-NRB-2011-04639,2011,72,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,9.9,moderate_burden
KE-NRB-2014-04640,2014,72,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,40.4,moderate_burden
KE-NRB-2015-04641,2015,91,75+,Male,Leukemia,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,1.8,moderate_burden
KE-NRB-2013-04642,2013,20,15-24,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,1.2,moderate_burden
KE-NRB-2016-04643,2016,60,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.2,moderate_burden
KE-NRB-2009-04644,2009,13,0-14,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,16.4,moderate_burden
KE-NRB-2011-04645,2011,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.3,moderate_burden
KE-NRB-2016-04646,2016,69,65-74,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04647,2016,42,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04648,2018,43,35-44,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,16.5,moderate_burden
KE-NRB-2015-04649,2015,50,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2013-04650,2013,33,25-34,Female,Thyroid,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,47.4,moderate_burden
KE-NRB-2017-04651,2017,51,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,28.9,moderate_burden
KE-NRB-2016-04652,2016,53,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,18.5,moderate_burden
KE-NRB-2018-04653,2018,43,35-44,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-04654,2012,73,65-74,Female,Breast,Lymphoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Chemotherapy only,Alive,15.9,moderate_burden
KE-NRB-2014-04655,2014,89,75+,Male,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,0.3,moderate_burden
KE-NRB-2017-04656,2017,43,35-44,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,39.0,moderate_burden
KE-NRB-2015-04657,2015,70,65-74,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,In situ,Urban,N/A,Alive,51.3,moderate_burden
KE-NRB-2011-04658,2011,37,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Benign/uncertain,Peri-urban,N/A,Alive,18.3,moderate_burden
KE-NRB-2013-04659,2013,33,25-34,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Chemo + Radiotherapy,Alive,8.3,moderate_burden
KE-NRB-2009-04660,2009,42,35-44,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.8,moderate_burden
KE-NRB-2016-04661,2016,40,35-44,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,7.8,moderate_burden
KE-NRB-2018-04662,2018,49,45-54,Male,Prostate,Leukemia,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Chemo + Radiotherapy,Alive,57.0,moderate_burden
KE-NRB-2015-04663,2015,61,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04664,2015,61,55-64,Male,Colorectum,Unspecified,Undifferentiated (Grade IV),Clinical only,In situ,Urban,N/A,Dead,4.2,moderate_burden
KE-NRB-2010-04665,2010,48,45-54,Female,Corpus uteri,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,26.5,moderate_burden
KE-NRB-2013-04666,2013,24,15-24,Male,Leukemia,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,4.0,moderate_burden
KE-NRB-2017-04667,2017,64,55-64,Female,Cervix uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Lost to follow-up,38.0,moderate_burden
KE-NRB-2013-04668,2013,73,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,12.6,moderate_burden
KE-NRB-2017-04669,2017,74,65-74,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,57.9,moderate_burden
KE-NRB-2016-04670,2016,73,65-74,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,No treatment,Dead,8.8,moderate_burden
KE-NRB-2014-04671,2014,33,25-34,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,21.7,moderate_burden
KE-NRB-2016-04672,2016,52,45-54,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,56.7,moderate_burden
KE-NRB-2014-04673,2014,59,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.1,moderate_burden
KE-NRB-2017-04674,2017,25,25-34,Female,Other,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,12.3,moderate_burden
KE-NRB-2013-04675,2013,59,55-64,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2010-04676,2010,43,35-44,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04677,2016,63,55-64,Male,Stomach,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.4,moderate_burden
KE-NRB-2015-04678,2015,63,55-64,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04679,2017,31,25-34,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,0.6,moderate_burden
KE-NRB-2017-04680,2017,24,15-24,Male,Colorectum,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,2.2,moderate_burden
KE-NRB-2016-04681,2016,55,55-64,Female,Other,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Radiotherapy,Dead,9.3,moderate_burden
KE-NRB-2016-04682,2016,68,65-74,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2013-04683,2013,66,65-74,Female,Cervix uteri,Sarcoma,Undifferentiated (Grade IV),Clinical only,In situ,Peri-urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2012-04684,2012,61,55-64,Female,Ovary,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Other,Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-04685,2018,52,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-04686,2018,35,35-44,Female,Breast,Leukemia,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Dead,35.3,moderate_burden
KE-NRB-2012-04687,2012,68,65-74,Female,Breast,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,22.4,moderate_burden
KE-NRB-2017-04688,2017,50,45-54,Male,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,41.3,moderate_burden
KE-NRB-2017-04689,2017,39,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,2.7,moderate_burden
KE-NRB-2010-04690,2010,51,45-54,Male,Colorectum,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,0.3,moderate_burden
KE-NRB-2009-04691,2009,35,35-44,Male,Pancreas,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.6,moderate_burden
KE-NRB-2013-04692,2013,45,45-54,Female,Ovary,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Alive,38.4,moderate_burden
KE-NRB-2012-04693,2012,89,75+,Male,Leukemia,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Palliative care only,Alive,4.5,moderate_burden
KE-NRB-2013-04694,2013,54,45-54,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,48.9,moderate_burden
KE-NRB-2012-04695,2012,49,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery only,Dead,12.7,moderate_burden
KE-NRB-2010-04696,2010,59,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,27.4,moderate_burden
KE-NRB-2010-04697,2010,70,65-74,Female,Thyroid,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,14.8,moderate_burden
KE-NRB-2017-04698,2017,48,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04699,2015,44,35-44,Female,Other,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,17.7,moderate_burden
KE-NRB-2016-04700,2016,29,25-34,Female,Cervix uteri,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,25.2,moderate_burden
KE-NRB-2011-04701,2011,58,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-04702,2012,69,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,35.2,moderate_burden
KE-NRB-2015-04703,2015,44,35-44,Male,Other,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,49.3,moderate_burden
KE-NRB-2013-04704,2013,60,55-64,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-04705,2013,49,45-54,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-04706,2011,46,45-54,Female,Corpus uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,34.0,moderate_burden
KE-NRB-2013-04707,2013,64,55-64,Male,Kaposi sarcoma,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,5.5,moderate_burden
KE-NRB-2009-04708,2009,31,25-34,Male,Other,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2014-04709,2014,68,65-74,Male,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,8.1,moderate_burden
KE-NRB-2010-04710,2010,49,45-54,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-04711,2016,68,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,5.2,moderate_burden
KE-NRB-2018-04712,2018,32,25-34,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Rural,N/A,Dead,15.0,moderate_burden
KE-NRB-2017-04713,2017,60,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2016-04714,2016,90,75+,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,2.9,moderate_burden
KE-NRB-2018-04715,2018,49,45-54,Male,Colorectum,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,5.3,moderate_burden
KE-NRB-2018-04716,2018,51,45-54,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,14.5,moderate_burden
KE-NRB-2017-04717,2017,70,65-74,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,32.7,moderate_burden
KE-NRB-2012-04718,2012,60,55-64,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Other,In situ,Urban,N/A,Alive,25.8,moderate_burden
KE-NRB-2012-04719,2012,35,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,24.7,moderate_burden
KE-NRB-2016-04720,2016,55,55-64,Male,Lung,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,9.4,moderate_burden
KE-NRB-2015-04721,2015,48,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,57.4,moderate_burden
KE-NRB-2016-04722,2016,59,55-64,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,In situ,Rural,N/A,Dead,48.2,moderate_burden
KE-NRB-2018-04723,2018,56,55-64,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,5.2,moderate_burden
KE-NRB-2015-04724,2015,74,65-74,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Chemotherapy only,Dead,5.6,moderate_burden
KE-NRB-2015-04725,2015,69,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,13.7,moderate_burden
KE-NRB-2015-04726,2015,48,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Radiotherapy only,Dead,0.2,moderate_burden
KE-NRB-2013-04727,2013,66,65-74,Female,Other,Non-keratinizing carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,9.6,moderate_burden
KE-NRB-2015-04728,2015,72,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,4.6,moderate_burden
KE-NRB-2014-04729,2014,34,25-34,Female,Corpus uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,7.2,moderate_burden
KE-NRB-2013-04730,2013,71,65-74,Male,Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,53.4,moderate_burden
KE-NRB-2016-04731,2016,45,45-54,Male,Other,Other specified,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery only,Alive,54.1,moderate_burden
KE-NRB-2015-04732,2015,56,55-64,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,10.6,moderate_burden
KE-NRB-2015-04733,2015,64,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,59.8,moderate_burden
KE-NRB-2010-04734,2010,59,55-64,Male,Oesophagus,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,0.2,moderate_burden
KE-NRB-2017-04735,2017,67,65-74,Male,Brain and CNS,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,49.9,moderate_burden
KE-NRB-2011-04736,2011,73,65-74,Female,Other,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,19.2,moderate_burden
KE-NRB-2018-04737,2018,44,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,13.9,moderate_burden
KE-NRB-2018-04738,2018,89,75+,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,60.0,moderate_burden
KE-NRB-2015-04739,2015,57,55-64,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-04740,2013,45,45-54,Male,Colorectum,Lymphoma,Well differentiated (Grade I),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,7.7,moderate_burden
KE-NRB-2010-04741,2010,56,55-64,Female,Corpus uteri,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,17.4,moderate_burden
KE-NRB-2016-04742,2016,69,65-74,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Dead,23.4,moderate_burden
KE-NRB-2018-04743,2018,44,35-44,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.2,moderate_burden
KE-NRB-2010-04744,2010,25,25-34,Male,Prostate,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,8.8,moderate_burden
KE-NRB-2009-04745,2009,41,35-44,Male,Brain and CNS,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Radiotherapy only,Alive,38.2,moderate_burden
KE-NRB-2018-04746,2018,63,55-64,Male,Liver,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2014-04747,2014,92,75+,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-04748,2014,57,55-64,Female,Ovary,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,30.1,moderate_burden
KE-NRB-2009-04749,2009,43,35-44,Male,Oesophagus,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,47.1,moderate_burden
KE-NRB-2015-04750,2015,79,75+,Male,Colorectum,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.4,moderate_burden
KE-NRB-2009-04751,2009,64,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,0.5,moderate_burden
KE-NRB-2018-04752,2018,66,65-74,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-04753,2009,50,45-54,Male,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,39.1,moderate_burden
KE-NRB-2013-04754,2013,9,0-14,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,6.6,moderate_burden
KE-NRB-2017-04755,2017,49,45-54,Female,Other,Sarcoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Dead,4.0,moderate_burden
KE-NRB-2014-04756,2014,55,55-64,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,40.1,moderate_burden
KE-NRB-2018-04757,2018,61,55-64,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,11.1,moderate_burden
KE-NRB-2015-04758,2015,52,45-54,Female,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Dead,33.7,moderate_burden
KE-NRB-2013-04759,2013,68,65-74,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Dead,51.5,moderate_burden
KE-NRB-2017-04760,2017,60,55-64,Male,Prostate,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,22.4,moderate_burden
KE-NRB-2012-04761,2012,59,55-64,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,10.9,moderate_burden
KE-NRB-2009-04762,2009,59,55-64,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,42.7,moderate_burden
KE-NRB-2012-04763,2012,70,65-74,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Dead,32.3,moderate_burden
KE-NRB-2012-04764,2012,43,35-44,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Benign/uncertain,Urban,N/A,Dead,25.4,moderate_burden
KE-NRB-2010-04765,2010,80,75+,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,9.2,moderate_burden
KE-NRB-2018-04766,2018,65,65-74,Female,Ovary,Sarcoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,8.7,moderate_burden
KE-NRB-2009-04767,2009,59,55-64,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.4,moderate_burden
KE-NRB-2016-04768,2016,46,45-54,Female,Other,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-04769,2017,73,65-74,Male,Other,Other specified,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,44.6,moderate_burden
KE-NRB-2015-04770,2015,57,55-64,Female,Breast,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,9.9,moderate_burden
KE-NRB-2018-04771,2018,42,35-44,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2011-04772,2011,52,45-54,Male,Colorectum,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,55.6,moderate_burden
KE-NRB-2018-04773,2018,33,25-34,Male,Stomach,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,6.7,moderate_burden
KE-NRB-2016-04774,2016,38,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,26.1,moderate_burden
KE-NRB-2012-04775,2012,59,55-64,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Alive,14.2,moderate_burden
KE-NRB-2018-04776,2018,42,35-44,Female,Other,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Lost to follow-up,14.6,moderate_burden
KE-NRB-2013-04777,2013,61,55-64,Male,Oesophagus,Squamous cell carcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,43.9,moderate_burden
KE-NRB-2014-04778,2014,39,35-44,Male,Kidney,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Dead,46.8,moderate_burden
KE-NRB-2017-04779,2017,83,75+,Male,Multiple myeloma,Adenocarcinoma,Unknown,Microscopy (histology/cytology),In situ,Urban,N/A,Alive,43.4,moderate_burden
KE-NRB-2013-04780,2013,62,55-64,Female,Cervix uteri,Sarcoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,23.7,moderate_burden
KE-NRB-2009-04781,2009,51,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,38.7,moderate_burden
KE-NRB-2013-04782,2013,56,55-64,Male,Non-Hodgkin lymphoma,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,43.1,moderate_burden
KE-NRB-2017-04783,2017,57,55-64,Male,Pancreas,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2013-04784,2013,73,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04785,2016,63,55-64,Female,Cervix uteri,Lymphoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,16.2,moderate_burden
KE-NRB-2011-04786,2011,85,75+,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,17.2,moderate_burden
KE-NRB-2017-04787,2017,35,35-44,Male,Colorectum,Adenocarcinoma,Unknown,Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,35.9,moderate_burden
KE-NRB-2018-04788,2018,50,45-54,Female,Breast,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,49.7,moderate_burden
KE-NRB-2012-04789,2012,71,65-74,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Rural,Surgery only,Dead,11.5,moderate_burden
KE-NRB-2011-04790,2011,75,75+,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,58.4,moderate_burden
KE-NRB-2014-04791,2014,69,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,12.0,moderate_burden
KE-NRB-2017-04792,2017,44,35-44,Male,Oesophagus,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,41.2,moderate_burden
KE-NRB-2011-04793,2011,61,55-64,Male,Liver,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,4.7,moderate_burden
KE-NRB-2017-04794,2017,52,45-54,Male,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,9.9,moderate_burden
KE-NRB-2014-04795,2014,70,65-74,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-04796,2018,33,25-34,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,13.0,moderate_burden
KE-NRB-2011-04797,2011,75,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,2.8,moderate_burden
KE-NRB-2015-04798,2015,59,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,9.1,moderate_burden
KE-NRB-2014-04799,2014,45,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2016-04800,2016,57,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,12.7,moderate_burden
KE-NRB-2018-04801,2018,61,55-64,Male,Other,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2012-04802,2012,62,55-64,Male,Leukemia,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,60.0,moderate_burden
KE-NRB-2014-04803,2014,45,45-54,Female,Other,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,46.5,moderate_burden
KE-NRB-2017-04804,2017,64,55-64,Male,Lung,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Dead,7.2,moderate_burden
KE-NRB-2009-04805,2009,36,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.5,moderate_burden
KE-NRB-2018-04806,2018,37,35-44,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Chemotherapy only,Lost to follow-up,11.4,moderate_burden
KE-NRB-2014-04807,2014,25,25-34,Female,Ovary,Lymphoma,Unknown,Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2013-04808,2013,27,25-34,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Palliative care only,Dead,10.3,moderate_burden
KE-NRB-2013-04809,2013,41,35-44,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,13.3,moderate_burden
KE-NRB-2018-04810,2018,65,65-74,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,46.2,moderate_burden
KE-NRB-2009-04811,2009,73,65-74,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Dead,2.6,moderate_burden
KE-NRB-2013-04812,2013,50,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,35.6,moderate_burden
KE-NRB-2016-04813,2016,59,55-64,Male,Multiple myeloma,Squamous cell carcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Surgery only,Lost to follow-up,46.0,moderate_burden
KE-NRB-2015-04814,2015,68,65-74,Male,Lung,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.8,moderate_burden
KE-NRB-2009-04815,2009,49,45-54,Male,Kaposi sarcoma,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,9.8,moderate_burden
KE-NRB-2018-04816,2018,42,35-44,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Rural,Chemotherapy only,Dead,50.2,moderate_burden
KE-NRB-2017-04817,2017,46,45-54,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,23.4,moderate_burden
KE-NRB-2018-04818,2018,36,35-44,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,47.0,moderate_burden
KE-NRB-2018-04819,2018,53,45-54,Male,Stomach,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,12.4,moderate_burden
KE-NRB-2011-04820,2011,37,35-44,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,41.7,moderate_burden
KE-NRB-2009-04821,2009,48,45-54,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Alive,37.9,moderate_burden
KE-NRB-2010-04822,2010,56,55-64,Male,Leukemia,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,19.3,moderate_burden
KE-NRB-2015-04823,2015,28,25-34,Male,Other,Other specified,Unknown,Imaging + clinical,In situ,Urban,N/A,Dead,12.5,moderate_burden
KE-NRB-2013-04824,2013,26,25-34,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,0.1,moderate_burden
KE-NRB-2013-04825,2013,73,65-74,Female,Thyroid,Sarcoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04826,2015,40,35-44,Female,Cervix uteri,Leukemia,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.1,moderate_burden
KE-NRB-2011-04827,2011,38,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04828,2015,62,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,0.4,moderate_burden
KE-NRB-2013-04829,2013,26,25-34,Female,Cervix uteri,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2016-04830,2016,54,45-54,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.7,moderate_burden
KE-NRB-2015-04831,2015,44,35-44,Male,Prostate,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Dead,11.3,moderate_burden
KE-NRB-2012-04832,2012,65,65-74,Male,Oesophagus,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,37.3,moderate_burden
KE-NRB-2013-04833,2013,73,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Chemotherapy only,Dead,14.0,moderate_burden
KE-NRB-2016-04834,2016,41,35-44,Male,Kaposi sarcoma,Lymphoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,26.7,moderate_burden
KE-NRB-2011-04835,2011,57,55-64,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-04836,2015,52,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,3.0,moderate_burden
KE-NRB-2016-04837,2016,44,35-44,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2009-04838,2009,55,55-64,Male,Oesophagus,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Surgery + Chemotherapy,Dead,24.1,moderate_burden
KE-NRB-2013-04839,2013,51,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Lost to follow-up,15.3,moderate_burden
KE-NRB-2014-04840,2014,53,45-54,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Alive,54.8,moderate_burden
KE-NRB-2014-04841,2014,32,25-34,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,37.6,moderate_burden
KE-NRB-2014-04842,2014,54,45-54,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,0.6,moderate_burden
KE-NRB-2009-04843,2009,63,55-64,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Peri-urban,Surgery + Radiotherapy,Dead,22.3,moderate_burden
KE-NRB-2013-04844,2013,57,55-64,Female,Breast,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,No treatment,Lost to follow-up,14.7,moderate_burden
KE-NRB-2015-04845,2015,25,25-34,Female,Thyroid,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-04846,2018,57,55-64,Male,Other,Squamous cell carcinoma,Unknown,Clinical only,Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04847,2015,50,45-54,Male,Liver,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,19.0,moderate_burden
KE-NRB-2014-04848,2014,37,35-44,Male,Prostate,Adenocarcinoma,Moderately differentiated (Grade II),Other,Malignant,Urban,Surgery only,Lost to follow-up,8.7,moderate_burden
KE-NRB-2018-04849,2018,53,45-54,Female,Cervix uteri,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,No treatment,Alive,26.2,moderate_burden
KE-NRB-2015-04850,2015,68,65-74,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,44.0,moderate_burden
KE-NRB-2014-04851,2014,71,65-74,Male,Stomach,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Clinical only,Malignant,Rural,Surgery only,Lost to follow-up,4.0,moderate_burden
KE-NRB-2017-04852,2017,68,65-74,Male,Stomach,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,1.7,moderate_burden
KE-NRB-2017-04853,2017,53,45-54,Female,Corpus uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,2.6,moderate_burden
KE-NRB-2015-04854,2015,55,55-64,Female,Other,Adenocarcinoma,Unknown,Clinical only,Malignant,Urban,Radiotherapy only,Dead,1.9,moderate_burden
KE-NRB-2018-04855,2018,48,45-54,Male,Oesophagus,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,35.5,moderate_burden
KE-NRB-2018-04856,2018,60,55-64,Male,Prostate,Unspecified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemo + Radiotherapy,Dead,29.0,moderate_burden
KE-NRB-2011-04857,2011,59,55-64,Male,Stomach,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Benign/uncertain,Rural,N/A,Dead,20.7,moderate_burden
KE-NRB-2017-04858,2017,25,25-34,Male,Non-Hodgkin lymphoma,Adenocarcinoma,Unknown,Other,Malignant,Urban,Chemo + Radiotherapy,Alive,4.1,moderate_burden
KE-NRB-2016-04859,2016,61,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,21.9,moderate_burden
KE-NRB-2018-04860,2018,91,75+,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Surgery + Radiotherapy,Alive,5.5,moderate_burden
KE-NRB-2014-04861,2014,67,65-74,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Death certificate only,Malignant,Urban,Surgery only,Dead,9.6,moderate_burden
KE-NRB-2014-04862,2014,54,45-54,Female,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Alive,38.9,moderate_burden
KE-NRB-2014-04863,2014,30,25-34,Female,Breast,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.4,moderate_burden
KE-NRB-2016-04864,2016,57,55-64,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2014-04865,2014,57,55-64,Male,Colorectum,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,28.6,moderate_burden
KE-NRB-2015-04866,2015,53,45-54,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,20.1,moderate_burden
KE-NRB-2017-04867,2017,34,25-34,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Lost to follow-up,1.3,moderate_burden
KE-NRB-2014-04868,2014,61,55-64,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,4.5,moderate_burden
KE-NRB-2017-04869,2017,48,45-54,Male,Colorectum,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Alive,4.8,moderate_burden
KE-NRB-2013-04870,2013,65,65-74,Male,Liver,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Rural,Radiotherapy only,Dead,2.8,moderate_burden
KE-NRB-2016-04871,2016,46,45-54,Female,Other,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,25.7,moderate_burden
KE-NRB-2011-04872,2011,42,35-44,Female,Other,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,8.8,moderate_burden
KE-NRB-2009-04873,2009,71,65-74,Male,Prostate,Sarcoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Dead,32.8,moderate_burden
KE-NRB-2009-04874,2009,40,35-44,Male,Leukemia,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,59.3,moderate_burden
KE-NRB-2017-04875,2017,46,45-54,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2017-04876,2017,61,55-64,Female,Other,Other specified,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery only,Alive,55.7,moderate_burden
KE-NRB-2018-04877,2018,41,35-44,Male,Lung,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,38.8,moderate_burden
KE-NRB-2018-04878,2018,7,0-14,Male,Non-Hodgkin lymphoma,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Dead,16.8,moderate_burden
KE-NRB-2012-04879,2012,55,55-64,Female,Corpus uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Dead,1.6,moderate_burden
KE-NRB-2015-04880,2015,92,75+,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2012-04881,2012,55,55-64,Female,Cervix uteri,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Dead,2.8,moderate_burden
KE-NRB-2017-04882,2017,90,75+,Female,Cervix uteri,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2009-04883,2009,57,55-64,Male,Colorectum,Leukemia,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,15.6,moderate_burden
KE-NRB-2015-04884,2015,31,25-34,Male,Kidney,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,11.5,moderate_burden
KE-NRB-2018-04885,2018,65,65-74,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,52.8,moderate_burden
KE-NRB-2018-04886,2018,94,75+,Male,Non-Hodgkin lymphoma,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Clinical only,In situ,Rural,N/A,Dead,6.6,moderate_burden
KE-NRB-2016-04887,2016,59,55-64,Male,Other,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,33.0,moderate_burden
KE-NRB-2014-04888,2014,79,75+,Male,Lung,Other specified,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2011-04889,2011,4,0-14,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2010-04890,2010,56,55-64,Female,Corpus uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Alive,16.2,moderate_burden
KE-NRB-2010-04891,2010,40,35-44,Male,Kaposi sarcoma,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,20.6,moderate_burden
KE-NRB-2018-04892,2018,25,25-34,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,28.2,moderate_burden
KE-NRB-2012-04893,2012,48,45-54,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Radiotherapy only,Dead,4.0,moderate_burden
KE-NRB-2015-04894,2015,48,45-54,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Peri-urban,N/A,Alive,43.8,moderate_burden
KE-NRB-2016-04895,2016,50,45-54,Male,Bladder,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),In situ,Urban,N/A,Lost to follow-up,56.1,moderate_burden
KE-NRB-2018-04896,2018,42,35-44,Male,Non-Hodgkin lymphoma,Sarcoma,Unknown,Imaging + clinical,Malignant,Peri-urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-04897,2013,43,35-44,Female,Breast,Other specified,Unknown,Microscopy (histology/cytology),Benign/uncertain,Peri-urban,N/A,Alive,13.8,moderate_burden
KE-NRB-2011-04898,2011,27,25-34,Male,Colorectum,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Dead,5.4,moderate_burden
KE-NRB-2010-04899,2010,27,25-34,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Rural,No treatment,Dead,54.5,moderate_burden
KE-NRB-2014-04900,2014,15,15-24,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,19.9,moderate_burden
KE-NRB-2018-04901,2018,55,55-64,Female,Breast,Leukemia,Undifferentiated (Grade IV),Clinical only,Malignant,Urban,Chemotherapy only,Dead,23.8,moderate_burden
KE-NRB-2017-04902,2017,39,35-44,Male,Bladder,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,15.3,moderate_burden
KE-NRB-2013-04903,2013,59,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemo + Radiotherapy,Dead,10.8,moderate_burden
KE-NRB-2017-04904,2017,7,0-14,Female,Corpus uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,56.8,moderate_burden
KE-NRB-2010-04905,2010,43,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Death certificate only,Malignant,Urban,Surgery only,Alive,9.7,moderate_burden
KE-NRB-2009-04906,2009,53,45-54,Female,Breast,Non-keratinizing carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,50.0,moderate_burden
KE-NRB-2018-04907,2018,58,55-64,Female,Ovary,Other specified,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2014-04908,2014,68,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Alive,18.6,moderate_burden
KE-NRB-2010-04909,2010,60,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,1.8,moderate_burden
KE-NRB-2017-04910,2017,58,55-64,Female,Breast,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Dead,18.2,moderate_burden
KE-NRB-2011-04911,2011,71,65-74,Female,Other,Lymphoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Rural,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2016-04912,2016,55,55-64,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2018-04913,2018,62,55-64,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2018-04914,2018,55,55-64,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.7,moderate_burden
KE-NRB-2010-04915,2010,44,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery only,Lost to follow-up,40.3,moderate_burden
KE-NRB-2010-04916,2010,29,25-34,Female,Other,Leukemia,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2013-04917,2013,77,75+,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,7.6,moderate_burden
KE-NRB-2015-04918,2015,62,55-64,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,29.0,moderate_burden
KE-NRB-2018-04919,2018,48,45-54,Male,Colorectum,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04920,2015,71,65-74,Female,Cervix uteri,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04921,2018,56,55-64,Male,Colorectum,Sarcoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,33.8,moderate_burden
KE-NRB-2010-04922,2010,6,0-14,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,6.1,moderate_burden
KE-NRB-2014-04923,2014,65,65-74,Male,Prostate,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2013-04924,2013,95,75+,Male,Oesophagus,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Palliative care only,Dead,0.3,moderate_burden
KE-NRB-2013-04925,2013,42,35-44,Female,Ovary,Squamous cell carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery + Radiotherapy,Alive,9.1,moderate_burden
KE-NRB-2014-04926,2014,31,25-34,Female,Cervix uteri,Other specified,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,0.6,moderate_burden
KE-NRB-2015-04927,2015,69,65-74,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Lost to follow-up,42.9,moderate_burden
KE-NRB-2015-04928,2015,61,55-64,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Radiotherapy,Dead,1.9,moderate_burden
KE-NRB-2014-04929,2014,71,65-74,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,In situ,Urban,N/A,Alive,60.0,moderate_burden
KE-NRB-2012-04930,2012,56,55-64,Female,Thyroid,Sarcoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Dead,1.6,moderate_burden
KE-NRB-2015-04931,2015,71,65-74,Male,Oesophagus,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,41.0,moderate_burden
KE-NRB-2018-04932,2018,61,55-64,Female,Breast,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Rural,N/A,Dead,60.0,moderate_burden
KE-NRB-2016-04933,2016,58,55-64,Male,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Dead,27.4,moderate_burden
KE-NRB-2017-04934,2017,48,45-54,Male,Prostate,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,20.6,moderate_burden
KE-NRB-2015-04935,2015,41,35-44,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,Malignant,Urban,Radiotherapy only,Alive,21.6,moderate_burden
KE-NRB-2014-04936,2014,47,45-54,Female,Cervix uteri,Adenocarcinoma,Unknown,Death certificate only,In situ,Urban,N/A,Dead,1.7,moderate_burden
KE-NRB-2016-04937,2016,82,75+,Female,Cervix uteri,Adenocarcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Chemotherapy only,Alive,60.0,moderate_burden
KE-NRB-2012-04938,2012,64,55-64,Female,Breast,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,8.0,moderate_burden
KE-NRB-2013-04939,2013,44,35-44,Male,Prostate,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,5.8,moderate_burden
KE-NRB-2014-04940,2014,28,25-34,Female,Cervix uteri,Non-keratinizing carcinoma,Unknown,Clinical only,Malignant,Rural,No treatment,Dead,7.5,moderate_burden
KE-NRB-2010-04941,2010,32,25-34,Female,Thyroid,Lymphoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2015-04942,2015,89,75+,Female,Thyroid,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2016-04943,2016,43,35-44,Female,Cervix uteri,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,1.1,moderate_burden
KE-NRB-2013-04944,2013,94,75+,Female,Thyroid,Squamous cell carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-04945,2012,71,65-74,Female,Ovary,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2018-04946,2018,65,65-74,Male,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Rural,Radiotherapy only,Dead,3.7,moderate_burden
KE-NRB-2018-04947,2018,61,55-64,Female,Other,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,59.6,moderate_burden
KE-NRB-2018-04948,2018,54,45-54,Female,Other,Leukemia,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Dead,60.0,moderate_burden
KE-NRB-2013-04949,2013,33,25-34,Male,Leukemia,Leukemia,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Lost to follow-up,11.4,moderate_burden
KE-NRB-2015-04950,2015,55,55-64,Female,Cervix uteri,Adenocarcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,17.0,moderate_burden
KE-NRB-2010-04951,2010,66,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Urban,Palliative care only,Alive,60.0,moderate_burden
KE-NRB-2018-04952,2018,74,65-74,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Rural,Surgery only,Alive,11.6,moderate_burden
KE-NRB-2017-04953,2017,55,55-64,Male,Brain and CNS,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,23.8,moderate_burden
KE-NRB-2017-04954,2017,41,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Urban,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2015-04955,2015,45,45-54,Female,Ovary,Adenocarcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,4.5,moderate_burden
KE-NRB-2014-04956,2014,50,45-54,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Benign/uncertain,Urban,N/A,Alive,12.6,moderate_burden
KE-NRB-2015-04957,2015,53,45-54,Female,Other,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemo + Radiotherapy,Dead,6.0,moderate_burden
KE-NRB-2018-04958,2018,87,75+,Female,Other,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Radiotherapy only,Alive,9.1,moderate_burden
KE-NRB-2017-04959,2017,59,55-64,Female,Breast,Lymphoma,Poorly differentiated (Grade III),Imaging + clinical,Malignant,Peri-urban,Chemo + Radiotherapy,Dead,4.2,moderate_burden
KE-NRB-2016-04960,2016,48,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,60.0,moderate_burden
KE-NRB-2014-04961,2014,60,55-64,Female,Cervix uteri,Lymphoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Peri-urban,Surgery + Chemotherapy,Alive,60.0,moderate_burden
KE-NRB-2012-04962,2012,48,45-54,Female,Corpus uteri,Adenocarcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,56.3,moderate_burden
KE-NRB-2016-04963,2016,44,35-44,Female,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,42.7,moderate_burden
KE-NRB-2011-04964,2011,29,25-34,Male,Leukemia,Leukemia,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery + Chemotherapy,Dead,25.6,moderate_burden
KE-NRB-2010-04965,2010,80,75+,Female,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,2.7,moderate_burden
KE-NRB-2018-04966,2018,59,55-64,Female,Cervix uteri,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,15.0,moderate_burden
KE-NRB-2016-04967,2016,57,55-64,Female,Breast,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,13.6,moderate_burden
KE-NRB-2010-04968,2010,52,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,0.0,moderate_burden
KE-NRB-2015-04969,2015,67,65-74,Male,Other,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Surgery only,Alive,16.6,moderate_burden
KE-NRB-2017-04970,2017,53,45-54,Female,Other,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,2.5,moderate_burden
KE-NRB-2017-04971,2017,33,25-34,Female,Breast,Non-keratinizing carcinoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery only,Alive,10.6,moderate_burden
KE-NRB-2015-04972,2015,20,15-24,Female,Breast,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,43.6,moderate_burden
KE-NRB-2018-04973,2018,43,35-44,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Palliative care only,Alive,21.7,moderate_burden
KE-NRB-2017-04974,2017,95,75+,Female,Breast,Squamous cell carcinoma,Unknown,Imaging + clinical,Malignant,Urban,Surgery only,Dead,4.2,moderate_burden
KE-NRB-2016-04975,2016,85,75+,Male,Other,Lymphoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2015-04976,2015,68,65-74,Female,Ovary,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Benign/uncertain,Urban,N/A,Alive,18.4,moderate_burden
KE-NRB-2016-04977,2016,25,25-34,Male,Other,Non-keratinizing carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,46.0,moderate_burden
KE-NRB-2011-04978,2011,29,25-34,Female,Cervix uteri,Adenocarcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Peri-urban,Chemo + Radiotherapy,Dead,6.5,moderate_burden
KE-NRB-2011-04979,2011,38,35-44,Male,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Rural,Surgery only,Alive,60.0,moderate_burden
KE-NRB-2013-04980,2013,64,55-64,Male,Other,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,27.0,moderate_burden
KE-NRB-2017-04981,2017,40,35-44,Female,Breast,Adenocarcinoma,Undifferentiated (Grade IV),Death certificate only,Malignant,Urban,Chemotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2010-04982,2010,47,45-54,Female,Breast,Adenocarcinoma,Moderately differentiated (Grade II),Death certificate only,Malignant,Urban,Chemotherapy only,Alive,37.8,moderate_burden
KE-NRB-2009-04983,2009,58,55-64,Male,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Peri-urban,Chemotherapy only,Alive,41.0,moderate_burden
KE-NRB-2012-04984,2012,42,35-44,Female,Other,Lymphoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Dead,5.5,moderate_burden
KE-NRB-2015-04985,2015,35,35-44,Male,Kidney,Squamous cell carcinoma,Well differentiated (Grade I),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,46.7,moderate_burden
KE-NRB-2016-04986,2016,52,45-54,Female,Thyroid,Sarcoma,Unknown,Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Alive,20.6,moderate_burden
KE-NRB-2012-04987,2012,56,55-64,Male,Other,Adenocarcinoma,Well differentiated (Grade I),Imaging + clinical,Malignant,Urban,Surgery + Chemotherapy,Alive,41.4,moderate_burden
KE-NRB-2017-04988,2017,49,45-54,Male,Kaposi sarcoma,Sarcoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,No treatment,Dead,8.0,moderate_burden
KE-NRB-2016-04989,2016,43,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,12.0,moderate_burden
KE-NRB-2016-04990,2016,59,55-64,Male,Prostate,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Chemotherapy only,Dead,3.5,moderate_burden
KE-NRB-2017-04991,2017,71,65-74,Female,Breast,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,12.9,moderate_burden
KE-NRB-2016-04992,2016,47,45-54,Female,Other,Squamous cell carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Surgery only,Dead,9.6,moderate_burden
KE-NRB-2010-04993,2010,74,65-74,Female,Breast,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,24.9,moderate_burden
KE-NRB-2011-04994,2011,49,45-54,Female,Breast,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Dead,10.4,moderate_burden
KE-NRB-2011-04995,2011,39,35-44,Female,Other,Adenocarcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Alive,12.5,moderate_burden
KE-NRB-2013-04996,2013,65,65-74,Female,Ovary,Squamous cell carcinoma,Undifferentiated (Grade IV),Microscopy (histology/cytology),Malignant,Urban,Surgery + Radiotherapy,Alive,60.0,moderate_burden
KE-NRB-2017-04997,2017,36,35-44,Female,Cervix uteri,Non-keratinizing carcinoma,Moderately differentiated (Grade II),Imaging + clinical,Malignant,Rural,Surgery only,Dead,14.6,moderate_burden
KE-NRB-2010-04998,2010,90,75+,Female,Breast,Leukemia,Moderately differentiated (Grade II),Microscopy (histology/cytology),Malignant,Urban,Surgery + Chemotherapy,Alive,14.2,moderate_burden
KE-NRB-2011-04999,2011,51,45-54,Female,Cervix uteri,Non-keratinizing carcinoma,Poorly differentiated (Grade III),Microscopy (histology/cytology),Malignant,Urban,Radiotherapy only,Lost to follow-up,60.0,moderate_burden
KE-NRB-2018-05000,2018,35,35-44,Female,Other,Squamous cell carcinoma,Moderately differentiated (Grade II),Microscopy (histology/cytology),In situ,Urban,N/A,Alive,60.0,moderate_burden